ONTOLOGY,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
BP,GO:0001666,response to hypoxia,15/92,317/18986,0.047318612,9.765121383,10.98156653,3.23E-11,9.52E-08,6.08E-08,PTGS2/PGF/P4HB/NR4A2/KCNA5/CXCL12/CA9/PTPN1/PRKCE/CCNA2/PPARG/PDK1/SLC2A1/PLAU/HSP90B1,15
BP,GO:0036293,response to decreased oxygen levels,15/92,331/18986,0.045317221,9.3520951,10.69668138,5.94E-11,9.52E-08,6.08E-08,PTGS2/PGF/P4HB/NR4A2/KCNA5/CXCL12/CA9/PTPN1/PRKCE/CCNA2/PPARG/PDK1/SLC2A1/PLAU/HSP90B1,15
BP,GO:0042327,positive regulation of phosphorylation,17/92,479/18986,0.035490605,7.324180811,9.782306843,1.27E-10,1.35E-07,8.65E-08,PTGS2/PLK1/NOX4/MMP9/KIT/KDR/EEF1A2/CALM1/AR/MIF/PTPN1/PLA2G1B/PDE5A/IL6/FGF2/SNCA/PDGFRB,17
BP,GO:0070482,response to oxygen levels,15/92,358/18986,0.041899441,8.646769492,10.19233422,1.78E-10,1.43E-07,9.11E-08,PTGS2/PGF/P4HB/NR4A2/KCNA5/CXCL12/CA9/PTPN1/PRKCE/CCNA2/PPARG/PDK1/SLC2A1/PLAU/HSP90B1,15
BP,GO:0043434,response to peptide hormone,16/92,446/18986,0.035874439,7.403392474,9.549045102,4.04E-10,2.59E-07,1.66E-07,PTGS2/PIK3R1/PDK4/PARP1/NR4A2/CYP1B1/CXCL12/CA2/PTPN1/PLA2G1B/PRKCZ/PRKCB/CCNA2/STAT1/PPARG/SLC2A1,16
BP,GO:0043410,positive regulation of MAPK cascade,16/92,472/18986,0.033898305,6.995578482,9.204267264,9.20E-10,4.91E-07,3.14E-07,XDH/NOX4/KIT/KDR/AR/MIF/PTPN1/PLA2G1B/PRKCZ/PRKCE/PDE5A/IL6/FGF2/PDGFRB/IGFBP6/IGFBP3,16
BP,GO:0009410,response to xenobiotic stimulus,15/92,451/18986,0.033259424,6.863732768,8.794343085,4.22E-09,1.56E-06,9.99E-07,PTGS2/NQO1/MAOB/CYP1B1/CDK1/CA9/ALDH2/ABCB1/BCHE/SLC28A3/PRKCB/TYMS/STAT1/SNCA/IGFBP2,15
BP,GO:0001934,positive regulation of protein phosphorylation,15/92,455/18986,0.032967033,6.80339226,8.743301514,4.76E-09,1.56E-06,9.99E-07,PTGS2/PLK1/NOX4/MMP9/KIT/KDR/CALM1/MIF/PTPN1/PLA2G1B/PDE5A/IL6/FGF2/SNCA/PDGFRB,15
BP,GO:0062197,cellular response to chemical stress,13/92,321/18986,0.040498442,8.357645943,9.277151809,4.88E-09,1.56E-06,9.99E-07,PTGS2/PARP1/NR4A2/NQO1/DAPK1/CYP1B1/CDK1/ALOX5/AXL/IL6/SNCA/SLC2A1/MYLK,13
BP,GO:0071375,cellular response to peptide hormone stimulus,13/92,321/18986,0.040498442,8.357645943,9.277151809,4.88E-09,1.56E-06,9.99E-07,PIK3R1/PDK4/PARP1/NR4A2/CYP1B1/CA2/PTPN1/PLA2G1B/PRKCZ/PRKCB/CCNA2/STAT1/PPARG,13
BP,GO:0009636,response to toxic substance,12/92,270/18986,0.044444444,9.171980676,9.437130349,7.09E-09,2.07E-06,1.32E-06,PTGS2/NQO1/MAOB/CYP1B1/CDK1/AKR1B10/ABCG2/ABCB1/PTGES/PRKCE/TYMS/ALOX5AP,12
BP,GO:0007584,response to nutrient,10/92,168/18986,0.05952381,12.28390269,10.25095908,8.69E-09,2.32E-06,1.48E-06,PTGS2/NQO1/CYP1B1/BCHE/PRKCB/ALDH1A2/TYMS/STAT1/PPARG/IGFBP2,10
BP,GO:0048660,regulation of smooth muscle cell proliferation,10/92,174/18986,0.057471264,11.86031984,10.04238839,1.22E-08,3.00E-06,1.92E-06,PTGS2/PIK3R1/MMP9/IL6/FGF2/STAT1/PPARG/PDGFRB/DNMT1/IGFBP3,10
BP,GO:0048659,smooth muscle cell proliferation,10/92,178/18986,0.056179775,11.5937958,9.908948002,1.51E-08,3.46E-06,2.21E-06,PTGS2/PIK3R1/MMP9/IL6/FGF2/STAT1/PPARG/PDGFRB/DNMT1/IGFBP3,10
BP,GO:0000086,G2/M transition of mitotic cell cycle,9/92,141/18986,0.063829787,13.17252544,10.12347082,2.74E-08,5.55E-06,3.55E-06,PLK1/CDK1/CALM1/AURKB/ABCB1/CCNB1/CCNA2/CHEK1/AURKA,9
BP,GO:0071902,positive regulation of protein serine/threonine kinase activity,9/92,142/18986,0.063380282,13.07976118,10.08215179,2.91E-08,5.55E-06,3.55E-06,NOX4/CALM1/MIF/PTPN1/PLA2G1B/PDE5A/FGF2/SNCA/PDGFRB,9
BP,GO:0051223,regulation of protein transport,14/92,446/18986,0.031390135,6.477968415,8.169008486,3.02E-08,5.55E-06,3.55E-06,PTGS2/PIK3R1/KCNA5/CFTR/CDK5/CDK1/ALOX5/PTPN1/PLA2G1B/PRKCZ/PRKCE/PRKCB/IL6/PPARG,14
BP,GO:0048661,positive regulation of smooth muscle cell proliferation,8/92,101/18986,0.079207921,16.34610418,10.79040122,3.12E-08,5.55E-06,3.55E-06,PTGS2/PIK3R1/MMP9/IL6/FGF2/STAT1/PDGFRB/DNMT1,8
BP,GO:0031100,animal organ regeneration,7/92,67/18986,0.104477612,21.56099935,11.76440023,3.42E-08,5.76E-06,3.68E-06,CXCL12/CDK1/AXL/IL6/CCNA2/TYMS/AURKA,7
BP,GO:0033002,muscle cell proliferation,11/92,252/18986,0.043650794,9.008195307,8.930112451,3.77E-08,6.05E-06,3.87E-06,PTGS2/PIK3R1/MMP9/CDK1/IL6/FGF2/STAT1/PPARG/PDGFRB/DNMT1/IGFBP3,11
BP,GO:0071900,regulation of protein serine/threonine kinase activity,11/92,262/18986,0.041984733,8.664371059,8.716961154,5.61E-08,8.57E-06,5.48E-06,PLK1/NOX4/CALM1/MIF/PTPN1/PLA2G1B/PRKCH/PDE5A/FGF2/SNCA/PDGFRB,11
BP,GO:0097193,intrinsic apoptotic signaling pathway,12/92,327/18986,0.036697248,7.573195054,8.366493398,5.89E-08,8.59E-06,5.49E-06,PTGS2/PIK3R1/PARP1/P4HB/MMP9/MCL1/CYP1B1/CXCL12/MIF/PTPN1/FGF2/PDK1,12
BP,GO:0044839,cell cycle G2/M phase transition,9/92,158/18986,0.056962025,11.7552284,9.472908558,7.34E-08,9.55E-06,6.10E-06,PLK1/CDK1/CALM1/AURKB/ABCB1/CCNB1/CCNA2/CHEK1/AURKA,9
BP,GO:0043269,regulation of monoatomic ion transport,14/92,480/18986,0.029166667,6.019112319,7.77192343,7.50E-08,9.55E-06,6.10E-06,PTGS2/MMP9/MAOB/KCNA5/CXCL12/CFTR/CALM1/CA2/ABCB1/PLA2G1B/PRKCE/SNCA/PDGFRB/MYLK,14
BP,GO:0006979,response to oxidative stress,13/92,405/18986,0.032098765,6.624208266,7.983468632,7.59E-08,9.55E-06,6.10E-06,PTGS2/PARP1/NR4A2/NQO1/KCNA5/DAPK1/CYP1B1/CDK1/ALOX5/AXL/IL6/STAT1/SNCA,13
BP,GO:0018105,peptidyl-serine phosphorylation,9/92,159/18986,0.056603774,11.68129614,9.437766234,7.75E-08,9.55E-06,6.10E-06,PTGS2/PLK1/CDK5/CDK1/PRKCZ/PRKCE/IL6/SNCA/AURKA,9
BP,GO:0043406,positive regulation of MAP kinase activity,7/92,77/18986,0.090909091,18.76086957,10.89714088,9.08E-08,1.05E-05,6.72E-06,NOX4/MIF/PTPN1/PLA2G1B/PDE5A/FGF2/PDGFRB,7
BP,GO:0097305,response to alcohol,11/92,275/18986,0.04,8.254782609,8.456283018,9.18E-08,1.05E-05,6.72E-06,RAD51/PARP1/NQO1/MAOB/CYP1B1/CFTR/CDK1/PRKCE/PRKCB/FGF2/TYMS,11
BP,GO:0023061,signal release,14/92,493/18986,0.028397566,5.860393333,7.630068733,1.04E-07,1.13E-05,7.21E-06,PTGS2/MAOB/KCNA5/CXCL12/CFTR/CDK5/ALOX5/MIF/PTGES/PRKCE/PRKCB/IL6/SNCA/PPARG,14
BP,GO:0010038,response to metal ion,12/92,345/18986,0.034782609,7.178071834,8.081000932,1.06E-07,1.13E-05,7.21E-06,PTGS2/PARP1/NQO1/MAOB/KIT/HSD17B1/CDK1/CALM1/TNNC1/SNCA/ALOX5AP/HSP90B1,12
BP,GO:1903829,positive regulation of protein localization,14/92,497/18986,0.028169014,5.813227189,7.587437092,1.15E-07,1.19E-05,7.60E-06,PTGS2/PLK1/PIK3R1/PARP1/CFTR/CDK5/CDK1/PLA2G1B/PRKCZ/PRKCH/PRKCE/PRKCB/SNCA/PPARG,14
BP,GO:0018209,peptidyl-serine modification,9/92,171/18986,0.052631579,10.86155606,9.03917201,1.45E-07,1.45E-05,9.26E-06,PTGS2/PLK1/CDK5/CDK1/PRKCZ/PRKCE/IL6/SNCA/AURKA,9
BP,GO:0051054,positive regulation of DNA metabolic process,11/92,295/18986,0.037288136,7.69513633,8.087074109,1.86E-07,1.81E-05,1.16E-05,RAD51/PARP1/NOX4/CYP1B1/CDK1/AURKB/NEK2/IL6/FGF2/CCNA2/PDGFRB,11
BP,GO:0051347,positive regulation of transferase activity,11/92,304/18986,0.036184211,7.467319794,7.932073014,2.52E-07,2.37E-05,1.52E-05,PLK1/NOX4/EEF1A2/CALM1/MIF/PTPN1/PLA2G1B/PDE5A/FGF2/SNCA/PDGFRB,11
BP,GO:0072593,reactive oxygen species metabolic process,10/92,242/18986,0.041322314,8.527667984,8.223832571,2.72E-07,2.49E-05,1.59E-05,XDH/PDK4/NQO1/NOX4/MAOB/CYP1B1/ALOX5/PRKCE/SNCA/PDGFRB,10
BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,9/92,189/18986,0.047619048,9.827122153,8.510263885,3.38E-07,3.01E-05,1.93E-05,PTGS2/PARP1/P4HB/MMP9/MCL1/CXCL12/MIF/PTPN1/FGF2,9
BP,GO:0034599,cellular response to oxidative stress,10/92,251/18986,0.039840637,8.221895029,8.037082799,3.80E-07,3.29E-05,2.10E-05,PARP1/NR4A2/NQO1/DAPK1/CYP1B1/CDK1/ALOX5/AXL/IL6/SNCA,10
BP,GO:0046456,icosanoid biosynthetic process,6/92,60/18986,0.1,20.63695652,10.63059676,4.45E-07,3.76E-05,2.40E-05,PTGS2/ALOX5/MIF/PLA2G1B/PTGES/ALOX5AP,6
BP,GO:0033674,positive regulation of kinase activity,10/92,258/18986,0.03875969,7.998820357,7.898166011,4.89E-07,4.02E-05,2.57E-05,NOX4/EEF1A2/CALM1/MIF/PTPN1/PLA2G1B/PDE5A/FGF2/SNCA/PDGFRB,10
BP,GO:0042542,response to hydrogen peroxide,7/92,99/18986,0.070707071,14.59178744,9.461280975,5.16E-07,4.13E-05,2.64E-05,NQO1/KCNA5/CYP1B1/CDK1/AXL/IL6/STAT1,7
BP,GO:0050673,epithelial cell proliferation,13/92,482/18986,0.026970954,5.565984124,7.085367245,5.57E-07,4.26E-05,2.72E-05,XDH/MMP12/KIT/KDR/CXCL12/AR/ALOX5/IL6/FGF2/ALDH1A2/STAT1/PPARG/IGFBP3,13
BP,GO:2001233,regulation of apoptotic signaling pathway,12/92,403/18986,0.029776675,6.144999461,7.284792773,5.58E-07,4.26E-05,2.72E-05,PTGS2/PARP1/P4HB/NR4A2/MMP9/MCL1/CXCL12/AR/MIF/PTPN1/FGF2/PPARG,12
BP,GO:0043279,response to alkaloid,7/92,103/18986,0.067961165,14.02511608,9.249153289,6.76E-07,5.04E-05,3.22E-05,RAD51/NQO1/CDK5/BCHE/PRKCE/CCNA2/CHEK1,7
BP,GO:1904375,regulation of protein localization to cell periphery,8/92,153/18986,0.052287582,10.7905655,8.484592689,7.77E-07,5.62E-05,3.59E-05,PLK1/PIK3R1/CDK5/AR/PRKCZ/PRKCH/PRKCE/SNCA,8
BP,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,6/92,66/18986,0.090909091,18.76086957,10.08585884,7.89E-07,5.62E-05,3.59E-05,PARP1/P4HB/MCL1/CYP1B1/FGF2/PDK1,6
BP,GO:0031960,response to corticosteroid,8/92,156/18986,0.051282051,10.58305463,8.386453858,9.01E-07,6.16E-05,3.94E-05,PTGS2/PARP1/MAOB/CYP1B1/BCHE/IL6/TYMS/IGFBP2,8
BP,GO:0032868,response to insulin,10/92,276/18986,0.036231884,7.47715816,7.563789049,9.05E-07,6.16E-05,3.94E-05,PIK3R1/PDK4/PARP1/PTPN1/PLA2G1B/PRKCZ/PRKCB/STAT1/PPARG/SLC2A1,10
BP,GO:0032869,cellular response to insulin stimulus,9/92,213/18986,0.042253521,8.719840784,7.906213975,9.23E-07,6.16E-05,3.94E-05,PIK3R1/PDK4/PARP1/PTPN1/PLA2G1B/PRKCZ/PRKCB/STAT1/PPARG,9
BP,GO:0009612,response to mechanical stimulus,9/92,222/18986,0.040540541,8.366333725,7.70375432,1.30E-06,8.52E-05,5.44E-05,PTGS2/KIT/KCNA5/CXCL12/FGF2/STAT1/CHEK1/SLC2A1/IGFBP2,9
BP,GO:0006730,one-carbon metabolic process,5/92,40/18986,0.125,25.79619565,10.95452479,1.38E-06,8.82E-05,5.63E-05,CA9/CA4/CA2/CA12/TYMS,5
BP,GO:1901654,response to ketone,9/92,224/18986,0.040178571,8.291634317,7.660314185,1.40E-06,8.82E-05,5.63E-05,PARP1/NQO1/MAOB/CYP1B1/CFTR/CA9/AR/PRKCE/TYMS,9
BP,GO:0098754,detoxification,8/92,167/18986,0.047904192,9.885967196,8.048258723,1.51E-06,9.28E-05,5.93E-05,PTGS2/NQO1/AKR1B10/ABCG2/ABCB1/PTGES/PRKCE/ALOX5AP,8
BP,GO:0042417,dopamine metabolic process,5/92,41/18986,0.12195122,25.16702015,10.80948459,1.56E-06,9.45E-05,6.04E-05,NR4A2/MAOB/MAOA/ALDH2/SNCA,5
BP,GO:0022411,cellular component disassembly,12/92,450/18986,0.026666667,5.503188406,6.746144244,1.77E-06,0.000105262,6.73E-05,PLK1/PIK3R1/MMP9/MMP13/MMP12/CDK1/CALM1/AURKB/TOP2A/PRKCB/IL6/AURKA,12
BP,GO:1903532,positive regulation of secretion by cell,10/92,298/18986,0.033557047,6.925153195,7.193886172,1.81E-06,0.000105412,6.74E-05,CXCL12/CFTR/CDK5/MIF/PLA2G1B/PTGES/PRKCE/PRKCB/SNCA/PPARG,10
BP,GO:0007088,regulation of mitotic nuclear division,7/92,121/18986,0.05785124,11.93873518,8.423035822,2.01E-06,0.000114891,7.34E-05,PLK1/AURKB/NEK2/CCNB1/PDGFRB/CHEK1/AURKA,7
BP,GO:0043549,regulation of kinase activity,12/92,460/18986,0.026086957,5.383553875,6.641278512,2.23E-06,0.00012171,7.78E-05,PLK1/NOX4/EEF1A2/CALM1/MIF/PTPN1/PLA2G1B/PRKCH/PDE5A/FGF2/SNCA/PDGFRB,12
BP,GO:0042180,cellular ketone metabolic process,9/92,237/18986,0.037974684,7.836818932,7.390544826,2.23E-06,0.00012171,7.78E-05,PTGS2/PDK4/NQO1/HSD17B1/AKR1B10/PRKCE/SNCA/PPARG/PDK1,9
BP,GO:0043405,regulation of MAP kinase activity,7/92,123/18986,0.056910569,11.7446094,8.342093717,2.24E-06,0.00012171,7.78E-05,NOX4/MIF/PTPN1/PLA2G1B/PDE5A/FGF2/PDGFRB,7
BP,GO:0015711,organic anion transport,12/92,462/18986,0.025974026,5.360248447,6.620672365,2.33E-06,0.000122271,7.81E-05,SLC16A3/PTGS2/CFTR/CA4/ABCG2/ABCB1/MIF/PLA2G1B/PTGES/SNCA/PPARG/SLC2A1,12
BP,GO:0051402,neuron apoptotic process,10/92,307/18986,0.03257329,6.722135675,7.053225785,2.36E-06,0.000122271,7.81E-05,PARP1/NR4A2/NQO1/MCL1/KDR/CDK5/AXL/FGF2/THRB/SNCA,10
BP,GO:0006690,icosanoid metabolic process,7/92,124/18986,0.056451613,11.64989481,8.302321547,2.36E-06,0.000122271,7.81E-05,PTGS2/CYP1B1/ALOX5/MIF/PLA2G1B/PTGES/ALOX5AP,7
BP,GO:0001936,regulation of endothelial cell proliferation,8/92,179/18986,0.044692737,9.223220792,7.713401949,2.53E-06,0.00012679,8.10E-05,XDH/KDR/CXCL12/ALOX5/FGF2/ALDH1A2/STAT1/PPARG,8
BP,GO:0015718,monocarboxylic acid transport,8/92,179/18986,0.044692737,9.223220792,7.713401949,2.53E-06,0.00012679,8.10E-05,SLC16A3/PTGS2/ABCG2/MIF/PLA2G1B/PTGES/PPARG/SLC2A1,8
BP,GO:0045860,positive regulation of protein kinase activity,9/92,243/18986,0.037037037,7.64331723,7.272870161,2.74E-06,0.000135252,8.64E-05,NOX4/CALM1/MIF/PTPN1/PLA2G1B/PDE5A/FGF2/SNCA/PDGFRB,9
BP,GO:2001234,negative regulation of apoptotic signaling pathway,9/92,244/18986,0.036885246,7.61199216,7.253648979,2.84E-06,0.000137759,8.80E-05,PTGS2/NR4A2/MMP9/MCL1/CXCL12/AR/MIF/PTPN1/FGF2,9
BP,GO:0045471,response to ethanol,7/92,129/18986,0.054263566,11.1983485,8.110089785,3.08E-06,0.00014732,9.41E-05,NQO1/MAOB/CDK1/PRKCE/PRKCB/FGF2/TYMS,7
BP,GO:0051047,positive regulation of secretion,10/92,322/18986,0.031055901,6.408992709,6.830920452,3.61E-06,0.0001702,0.000108747,CXCL12/CFTR/CDK5/MIF/PLA2G1B/PTGES/PRKCE/PRKCB/SNCA/PPARG,10
BP,GO:0043523,regulation of neuron apoptotic process,9/92,254/18986,0.035433071,7.312307429,7.067245612,3.94E-06,0.000181579,0.000116017,PARP1/NR4A2/NQO1/MCL1/KDR/CDK5/AXL/FGF2/SNCA,9
BP,GO:0051384,response to glucocorticoid,7/92,134/18986,0.052238806,10.78049968,7.928152322,3.96E-06,0.000181579,0.000116017,PTGS2/MAOB/CYP1B1/BCHE/IL6/TYMS/IGFBP2,7
BP,GO:1904951,positive regulation of establishment of protein localization,10/92,327/18986,0.03058104,6.310995878,6.759941183,4.14E-06,0.000182107,0.000116354,PTGS2/PIK3R1/CFTR/CDK5/CDK1/PLA2G1B/PRKCZ/PRKCE/PRKCB/PPARG,10
BP,GO:0006631,fatty acid metabolic process,11/92,405/18986,0.027160494,5.605099302,6.536860672,4.15E-06,0.000182107,0.000116354,PTGS2/PDK4/CYP1B1/ALOX5/MIF/PLA2G1B/PTGES/SNCA/PPARG/PDK1/ALOX5AP,11
BP,GO:0097237,cellular response to toxic substance,7/92,135/18986,0.051851852,10.70064412,7.892916689,4.17E-06,0.000182107,0.000116354,PTGS2/NQO1/CYP1B1/AKR1B10/ABCG2/PTGES/ALOX5AP,7
BP,GO:0060326,cell chemotaxis,10/92,328/18986,0.030487805,6.291755037,6.745922822,4.25E-06,0.000182107,0.000116354,PGF/KIT/KDR/CXCL12/ALOX5/MIF/PLA2G1B/IL6/FGF2/PDGFRB,10
BP,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,4/92,23/18986,0.173913043,35.89035917,11.68296551,4.26E-06,0.000182107,0.000116354,CDK1/AURKB/NEK2/CCNB1,4
BP,GO:0051222,positive regulation of protein transport,9/92,257/18986,0.035019455,7.226949755,7.01329145,4.33E-06,0.000182711,0.00011674,PTGS2/PIK3R1/CFTR/CDK1/PLA2G1B/PRKCZ/PRKCE/PRKCB/PPARG,9
BP,GO:0048009,insulin-like growth factor receptor signaling pathway,5/92,53/18986,0.094339623,19.46882691,9.395173126,5.72E-06,0.000234994,0.000150145,PIK3R1/AR/IGFBP6/IGFBP3/IGFBP2,5
BP,GO:2000573,positive regulation of DNA biosynthetic process,5/92,53/18986,0.094339623,19.46882691,9.395173126,5.72E-06,0.000234994,0.000150145,NOX4/CYP1B1/FGF2/CCNA2/PDGFRB,5
BP,GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,4/92,25/18986,0.16,33.01913043,11.17856811,6.04E-06,0.000239211,0.00015284,AR/IGFBP6/IGFBP3/IGFBP2,4
BP,GO:0031400,negative regulation of protein modification process,10/92,342/18986,0.029239766,6.034197813,6.555578791,6.14E-06,0.000239211,0.00015284,XDH/PLK1/CDK5/CALM1/PTPN1/PRKCZ/PRKCH/PRKCE/SNCA/IGFBP3,10
BP,GO:0071214,cellular response to abiotic stimulus,10/92,342/18986,0.029239766,6.034197813,6.555578791,6.14E-06,0.000239211,0.00015284,RAD51/PTGS2/PIK3R1/PARP1/MMP9/AURKB/FGF2/CHEK1/SLC2A1/MYLK,10
BP,GO:0104004,cellular response to environmental stimulus,10/92,342/18986,0.029239766,6.034197813,6.555578791,6.14E-06,0.000239211,0.00015284,RAD51/PTGS2/PIK3R1/PARP1/MMP9/AURKB/FGF2/CHEK1/SLC2A1/MYLK,10
BP,GO:0001935,endothelial cell proliferation,8/92,202/18986,0.03960396,8.173052088,7.15192396,6.19E-06,0.000239211,0.00015284,XDH/KDR/CXCL12/ALOX5/FGF2/ALDH1A2/STAT1/PPARG,8
BP,GO:2000278,regulation of DNA biosynthetic process,6/92,94/18986,0.063829787,13.17252544,8.255490997,6.35E-06,0.000242188,0.000154742,NOX4/CYP1B1/FGF2/CCNA2/PDGFRB/CHEK1,6
BP,GO:0045859,regulation of protein kinase activity,11/92,427/18986,0.025761124,5.316311985,6.294869609,6.86E-06,0.000258615,0.000165238,PLK1/NOX4/CALM1/MIF/PTPN1/PLA2G1B/PRKCH/PDE5A/FGF2/SNCA/PDGFRB,11
BP,GO:1904645,response to amyloid-beta,5/92,56/18986,0.089285714,18.42585404,9.1127622,7.52E-06,0.000280473,0.000179204,PARP1/MMP9/MMP13/MMP12/CDK5,5
BP,GO:0006584,catecholamine metabolic process,5/92,57/18986,0.087719298,18.10259344,9.023454297,8.22E-06,0.000299311,0.00019124,NR4A2/MAOB/MAOA/ALDH2/SNCA,5
BP,GO:0009712,catechol-containing compound metabolic process,5/92,57/18986,0.087719298,18.10259344,9.023454297,8.22E-06,0.000299311,0.00019124,NR4A2/MAOB/MAOA/ALDH2/SNCA,5
BP,GO:0051783,regulation of nuclear division,7/92,151/18986,0.046357616,9.566801037,7.374992803,8.72E-06,0.000313956,0.000200597,PLK1/AURKB/NEK2/CCNB1/PDGFRB/CHEK1/AURKA,7
BP,GO:0046942,carboxylic acid transport,10/92,357/18986,0.028011204,5.78066009,6.363037191,8.95E-06,0.000318684,0.000203618,SLC16A3/PTGS2/ABCG2/ABCB1/MIF/PLA2G1B/PTGES/SNCA/PPARG/SLC2A1,10
BP,GO:0015849,organic acid transport,10/92,358/18986,0.027932961,5.764512995,6.350591436,9.17E-06,0.00032296,0.00020635,SLC16A3/PTGS2/ABCG2/ABCB1/MIF/PLA2G1B/PTGES/SNCA/PPARG/SLC2A1,10
BP,GO:0031589,cell-substrate adhesion,10/92,361/18986,0.027700831,5.716608455,6.313534301,9.86E-06,0.000341284,0.000218058,PIK3R1/P4HB/MMP12/KDR/CDK5/AXL/PTPN1/PRKCZ/PRKCE/PLAU,10
BP,GO:0042060,wound healing,11/92,444/18986,0.024774775,5.112759499,6.119046727,9.90E-06,0.000341284,0.000218058,MMP12/KDR/ALOX5/AXL/PRKCE/IL6/FGF2/F10/PPARG/PLAU/MYLK,11
BP,GO:0006816,calcium ion transport,11/92,445/18986,0.024719101,5.101270151,6.108985084,1.01E-05,0.000344847,0.000220334,PTGS2/CXCL12/CDK5/CALM1/PLA2G1B/PRKCE/PRKCB/FGF2/SNCA/PDGFRB/MYLK,11
BP,GO:0071456,cellular response to hypoxia,7/92,156/18986,0.044871795,9.260172798,7.228755416,1.08E-05,0.000363965,0.00023255,PTGS2/P4HB/PTPN1/PRKCE/CCNA2/PPARG/PDK1,7
BP,GO:0048010,vascular endothelial growth factor receptor signaling pathway,5/92,62/18986,0.080645161,16.64270687,8.608719179,1.25E-05,0.000416017,0.000265807,PGF/KDR/AXL/PTPN1/PRKCB,5
BP,GO:0010810,regulation of cell-substrate adhesion,8/92,223/18986,0.035874439,7.403392474,6.711949378,1.27E-05,0.000421323,0.000269197,PIK3R1/P4HB/MMP12/KDR/PTPN1/PRKCZ/PRKCE/PLAU,8
BP,GO:0010389,regulation of G2/M transition of mitotic cell cycle,6/92,107/18986,0.056074766,11.57212515,7.652475541,1.34E-05,0.00043812,0.00027993,PLK1/CDK1/AURKB/CCNB1/CHEK1/AURKA,6
BP,GO:0036294,cellular response to decreased oxygen levels,7/92,163/18986,0.042944785,8.862496666,7.03472483,1.44E-05,0.000464804,0.000296979,PTGS2/P4HB/PTPN1/PRKCE/CCNA2/PPARG/PDK1,7
BP,GO:0048511,rhythmic process,9/92,299/18986,0.030100334,6.211792933,6.338554268,1.46E-05,0.000468741,0.000299495,PARP1/CYP1B1/CDK5/CDK1/CA12/AXL/TOP2A/TYMS/PPARG,9
BP,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,6/92,112/18986,0.053571429,11.05551242,7.447637015,1.74E-05,0.000541464,0.000345959,PTGS2/MMP9/CXCL12/MIF/PTPN1/FGF2,6
BP,GO:0006935,chemotaxis,11/92,472/18986,0.023305085,4.809460206,5.848191292,1.75E-05,0.000541464,0.000345959,PGF/KIT/KDR/CXCL12/ALOX5/MIF/PLA2G1B/IL6/FGF2/PDGFRB/PLAU,11
BP,GO:0010563,negative regulation of phosphorus metabolic process,9/92,306/18986,0.029411765,6.069693095,6.238658386,1.76E-05,0.000541464,0.000345959,XDH/PLK1/PARP1/CALM1/PTPN1/PRKCZ/PRKCH/SNCA/IGFBP3,9
BP,GO:0045936,negative regulation of phosphate metabolic process,9/92,306/18986,0.029411765,6.069693095,6.238658386,1.76E-05,0.000541464,0.000345959,XDH/PLK1/PARP1/CALM1/PTPN1/PRKCZ/PRKCH/SNCA/IGFBP3,9
BP,GO:0042330,taxis,11/92,474/18986,0.023206751,4.789167125,5.829663937,1.82E-05,0.000551696,0.000352497,PGF/KIT/KDR/CXCL12/ALOX5/MIF/PLA2G1B/IL6/FGF2/PDGFRB/PLAU,11
BP,GO:0070301,cellular response to hydrogen peroxide,5/92,67/18986,0.074626866,15.40071382,8.239665696,1.82E-05,0.000551696,0.000352497,NQO1/CYP1B1/CDK1/AXL/IL6,5
BP,GO:0001933,negative regulation of protein phosphorylation,8/92,236/18986,0.033898305,6.995578482,6.467310565,1.92E-05,0.000575052,0.00036742,XDH/PLK1/CALM1/PTPN1/PRKCZ/PRKCH/SNCA/IGFBP3,8
BP,GO:0071897,DNA biosynthetic process,7/92,175/18986,0.04,8.254782609,6.727825905,2.27E-05,0.000674491,0.000430955,NOX4/CYP1B1/FGF2/CCNA2/TYMS/PDGFRB/CHEK1,7
BP,GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,9/92,317/18986,0.028391167,5.85907283,6.08779151,2.32E-05,0.000677869,0.000433113,XDH/PIK3R1/NOX4/KIT/KDR/AXL/PTPN1/FGF2/PDGFRB,9
BP,GO:0042416,dopamine biosynthetic process,3/92,12/18986,0.25,51.5923913,12.23301874,2.35E-05,0.000677869,0.000433113,NR4A2/ALDH2/SNCA,3
BP,GO:0051081,nuclear membrane disassembly,3/92,12/18986,0.25,51.5923913,12.23301874,2.35E-05,0.000677869,0.000433113,PLK1/CDK1/PRKCB,3
BP,GO:0071453,cellular response to oxygen levels,7/92,178/18986,0.039325843,8.115657059,6.655657437,2.53E-05,0.000710461,0.000453937,PTGS2/P4HB/PTPN1/PRKCE/CCNA2/PPARG/PDK1,7
BP,GO:0015908,fatty acid transport,6/92,120/18986,0.05,10.31847826,7.145505589,2.57E-05,0.000710461,0.000453937,PTGS2/MIF/PLA2G1B/PTGES/PPARG/SLC2A1,6
BP,GO:0032355,response to estradiol,6/92,120/18986,0.05,10.31847826,7.145505589,2.57E-05,0.000710461,0.000453937,PTGS2/NQO1/CYP1B1/CCNA2/ALDH1A2/IGFBP2,6
BP,GO:0051928,positive regulation of calcium ion transport,6/92,120/18986,0.05,10.31847826,7.145505589,2.57E-05,0.000710461,0.000453937,CXCL12/CALM1/PLA2G1B/SNCA/PDGFRB/MYLK,6
BP,GO:1902749,regulation of cell cycle G2/M phase transition,6/92,120/18986,0.05,10.31847826,7.145505589,2.57E-05,0.000710461,0.000453937,PLK1/CDK1/AURKB/CCNB1/CHEK1/AURKA,6
BP,GO:0050918,positive chemotaxis,5/92,72/18986,0.069444444,14.33121981,7.908273926,2.59E-05,0.000710461,0.000453937,PGF/KDR/CXCL12/MIF/FGF2,5
BP,GO:0050678,regulation of epithelial cell proliferation,10/92,406/18986,0.024630542,5.082994217,5.803048305,2.71E-05,0.000733637,0.000468746,XDH/MMP12/KDR/CXCL12/AR/ALOX5/FGF2/ALDH1A2/STAT1/PPARG,10
BP,GO:0046777,protein autophosphorylation,7/92,180/18986,0.038888889,8.025483092,6.608478607,2.72E-05,0.000733637,0.000468746,KIT/KDR/DAPK1/CALM1/NEK2/PDGFRB/AURKA,7
BP,GO:2000379,positive regulation of reactive oxygen species metabolic process,5/92,74/18986,0.067567568,13.94388954,7.784830971,2.96E-05,0.000786073,0.000502249,XDH/CYP1B1/PRKCE/SNCA/PDGFRB,5
BP,GO:0071248,cellular response to metal ion,7/92,183/18986,0.038251366,7.893917795,6.539060134,3.03E-05,0.000786073,0.000502249,PTGS2/PARP1/NQO1/HSD17B1/SNCA/ALOX5AP/HSP90B1,7
BP,GO:0042886,amide transport,9/92,328/18986,0.027439024,5.662579533,5.943850663,3.03E-05,0.000786073,0.000502249,KCNA5/CFTR/CA2/ALOX5/ABCG2/ABCB1/PRKCE/PRKCB/IL6,9
BP,GO:0030397,membrane disassembly,3/92,13/18986,0.230769231,47.62374582,11.73405431,3.04E-05,0.000786073,0.000502249,PLK1/CDK1/PRKCB,3
BP,GO:0060081,membrane hyperpolarization,3/92,13/18986,0.230769231,47.62374582,11.73405431,3.04E-05,0.000786073,0.000502249,KCNA5/CFTR/PRKCZ,3
BP,GO:1990748,cellular detoxification,6/92,125/18986,0.048,9.90573913,6.970755938,3.24E-05,0.000831447,0.000531239,PTGS2/NQO1/AKR1B10/ABCG2/PTGES/ALOX5AP,6
BP,GO:0042326,negative regulation of phosphorylation,8/92,256/18986,0.03125,6.449048913,6.125041833,3.43E-05,0.000873513,0.000558117,XDH/PLK1/CALM1/PTPN1/PRKCZ/PRKCH/SNCA/IGFBP3,8
BP,GO:0006805,xenobiotic metabolic process,6/92,127/18986,0.047244094,9.749743239,6.9035917,3.55E-05,0.000894921,0.000571795,NQO1/CYP1B1/ALDH2/ABCB1/BCHE/SLC28A3,6
BP,GO:0033044,regulation of chromosome organization,8/92,258/18986,0.031007752,6.399056286,6.092832888,3.63E-05,0.000901666,0.000576105,PLK1/PARP1/FEN1/CDK1/AURKB/NEK2/CCNB1/TOP2A,8
BP,GO:0051924,regulation of calcium ion transport,8/92,258/18986,0.031007752,6.399056286,6.092832888,3.63E-05,0.000901666,0.000576105,PTGS2/CXCL12/CALM1/PLA2G1B/PRKCE/SNCA/PDGFRB/MYLK,8
BP,GO:0051302,regulation of cell division,7/92,190/18986,0.036842105,7.603089245,6.383053849,3.85E-05,0.000943674,0.000602945,PLK1/PGF/CALM1/AURKB/PRKCE/FGF2/AURKA,7
BP,GO:0007100,mitotic centrosome separation,3/92,14/18986,0.214285714,44.22204969,11.28885974,3.86E-05,0.000943674,0.000602945,NEK2/CHEK1/AURKA,3
BP,GO:0048545,response to steroid hormone,9/92,340/18986,0.026470588,5.462723785,5.794071965,4.01E-05,0.000974441,0.000622603,PTGS2/PARP1/MAOB/CYP1B1/AR/BCHE/IL6/TYMS/IGFBP2,9
BP,GO:0018107,peptidyl-threonine phosphorylation,5/92,79/18986,0.063291139,13.06136489,7.496109961,4.07E-05,0.000980249,0.000626314,PLK1/CDK5/CDK1/CALM1/CHEK1,5
BP,GO:0042593,glucose homeostasis,8/92,265/18986,0.030188679,6.23002461,5.982730043,4.39E-05,0.001049174,0.000670352,PIK3R1/PDK4/NOX4/CFTR/ALOX5/PRKCE/IL6/PPARG,8
BP,GO:0033500,carbohydrate homeostasis,8/92,266/18986,0.030075188,6.206603465,5.96732454,4.50E-05,0.001069478,0.000683325,PIK3R1/PDK4/NOX4/CFTR/ALOX5/PRKCE/IL6/PPARG,8
BP,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,4/92,41/18986,0.097560976,20.13361612,8.558131175,4.56E-05,0.001074448,0.000686501,KIT/CYP1B1/CALM1/IL6,4
BP,GO:0044070,regulation of monoatomic anion transport,3/92,15/18986,0.2,41.27391304,10.88833826,4.80E-05,0.001108097,0.000708001,CFTR/CA2/ABCB1,3
BP,GO:0061684,chaperone-mediated autophagy,3/92,15/18986,0.2,41.27391304,10.88833826,4.80E-05,0.001108097,0.000708001,EEF1A2/EEF1A1/SNCA,3
BP,GO:0062012,regulation of small molecule metabolic process,9/92,348/18986,0.025862069,5.337143928,5.698113054,4.80E-05,0.001108097,0.000708001,PTGS2/PDK4/PARP1/KIT/PRKCE/SNCA/PPARG/PDK1/IGFBP3,9
BP,GO:0140238,presynaptic endocytosis,5/92,82/18986,0.06097561,12.58351007,7.33512487,4.87E-05,0.001114609,0.000712161,CDK5/CALM1/SNCA/DNM1/MYLK,5
BP,GO:0046683,response to organophosphorus,6/92,135/18986,0.044444444,9.171980676,6.649121631,4.99E-05,0.001135598,0.000725572,PTGS2/CYP1B1/CFTR/TYMS/STAT1/HSP90B1,6
BP,GO:0050708,regulation of protein secretion,8/92,272/18986,0.029411765,6.069693095,5.876517956,5.27E-05,0.001189846,0.000760232,KCNA5/CFTR/ALOX5/PLA2G1B/PRKCE/PRKCB/IL6/PPARG,8
BP,GO:0000302,response to reactive oxygen species,7/92,200/18986,0.035,7.222934783,6.173484289,5.33E-05,0.001194552,0.000763239,NQO1/KCNA5/CYP1B1/CDK1/AXL/IL6/STAT1,7
BP,GO:0032496,response to lipopolysaccharide,9/92,354/18986,0.025423729,5.246683861,5.628064732,5.48E-05,0.001220491,0.000779813,PTGS2/NQO1/MMP9/MAOB/MIF/AXL/PRKCE/IL6/SNCA,9
BP,GO:0090068,positive regulation of cell cycle process,8/92,274/18986,0.02919708,6.025388765,5.846851995,5.55E-05,0.001226816,0.000783854,KCNA5/FEN1/CDK1/AURKB/CCNB1/PRKCE/PDGFRB/AURKA,8
BP,GO:0071695,anatomical structure maturation,8/92,276/18986,0.028985507,5.981726528,5.817478534,5.84E-05,0.001276044,0.000815307,NR4A2/KDR/CFTR/AXL/ALDH1A2/TYMS/PPARG/AURKA,8
BP,GO:0042762,regulation of sulfur metabolic process,3/92,16/18986,0.1875,38.69429348,10.52541413,5.89E-05,0.001276044,0.000815307,PDK4/SNCA/PDK1,3
BP,GO:0051299,centrosome separation,3/92,16/18986,0.1875,38.69429348,10.52541413,5.89E-05,0.001276044,0.000815307,NEK2/CHEK1/AURKA,3
BP,GO:0018108,peptidyl-tyrosine phosphorylation,7/92,204/18986,0.034313725,7.08130861,6.093663494,6.04E-05,0.001290541,0.00082457,NOX4/KIT/KDR/PTPN1/PRKCZ/IL6/PDGFRB,7
BP,GO:0031099,regeneration,7/92,204/18986,0.034313725,7.08130861,6.093663494,6.04E-05,0.001290541,0.00082457,CXCL12/CDK1/AXL/IL6/CCNA2/TYMS/AURKA,7
BP,GO:0018212,peptidyl-tyrosine modification,7/92,206/18986,0.033980583,7.012558041,6.054556787,6.42E-05,0.001362327,0.000870436,NOX4/KIT/KDR/PTPN1/PRKCZ/IL6/PDGFRB,7
BP,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,8/92,280/18986,0.028571429,5.896273292,5.759588556,6.46E-05,0.001362327,0.000870436,XDH/NOX4/KIT/KDR/AXL/PTPN1/FGF2/PDGFRB,8
BP,GO:0000280,nuclear division,10/92,451/18986,0.022172949,4.575821845,5.362966793,6.56E-05,0.001374799,0.000878405,RAD51/PLK1/CDK1/AURKB/NEK2/CCNB1/TOP2A/PDGFRB/CHEK1/AURKA,10
BP,GO:0140014,mitotic nuclear division,8/92,282/18986,0.028368794,5.854455751,5.731062081,6.79E-05,0.001413284,0.000902995,PLK1/CDK1/AURKB/NEK2/CCNB1/PDGFRB/CHEK1/AURKA,8
BP,GO:0045787,positive regulation of cell cycle,9/92,365/18986,0.024657534,5.088564622,5.503678513,6.93E-05,0.001434391,0.000916481,KCNA5/FEN1/CDK1/AURKB/CCNB1/PRKCE/PDGFRB/CHEK1/AURKA,9
BP,GO:0018210,peptidyl-threonine modification,5/92,89/18986,0.056179775,11.5937958,6.990165014,7.21E-05,0.001479804,0.000945496,PLK1/CDK5/CDK1/CALM1/CHEK1,5
BP,GO:0048469,cell maturation,7/92,210/18986,0.033333333,6.878985507,5.977887774,7.25E-05,0.001479804,0.000945496,NR4A2/KDR/CFTR/AXL/TYMS/PPARG/AURKA,7
BP,GO:0050921,positive regulation of chemotaxis,6/92,145/18986,0.04137931,8.539430285,6.35927806,7.44E-05,0.001508693,0.000963955,PGF/KDR/CXCL12/IL6/FGF2/PDGFRB,6
BP,GO:1901342,regulation of vasculature development,9/92,369/18986,0.024390244,5.03340403,5.459681655,7.54E-05,0.001519913,0.000971123,KDR/CYP1B1/CXCL12/ALOX5/PRKCB/IL6/FGF2/STAT1/PPARG,9
BP,GO:0032309,icosanoid secretion,4/92,47/18986,0.085106383,17.56336725,7.933344201,7.85E-05,0.001564305,0.000999487,PTGS2/MIF/PLA2G1B/PTGES,4
BP,GO:0010639,negative regulation of organelle organization,9/92,371/18986,0.02425876,5.006269776,5.437920876,7.86E-05,0.001564305,0.000999487,PLK1/PIK3R1/PARP1/AURKB/CCNB1/TOP2A/SNCA/PPARG/CHEK1,9
BP,GO:0043270,positive regulation of monoatomic ion transport,7/92,215/18986,0.03255814,6.7190091,5.884825258,8.40E-05,0.001628502,0.001040505,CXCL12/CFTR/CALM1/PLA2G1B/SNCA/PDGFRB/MYLK,7
BP,GO:0042053,regulation of dopamine metabolic process,3/92,18/18986,0.166666667,34.39492754,9.891069339,8.52E-05,0.001628502,0.001040505,NR4A2/MAOB/ALDH2,3
BP,GO:0042069,regulation of catecholamine metabolic process,3/92,18/18986,0.166666667,34.39492754,9.891069339,8.52E-05,0.001628502,0.001040505,NR4A2/MAOB/ALDH2,3
BP,GO:0002237,response to molecule of bacterial origin,9/92,375/18986,0.024,4.952869565,5.394864263,8.53E-05,0.001628502,0.001040505,PTGS2/NQO1/MMP9/MAOB/MIF/AXL/PRKCE/IL6/SNCA,9
BP,GO:0002673,regulation of acute inflammatory response,4/92,48/18986,0.083333333,17.19746377,7.840393115,8.53E-05,0.001628502,0.001040505,PTGS2/PTGES/IL6/ALOX5AP,4
BP,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,4/92,48/18986,0.083333333,17.19746377,7.840393115,8.53E-05,0.001628502,0.001040505,PARP1/P4HB/MCL1/FGF2,4
BP,GO:1904894,positive regulation of receptor signaling pathway via STAT,4/92,48/18986,0.083333333,17.19746377,7.840393115,8.53E-05,0.001628502,0.001040505,KIT/CYP1B1/CALM1/IL6,4
BP,GO:0050920,regulation of chemotaxis,7/92,216/18986,0.032407407,6.687902576,5.866568517,8.65E-05,0.001640225,0.001047995,PGF/KDR/CXCL12/MIF/IL6/FGF2/PDGFRB,7
BP,GO:0044772,mitotic cell cycle phase transition,10/92,467/18986,0.021413276,4.419048506,5.220260739,8.76E-05,0.001651661,0.001055301,PLK1/KCNA5/CDK1/CALM1/AURKB/ABCB1/CCNB1/CCNA2/CHEK1/AURKA,10
BP,GO:0014910,regulation of smooth muscle cell migration,5/92,93/18986,0.053763441,11.09513791,6.809896751,8.89E-05,0.00165721,0.001058847,CYP1B1/PTPN1/PDGFRB/PLAU/IGFBP3,5
BP,GO:0033273,response to vitamin,5/92,93/18986,0.053763441,11.09513791,6.809896751,8.89E-05,0.00165721,0.001058847,PTGS2/BCHE/PRKCB/ALDH1A2/TYMS,5
BP,GO:0014074,response to purine-containing compound,6/92,150/18986,0.04,8.254782609,6.224621533,8.97E-05,0.00166221,0.001062042,PTGS2/CYP1B1/CFTR/STAT1/CHEK1/HSP90B1,6
BP,GO:1900182,positive regulation of protein localization to nucleus,5/92,94/18986,0.053191489,10.97710453,6.766541344,9.35E-05,0.001723625,0.001101282,PTGS2/PLK1/PIK3R1/PARP1/CDK1,5
BP,GO:0032465,regulation of cytokinesis,5/92,95/18986,0.052631579,10.86155606,6.723834816,9.84E-05,0.001802119,0.001151434,PLK1/CALM1/AURKB/PRKCE/AURKA,5
BP,GO:0010565,regulation of cellular ketone metabolic process,6/92,153/18986,0.039215686,8.092924126,6.146792254,0.000100047,0.001812143,0.001157839,PTGS2/PDK4/PRKCE/SNCA/PPARG/PDK1,6
BP,GO:2000377,regulation of reactive oxygen species metabolic process,6/92,153/18986,0.039215686,8.092924126,6.146792254,0.000100047,0.001812143,0.001157839,XDH/CYP1B1/ALOX5/PRKCE/SNCA/PDGFRB,6
BP,GO:0032310,prostaglandin secretion,3/92,19/18986,0.157894737,32.58466819,9.611497473,0.000100861,0.001816628,0.001160705,PTGS2/MIF/PTGES,3
BP,GO:1904892,regulation of receptor signaling pathway via STAT,5/92,96/18986,0.052083333,10.74841486,6.681760415,0.00010338,0.001851598,0.001183048,KIT/CYP1B1/CALM1/IL6/PPARG,5
BP,GO:0038084,vascular endothelial growth factor signaling pathway,4/92,51/18986,0.078431373,16.18584825,7.577548906,0.000108389,0.001921458,0.001227684,XDH/PGF/KDR/PDGFRB,4
BP,GO:0072330,monocarboxylic acid biosynthetic process,7/92,224/18986,0.03125,6.449048913,5.724563914,0.000108479,0.001921458,0.001227684,PTGS2/PDK4/ALOX5/MIF/PLA2G1B/PTGES/ALDH1A2,7
BP,GO:0006576,biogenic amine metabolic process,5/92,99/18986,0.050505051,10.42270531,6.559171332,0.000119596,0.002106728,0.001346059,NR4A2/MAOB/MAOA/ALDH2/SNCA,5
BP,GO:0034762,regulation of transmembrane transport,10/92,487/18986,0.020533881,4.237568074,5.050641258,0.000123575,0.002164922,0.001383241,PIK3R1/MMP9/DAPK1/CFTR/CALM1/CA2/PLA2G1B/PRKCE/PRKCB/SNCA,10
BP,GO:0014909,smooth muscle cell migration,5/92,100/18986,0.05,10.31847826,6.51946957,0.000125413,0.002177692,0.001391401,CYP1B1/PTPN1/PDGFRB/PLAU/IGFBP3,5
BP,GO:0051656,establishment of organelle localization,10/92,488/18986,0.020491803,4.228884533,5.042400034,0.000125662,0.002177692,0.001391401,PLK1/KIT/CDK5/CDK1/AURKB/NEK2/CCNB1/PRKCZ/SNCA/DNM1,10
BP,GO:0097696,cell surface receptor signaling pathway via STAT,6/92,160/18986,0.0375,7.738858696,5.973165843,0.000127916,0.002204828,0.001408738,KIT/CYP1B1/CALM1/IL6/STAT1/PPARG,6
BP,GO:2001251,negative regulation of chromosome organization,5/92,101/18986,0.04950495,10.21631511,6.480324689,0.000131444,0.002253526,0.001439854,PLK1/PARP1/AURKB/CCNB1/TOP2A,5
BP,GO:0008608,attachment of spindle microtubules to kinetochore,4/92,54/18986,0.074074074,15.28663446,7.336109818,0.000135656,0.002295424,0.001466624,CDK1/AURKB/NEK2/CCNB1,4
BP,GO:0048146,positive regulation of fibroblast proliferation,4/92,54/18986,0.074074074,15.28663446,7.336109818,0.000135656,0.002295424,0.001466624,MIF/CCNB1/PLA2G1B/CCNA2,4
BP,GO:0000723,telomere maintenance,6/92,162/18986,0.037037037,7.64331723,5.925483599,0.000136915,0.002295424,0.001466624,RAD51/PARP1/FEN1/AURKB/NEK2/APEX1,6
BP,GO:0019370,leukotriene biosynthetic process,3/92,21/18986,0.142857143,29.48136646,9.112369138,0.000137468,0.002295424,0.001466624,ALOX5/PLA2G1B/ALOX5AP,3
BP,GO:1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,3/92,21/18986,0.142857143,29.48136646,9.112369138,0.000137468,0.002295424,0.001466624,PARP1/MCL1/FGF2,3
BP,GO:0120254,olefinic compound metabolic process,6/92,163/18986,0.036809816,7.596425714,5.901947146,0.000141599,0.002352151,0.001502868,PTGS2/HSD17B1/CYP1B1/ALOX5/AKR1B10/ALDH1A2,6
BP,GO:0006633,fatty acid biosynthetic process,6/92,165/18986,0.036363636,7.504347826,5.855468394,0.000151347,0.002501131,0.001598057,PTGS2/PDK4/ALOX5/MIF/PLA2G1B/PTGES,6
BP,GO:1902895,positive regulation of miRNA transcription,4/92,56/18986,0.071428571,14.74068323,7.185620772,0.000156389,0.002571195,0.001642823,AR/IL6/FGF2/PPARG,4
BP,GO:0009713,catechol-containing compound biosynthetic process,3/92,22/18986,0.136363636,28.14130435,8.888210695,0.000158615,0.002578173,0.001647281,NR4A2/ALDH2/SNCA,3
BP,GO:0042423,catecholamine biosynthetic process,3/92,22/18986,0.136363636,28.14130435,8.888210695,0.000158615,0.002578173,0.001647281,NR4A2/ALDH2/SNCA,3
BP,GO:0070371,ERK1 and ERK2 cascade,8/92,319/18986,0.02507837,5.175412294,5.248010585,0.000159226,0.002578173,0.001647281,NOX4/KDR/CDK1/MIF/PTPN1/PRKCZ/FGF2/PDGFRB,8
BP,GO:0010959,regulation of metal ion transport,9/92,408/18986,0.022058824,4.552269821,5.061436672,0.000161147,0.002590772,0.001655331,PTGS2/KCNA5/CXCL12/CALM1/PLA2G1B/PRKCE/SNCA/PDGFRB/MYLK,9
BP,GO:1902850,microtubule cytoskeleton organization involved in mitosis,6/92,167/18986,0.035928144,7.414475397,5.80976234,0.00016162,0.002590772,0.001655331,PLK1/CDK1/AURKB/NEK2/CCNB1/AURKA,6
BP,GO:0030595,leukocyte chemotaxis,7/92,240/18986,0.029166667,6.019112319,5.460287221,0.000166229,0.002651389,0.001694061,PGF/KIT/CXCL12/ALOX5/MIF/PLA2G1B/IL6,7
BP,GO:2000107,negative regulation of leukocyte apoptotic process,4/92,57/18986,0.070175439,14.48207475,7.113241964,0.000167572,0.002659581,0.001699296,CXCL12/AURKB/MIF/AXL,4
BP,GO:0033047,regulation of mitotic sister chromatid segregation,4/92,58/18986,0.068965517,14.23238381,7.042664198,0.000179321,0.002816946,0.001799841,PLK1/CDK1/AURKB/CCNB1,4
BP,GO:0097529,myeloid leukocyte migration,7/92,243/18986,0.028806584,5.94480229,5.413395715,0.000179415,0.002816946,0.001799841,PIK3R1/PGF/KIT/CXCL12/MIF/PLA2G1B/IL6,7
BP,GO:0019217,regulation of fatty acid metabolic process,5/92,108/18986,0.046296296,9.554146538,6.220822812,0.000180123,0.002816946,0.001799841,PTGS2/PDK4/SNCA/PPARG/PDK1,5
BP,GO:0036480,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,3/92,23/18986,0.130434783,26.91776938,8.678512143,0.000181769,0.002828886,0.00180747,PARP1/MCL1/FGF2,3
BP,GO:0048144,fibroblast proliferation,5/92,109/18986,0.04587156,9.466493817,6.18568237,0.000188067,0.002912763,0.001861062,CDK1/MIF/CCNB1/PLA2G1B/CCNA2,5
BP,GO:0045839,negative regulation of mitotic nuclear division,4/92,59/18986,0.06779661,13.99115696,6.973811491,0.000191654,0.002954047,0.00188744,PLK1/AURKB/CCNB1/CHEK1,4
BP,GO:0050796,regulation of insulin secretion,6/92,173/18986,0.034682081,7.157325961,5.677059264,0.000195788,0.002985766,0.001907706,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6,6
BP,GO:0055074,calcium ion homeostasis,8/92,329/18986,0.024316109,5.018104929,5.130215115,0.000196499,0.002985766,0.001907706,KDR/CXCL12/CALM1/PRKCE/PRKCB/FGF2/SNCA/HSP90B1,8
BP,GO:0045786,negative regulation of cell cycle,9/92,419/18986,0.021479714,4.432759157,4.958116602,0.000196506,0.002985766,0.001907706,RAD51/PTGS2/PLK1/CDK5/CDK1/AURKB/NEK2/CCNB1/CHEK1,9
BP,GO:1901616,organic hydroxy compound catabolic process,4/92,60/18986,0.066666667,13.75797101,6.906612294,0.000204586,0.003067458,0.001959902,MAOB/MAOA/ALDH2/AKR1B10,4
BP,GO:1903409,reactive oxygen species biosynthetic process,4/92,60/18986,0.066666667,13.75797101,6.906612294,0.000204586,0.003067458,0.001959902,NOX4/MAOB/ALOX5/SNCA,4
BP,GO:0046394,carboxylic acid biosynthetic process,8/92,331/18986,0.024169184,4.987784054,5.107228178,0.000204752,0.003067458,0.001959902,PTGS2/PDK4/ALOX5/MIF/PLA2G1B/PTGES/ALDH1A2/ALOX5AP,8
BP,GO:0036120,cellular response to platelet-derived growth factor stimulus,3/92,24/18986,0.125,25.79619565,8.481757727,0.000207008,0.003086827,0.001972277,PTPN1/CCNA2/PDGFRB,3
BP,GO:0016053,organic acid biosynthetic process,8/92,334/18986,0.023952096,4.942983598,5.073092247,0.000217666,0.003222794,0.002059151,PTGS2/PDK4/ALOX5/MIF/PLA2G1B/PTGES/ALDH1A2/ALOX5AP,8
BP,GO:0042908,xenobiotic transport,4/92,61/18986,0.06557377,13.53243051,6.840999165,0.000218137,0.003222794,0.002059151,ABCG2/ABCB1/SLC28A3/SLC2A1,4
BP,GO:0014812,muscle cell migration,5/92,114/18986,0.043859649,9.05129672,6.016536461,0.000231874,0.003394462,0.002168836,CYP1B1/PTPN1/PDGFRB/PLAU/IGFBP3,5
BP,GO:0033559,unsaturated fatty acid metabolic process,5/92,114/18986,0.043859649,9.05129672,6.016536461,0.000231874,0.003394462,0.002168836,PTGS2/CYP1B1/ALOX5/MIF/PTGES,5
BP,GO:0014059,regulation of dopamine secretion,3/92,25/18986,0.12,24.76434783,8.296645701,0.000234413,0.003412102,0.002180107,CXCL12/PRKCB/SNCA,3
BP,GO:0090257,regulation of muscle system process,7/92,254/18986,0.027559055,5.687350223,5.247947072,0.000235207,0.003412102,0.002180107,PTGS2/PARP1/KIT/CALM1/TNNC1/PDE5A/PPARG,7
BP,GO:0018958,phenol-containing compound metabolic process,5/92,117/18986,0.042735043,8.819212189,5.919959644,0.000261645,0.003745919,0.002393394,NR4A2/MAOB/MAOA/ALDH2/SNCA,5
BP,GO:1903076,regulation of protein localization to plasma membrane,5/92,117/18986,0.042735043,8.819212189,5.919959644,0.000261645,0.003745919,0.002393394,PIK3R1/CDK5/AR/PRKCH/PRKCE,5
BP,GO:0071715,icosanoid transport,4/92,64/18986,0.0625,12.89809783,6.653057274,0.000262664,0.003745919,0.002393394,PTGS2/MIF/PLA2G1B/PTGES,4
BP,GO:0036119,response to platelet-derived growth factor,3/92,26/18986,0.115384615,23.81187291,8.122050954,0.00026406,0.003745919,0.002393394,PTPN1/CCNA2/PDGFRB,3
BP,GO:0050927,positive regulation of positive chemotaxis,3/92,26/18986,0.115384615,23.81187291,8.122050954,0.00026406,0.003745919,0.002393394,PGF/KDR/CXCL12,3
BP,GO:0019216,regulation of lipid metabolic process,8/92,344/18986,0.023255814,4.799292214,4.962184708,0.000265639,0.003751717,0.002397098,PTGS2/PDK4/KIT/EEF1A2/PRKCE/SNCA/PPARG/PDK1,8
BP,GO:0051235,maintenance of location,8/92,345/18986,0.023188406,4.785381222,4.951329478,0.000270879,0.003808935,0.002433657,CDK5/CALM1/PRKCE/IL6/FGF2/SNCA/PPARG/HSP90B1,8
BP,GO:0046883,regulation of hormone secretion,7/92,261/18986,0.026819923,5.534815925,5.147617427,0.000277466,0.003884521,0.002481951,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6/PPARG,7
BP,GO:0022617,extracellular matrix disassembly,4/92,65/18986,0.061538462,12.69966555,6.593186208,0.000278857,0.00388703,0.002483554,MMP9/MMP13/MMP12/IL6,4
BP,GO:0003015,heart process,7/92,262/18986,0.026717557,5.513690674,5.133580559,0.000283972,0.003941185,0.002518155,NOX4/KCNA5/CALM1/PTPN1/TNNC1/PDE5A/THRB,7
BP,GO:0015909,long-chain fatty acid transport,4/92,66/18986,0.060606061,12.50724638,6.534616008,0.000295755,0.004073245,0.002602533,MIF/PLA2G1B/PPARG/SLC2A1,4
BP,GO:0050926,regulation of positive chemotaxis,3/92,27/18986,0.111111111,22.92995169,7.956995321,0.000296028,0.004073245,0.002602533,PGF/KDR/CXCL12,3
BP,GO:0021700,developmental maturation,8/92,350/18986,0.022857143,4.717018634,4.89767168,0.000298363,0.004087824,0.002611848,NR4A2/KDR/CFTR/AXL/ALDH1A2/TYMS/PPARG/AURKA,8
BP,GO:0009308,amine metabolic process,5/92,121/18986,0.041322314,8.527667984,5.79644868,0.000305755,0.004153608,0.00265388,NR4A2/MAOB/MAOA/ALDH2/SNCA,5
BP,GO:0034341,response to type II interferon,5/92,121/18986,0.041322314,8.527667984,5.79644868,0.000305755,0.004153608,0.00265388,DAPK1/CALM1/STAT1/SNCA/PPARG,5
BP,GO:0051784,negative regulation of nuclear division,4/92,67/18986,0.059701493,12.32057106,6.477298428,0.000313375,0.004221346,0.00269716,PLK1/AURKB/CCNB1/CHEK1,4
BP,GO:2000630,positive regulation of miRNA metabolic process,4/92,67/18986,0.059701493,12.32057106,6.477298428,0.000313375,0.004221346,0.00269716,AR/IL6/FGF2/PPARG,4
BP,GO:0007565,female pregnancy,6/92,189/18986,0.031746032,6.551414769,5.352141253,0.000315277,0.004225189,0.002699615,PTGS2/PARP1/MMP9/AR/SLC2A1/IGFBP2,6
BP,GO:0060537,muscle tissue development,9/92,447/18986,0.020134228,4.155091917,4.710422733,0.00031667,0.004225189,0.002699615,NOX4/HSD17B1/CDK5/CDK1/TNNC1/FGF2/ALDH1A2/PDGFRB/MYLK,9
BP,GO:0071887,leukocyte apoptotic process,5/92,122/18986,0.040983607,8.457769066,5.766459039,0.000317614,0.004225189,0.002699615,CXCL12/AURKB/MIF/AXL/IL6,5
BP,GO:0002675,positive regulation of acute inflammatory response,3/92,28/18986,0.107142857,22.11102484,7.800623768,0.000330391,0.004377,0.002796612,PTGS2/IL6/ALOX5AP,3
BP,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,6/92,192/18986,0.03125,6.449048913,5.295402405,0.000342963,0.004524854,0.002891081,NOX4/KIT/KDR/AXL/FGF2/PDGFRB,6
BP,GO:0032200,telomere organization,6/92,193/18986,0.031088083,6.415634152,5.276757971,0.000352603,0.004632977,0.002960165,RAD51/PARP1/FEN1/AURKB/NEK2/APEX1,6
BP,GO:0001952,regulation of cell-matrix adhesion,5/92,125/18986,0.04,8.254782609,5.678508904,0.000355289,0.004649212,0.002970538,PIK3R1/MMP12/KDR/PRKCZ/PLAU,5
BP,GO:0045765,regulation of angiogenesis,8/92,360/18986,0.022222222,4.585990338,4.793335472,0.000360193,0.004694226,0.002999299,KDR/CYP1B1/ALOX5/PRKCB/IL6/FGF2/STAT1/PPARG,8
BP,GO:1905475,regulation of protein localization to membrane,6/92,194/18986,0.030927835,6.382563873,5.258244958,0.000362455,0.004704575,0.003005911,PIK3R1/CDK5/AR/PRKCZ/PRKCH/PRKCE,6
BP,GO:0090594,inflammatory response to wounding,3/92,29/18986,0.103448276,21.34857571,7.652185144,0.000367224,0.004726534,0.003019941,ALOX5/IL6/PPARG,3
BP,GO:1903421,regulation of synaptic vesicle recycling,3/92,29/18986,0.103448276,21.34857571,7.652185144,0.000367224,0.004726534,0.003019941,CDK5/SNCA/MYLK,3
BP,GO:0002718,regulation of cytokine production involved in immune response,5/92,126/18986,0.03968254,8.189268461,5.649843116,0.000368569,0.004726534,0.003019941,KIT/MIF/AXL/PRKCZ/IL6,5
BP,GO:1990778,protein localization to cell periphery,8/92,362/18986,0.022099448,4.560653375,4.772926652,0.000373733,0.004773653,0.003050047,PLK1/PIK3R1/CDK5/AR/PRKCZ/PRKCH/PRKCE/SNCA,8
BP,GO:0002367,cytokine production involved in immune response,5/92,127/18986,0.039370079,8.124786032,5.62149224,0.000382222,0.004862711,0.003106949,KIT/MIF/AXL/PRKCZ/IL6,5
BP,GO:0006869,lipid transport,9/92,459/18986,0.019607843,4.046462063,4.61038109,0.000384167,0.004868142,0.00311042,PTGS2/CFTR/ABCG2/ABCB1/MIF/PLA2G1B/PTGES/PPARG/SLC2A1,9
BP,GO:0010720,positive regulation of cell development,9/92,460/18986,0.019565217,4.037665406,4.602197798,0.000390291,0.004921344,0.003144412,KIT/CXCL12/AXL/PRKCZ/PRKCH/PDE5A/IL6/FGF2/AURKA,9
BP,GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,4/92,71/18986,0.056338028,11.62645438,6.25967294,0.000391436,0.004921344,0.003144412,PLK1/CDK1/AURKB/CHEK1,4
BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,6/92,197/18986,0.030456853,6.285367469,5.20347804,0.000393308,0.004925569,0.003147111,NOX4/KDR/MIF/PRKCZ/FGF2/PDGFRB,6
BP,GO:0030324,lung development,6/92,198/18986,0.03030303,6.253623188,5.185474447,0.000404036,0.004956487,0.003166866,MMP12/KDR/FGF2/ALDH1A2/THRB/HSD11B1,6
BP,GO:0071466,cellular response to xenobiotic stimulus,6/92,198/18986,0.03030303,6.253623188,5.185474447,0.000404036,0.004956487,0.003166866,NQO1/CYP1B1/ALDH2/ABCB1/BCHE/SLC28A3,6
BP,GO:0001963,"synaptic transmission, dopaminergic",3/92,30/18986,0.1,20.63695652,7.511016479,0.000406599,0.004956487,0.003166866,PTGS2/CDK5/SNCA,3
BP,GO:0014046,dopamine secretion,3/92,30/18986,0.1,20.63695652,7.511016479,0.000406599,0.004956487,0.003166866,CXCL12/PRKCB/SNCA,3
BP,GO:0015732,prostaglandin transport,3/92,30/18986,0.1,20.63695652,7.511016479,0.000406599,0.004956487,0.003166866,PTGS2/MIF/PTGES,3
BP,GO:0051984,positive regulation of chromosome segregation,3/92,30/18986,0.1,20.63695652,7.511016479,0.000406599,0.004956487,0.003166866,CDK1/AURKB/CCNB1,3
BP,GO:0090140,regulation of mitochondrial fission,3/92,30/18986,0.1,20.63695652,7.511016479,0.000406599,0.004956487,0.003166866,KDR/PPARG/AURKA,3
BP,GO:0003012,muscle system process,9/92,465/18986,0.019354839,3.994249649,4.56162444,0.000422133,0.005126354,0.0032754,PTGS2/PARP1/KIT/KCNA5/CALM1/TNNC1/PDE5A/PPARG/MYLK,9
BP,GO:0008286,insulin receptor signaling pathway,5/92,130/18986,0.038461538,7.93729097,5.538269187,0.00042548,0.005147508,0.003288915,PIK3R1/PDK4/PTPN1/PRKCZ/PRKCB,5
BP,GO:1902750,negative regulation of cell cycle G2/M phase transition,4/92,73/18986,0.054794521,11.30792138,6.157289525,0.000435267,0.005246113,0.003351918,PLK1/CDK1/AURKB/CHEK1,4
BP,GO:0009306,protein secretion,8/92,371/18986,0.021563342,4.450017579,4.682890485,0.000439902,0.005282121,0.003374925,KCNA5/CFTR/ALOX5/PLA2G1B/PRKCE/PRKCB/IL6/PPARG,8
BP,GO:0001516,prostaglandin biosynthetic process,3/92,31/18986,0.096774194,19.97124825,7.376530092,0.000448589,0.005314858,0.003395841,PTGS2/MIF/PTGES,3
BP,GO:0046457,prostanoid biosynthetic process,3/92,31/18986,0.096774194,19.97124825,7.376530092,0.000448589,0.005314858,0.003395841,PTGS2/MIF/PTGES,3
BP,GO:0097421,liver regeneration,3/92,31/18986,0.096774194,19.97124825,7.376530092,0.000448589,0.005314858,0.003395841,IL6/TYMS/AURKA,3
BP,GO:0030323,respiratory tube development,6/92,202/18986,0.02970297,6.129789066,5.114679342,0.00044926,0.005314858,0.003395841,MMP12/KDR/FGF2/ALDH1A2/THRB/HSD11B1,6
BP,GO:0007259,cell surface receptor signaling pathway via JAK-STAT,5/92,132/18986,0.037878788,7.817028986,5.48425467,0.000456306,0.00537837,0.003436421,KIT/CYP1B1/CALM1/IL6/STAT1,5
BP,GO:0071260,cellular response to mechanical stimulus,4/92,74/18986,0.054054054,11.15511163,6.10757897,0.000458447,0.005383809,0.003439896,PTGS2/FGF2/CHEK1/SLC2A1,4
BP,GO:0000075,cell cycle checkpoint signaling,6/92,203/18986,0.02955665,6.099593061,5.097277999,0.00046116,0.005395907,0.003447626,RAD51/PLK1/CDK1/AURKB/CCNB1/CHEK1,6
BP,GO:0035592,establishment of protein localization to extracellular region,8/92,374/18986,0.021390374,4.414322251,4.653514231,0.000463967,0.005409008,0.003455997,KCNA5/CFTR/ALOX5/PLA2G1B/PRKCE/PRKCB/IL6/PPARG,8
BP,GO:0090276,regulation of peptide hormone secretion,6/92,204/18986,0.029411765,6.069693095,5.079992764,0.000473305,0.005497879,0.00351278,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6,6
BP,GO:0071496,cellular response to external stimulus,4/92,75/18986,0.053333333,11.00637681,6.058812272,0.000482493,0.00558438,0.003568048,PTGS2/FGF2/CHEK1/SLC2A1,4
BP,GO:0007052,mitotic spindle organization,5/92,134/18986,0.037313433,7.700356911,5.431363628,0.000488786,0.005616664,0.003588675,PLK1/AURKB/NEK2/CCNB1/AURKA,5
BP,GO:0043271,negative regulation of monoatomic ion transport,5/92,134/18986,0.037313433,7.700356911,5.431363628,0.000488786,0.005616664,0.003588675,PTGS2/MMP9/MAOB/CALM1/PRKCE,5
BP,GO:0010575,positive regulation of vascular endothelial growth factor production,3/92,32/18986,0.09375,19.34714674,7.248202937,0.000493263,0.005647865,0.00360861,PTGS2/CYP1B1/IL6,3
BP,GO:0030073,insulin secretion,6/92,206/18986,0.029126214,6.010764035,5.045765079,0.000498342,0.005685712,0.003632792,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6,6
BP,GO:1902893,regulation of miRNA transcription,4/92,76/18986,0.052631579,10.86155606,6.010958626,0.000507425,0.005768812,0.003685888,AR/IL6/FGF2/PPARG,4
BP,GO:0002791,regulation of peptide secretion,6/92,207/18986,0.028985507,5.981726528,5.028819919,0.000511242,0.005771274,0.003687461,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6,6
BP,GO:0090087,regulation of peptide transport,6/92,207/18986,0.028985507,5.981726528,5.028819919,0.000511242,0.005771274,0.003687461,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6,6
BP,GO:0061448,connective tissue development,7/92,290/18986,0.024137931,4.981334333,4.767498413,0.000522301,0.005816775,0.003716533,PARP1/MMP13/HSD17B1/FGF2/TYMS/PPARG/PDGFRB,7
BP,GO:1901987,regulation of cell cycle phase transition,9/92,479/18986,0.018789144,3.877507488,4.450957687,0.000522884,0.005816775,0.003716533,RAD51/PLK1/KCNA5/CDK5/CDK1/AURKB/CCNB1/CHEK1/AURKA,9
BP,GO:0051208,sequestering of calcium ion,5/92,136/18986,0.036764706,7.587116368,5.379555242,0.000522979,0.005816775,0.003716533,CALM1/PRKCE/FGF2/SNCA/HSP90B1,5
BP,GO:0051091,positive regulation of DNA-binding transcription factor activity,6/92,208/18986,0.028846154,5.952968227,5.011985445,0.000524401,0.005816775,0.003716533,KIT/AR/PLA2G1B/PRKCZ/PRKCH/IL6,6
BP,GO:0015844,monoamine transport,4/92,77/18986,0.051948052,10.72049689,5.963988624,0.000533261,0.005816775,0.003716533,MAOB/CXCL12/PRKCB/SNCA,4
BP,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,4/92,77/18986,0.051948052,10.72049689,5.963988624,0.000533261,0.005816775,0.003716533,KIT/CYP1B1/CALM1/IL6,4
BP,GO:0061614,miRNA transcription,4/92,77/18986,0.051948052,10.72049689,5.963988624,0.000533261,0.005816775,0.003716533,AR/IL6/FGF2/PPARG,4
BP,GO:1900076,regulation of cellular response to insulin stimulus,4/92,77/18986,0.051948052,10.72049689,5.963988624,0.000533261,0.005816775,0.003716533,PTPN1/PRKCZ/PRKCB/PPARG,4
BP,GO:1904377,positive regulation of protein localization to cell periphery,4/92,77/18986,0.051948052,10.72049689,5.963988624,0.000533261,0.005816775,0.003716533,PIK3R1/PRKCH/PRKCE/SNCA,4
BP,GO:0071692,protein localization to extracellular region,8/92,382/18986,0.020942408,4.321875711,4.576665314,0.000533416,0.005816775,0.003716533,KCNA5/CFTR/ALOX5/PLA2G1B/PRKCE/PRKCB/IL6/PPARG,8
BP,GO:0033238,regulation of amine metabolic process,3/92,33/18986,0.090909091,18.76086957,7.125567728,0.000540693,0.005876137,0.003754461,NR4A2/MAOB/ALDH2,3
BP,GO:0015850,organic hydroxy compound transport,7/92,292/18986,0.023972603,4.947215605,4.743166986,0.000544059,0.005892752,0.003765077,SLC16A3/MAOB/CXCL12/CFTR/PRKCB/SNCA/PPARG,7
BP,GO:0044703,multi-organism reproductive process,6/92,210/18986,0.028571429,5.896273292,4.978643376,0.000551508,0.00595332,0.003803776,PTGS2/PARP1/MMP9/AR/SLC2A1/IGFBP2,6
BP,GO:0035924,cellular response to vascular endothelial growth factor stimulus,4/92,78/18986,0.051282051,10.58305463,5.917874178,0.000560019,0.006004752,0.003836638,XDH/PGF/KDR/PDGFRB,4
BP,GO:0048488,synaptic vesicle endocytosis,4/92,78/18986,0.051282051,10.58305463,5.917874178,0.000560019,0.006004752,0.003836638,CDK5/SNCA/DNM1/MYLK,4
BP,GO:0001937,negative regulation of endothelial cell proliferation,4/92,79/18986,0.050632911,10.44909191,5.872588438,0.000587718,0.006273407,0.00400829,XDH/ALOX5/STAT1/PPARG,4
BP,GO:0070372,regulation of ERK1 and ERK2 cascade,7/92,296/18986,0.023648649,4.88036134,4.695162553,0.000589743,0.006273407,0.00400829,NOX4/KDR/MIF/PTPN1/PRKCZ/FGF2/PDGFRB,7
BP,GO:0006691,leukotriene metabolic process,3/92,34/18986,0.088235294,18.20907928,7.008205515,0.000590945,0.006273407,0.00400829,ALOX5/PLA2G1B/ALOX5AP,3
BP,GO:0061041,regulation of wound healing,5/92,140/18986,0.035714286,7.370341615,5.279033351,0.000596729,0.00631391,0.004034169,ALOX5/PRKCE/FGF2/PLAU/MYLK,5
BP,GO:0034764,positive regulation of transmembrane transport,6/92,216/18986,0.027777778,5.732487923,4.881142791,0.000639421,0.006743363,0.004308561,PIK3R1/CFTR/CALM1/CA2/PLA2G1B/SNCA,6
BP,GO:0048384,retinoic acid receptor signaling pathway,3/92,35/18986,0.085714286,17.68881988,6.895739433,0.000644087,0.006748178,0.004311638,ALDH1A2/THRB/PPARG,3
BP,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,3/92,35/18986,0.085714286,17.68881988,6.895739433,0.000644087,0.006748178,0.004311638,PTGS2/KDR/FGF2,3
BP,GO:0007098,centrosome cycle,5/92,143/18986,0.034965035,7.215719064,5.206209385,0.000656969,0.00686073,0.004383551,PLK1/CDK1/NEK2/CHEK1/AURKA,5
BP,GO:0044706,multi-multicellular organism process,6/92,218/18986,0.027522936,5.67989629,4.849452806,0.00067102,0.006984709,0.004462765,PTGS2/PARP1/MMP9/AR/SLC2A1/IGFBP2,6
BP,GO:0010569,regulation of double-strand break repair via homologous recombination,4/92,82/18986,0.048780488,10.06680806,5.74145219,0.000676645,0.007012118,0.004480278,RAD51/PLK1/PARP1/CHEK1,4
BP,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,5/92,144/18986,0.034722222,7.165609903,5.182401409,0.000678028,0.007012118,0.004480278,XDH/PTGS2/MMP9/DAPK1/SNCA,5
BP,GO:0006874,intracellular calcium ion homeostasis,7/92,304/18986,0.023026316,4.751930778,4.601688152,0.000690261,0.007115682,0.004546448,CXCL12/CALM1/PRKCE/PRKCB/FGF2/SNCA/HSP90B1,7
BP,GO:1900180,regulation of protein localization to nucleus,5/92,146/18986,0.034246575,7.067450864,5.135461829,0.000721657,0.007415484,0.004738002,PTGS2/PLK1/PIK3R1/PARP1/CDK1,5
BP,GO:0007095,mitotic G2 DNA damage checkpoint signaling,3/92,37/18986,0.081081081,16.73266745,6.684167676,0.000759304,0.007752641,0.004953423,PLK1/CDK1/CHEK1,3
BP,GO:0070633,transepithelial transport,3/92,37/18986,0.081081081,16.73266745,6.684167676,0.000759304,0.007752641,0.004953423,CFTR/ABCG2/ABCB1,3
BP,GO:0034614,cellular response to reactive oxygen species,5/92,148/18986,0.033783784,6.971944771,5.089399033,0.000767353,0.007800641,0.004984091,NQO1/CYP1B1/CDK1/AXL/IL6,5
BP,GO:0050900,leukocyte migration,8/92,404/18986,0.01980198,4.086526044,4.375741516,0.000768872,0.007800641,0.004984091,PIK3R1/PGF/KIT/CXCL12/ALOX5/MIF/PLA2G1B/IL6,8
BP,GO:0051651,maintenance of location in cell,6/92,224/18986,0.026785714,5.527756211,4.756688779,0.000773132,0.007810438,0.004990351,CDK5/CALM1/PRKCE/FGF2/SNCA/HSP90B1,6
BP,GO:0002720,positive regulation of cytokine production involved in immune response,4/92,85/18986,0.047058824,9.711508951,5.616913268,0.00077471,0.007810438,0.004990351,KIT/MIF/PRKCZ/IL6,4
BP,GO:0060541,respiratory system development,6/92,225/18986,0.026666667,5.503188406,4.741553375,0.000791258,0.007952272,0.005080973,MMP12/KDR/FGF2/ALDH1A2/THRB/HSD11B1,6
BP,GO:0150076,neuroinflammatory response,4/92,86/18986,0.046511628,9.598584429,5.576767546,0.000809516,0.008110336,0.005181966,PTGS2/MMP9/IL6/SNCA,4
BP,GO:0050714,positive regulation of protein secretion,5/92,150/18986,0.033333333,6.878985507,5.044184196,0.000815179,0.008141628,0.00520196,CFTR/PLA2G1B/PRKCE/PRKCB/PPARG,5
BP,GO:0042401,biogenic amine biosynthetic process,3/92,38/18986,0.078947368,16.2923341,6.584474905,0.000821508,0.008179363,0.00522607,NR4A2/ALDH2/SNCA,3
BP,GO:0030534,adult behavior,5/92,151/18986,0.033112583,6.833429312,5.021886117,0.000839909,0.008310953,0.005310147,NR4A2/CXCL12/CDK5/FGF2/SNCA,5
BP,GO:0033157,regulation of intracellular protein transport,5/92,151/18986,0.033112583,6.833429312,5.021886117,0.000839909,0.008310953,0.005310147,PTGS2/PIK3R1/CDK5/CDK1/PTPN1,5
BP,GO:0071222,cellular response to lipopolysaccharide,6/92,228/18986,0.026315789,5.430778032,4.696684749,0.000847615,0.008361396,0.005342377,PTGS2/MMP9/MIF/AXL/PRKCE/IL6,6
BP,GO:0007093,mitotic cell cycle checkpoint signaling,5/92,152/18986,0.032894737,6.78847254,4.999789812,0.000865195,0.008508639,0.005436455,PLK1/CDK1/AURKB/CCNB1/CHEK1,5
BP,GO:0009309,amine biosynthetic process,3/92,39/18986,0.076923077,15.87458194,6.488496927,0.000886859,0.008668509,0.005538601,NR4A2/ALDH2/SNCA,3
BP,GO:0071312,cellular response to alkaloid,3/92,39/18986,0.076923077,15.87458194,6.488496927,0.000886859,0.008668509,0.005538601,RAD51/CCNA2/CHEK1,3
BP,GO:0046879,hormone secretion,7/92,319/18986,0.021943574,4.528485757,4.434898711,0.000915117,0.008917519,0.005697702,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6/PPARG,7
BP,GO:0034504,protein localization to nucleus,7/92,321/18986,0.021806854,4.500270893,4.413442111,0.000949016,0.009219833,0.005890861,PTGS2/PLK1/PIK3R1/PARP1/MMP12/CDK5/CDK1,7
BP,GO:0036465,synaptic vesicle recycling,4/92,90/18986,0.044444444,9.171980676,5.422516779,0.000959829,0.009268709,0.005922089,CDK5/SNCA/DNM1/MYLK,4
BP,GO:0048145,regulation of fibroblast proliferation,4/92,90/18986,0.044444444,9.171980676,5.422516779,0.000959829,0.009268709,0.005922089,MIF/CCNB1/PLA2G1B/CCNA2,4
BP,GO:0031023,microtubule organizing center organization,5/92,156/18986,0.032051282,6.614409142,4.913358531,0.000972054,0.009358569,0.005979504,PLK1/CDK1/NEK2/CHEK1/AURKA,5
BP,GO:0000819,sister chromatid segregation,6/92,235/18986,0.025531915,5.269010176,4.59500685,0.000991172,0.009490951,0.006064087,PLK1/CDK1/AURKB/NEK2/CCNB1/TOP2A,6
BP,GO:0009411,response to UV,5/92,157/18986,0.031847134,6.572279147,4.892223866,0.001000236,0.009490951,0.006064087,PIK3R1/PARP1/MMP9/FEN1/AURKB,5
BP,GO:0034644,cellular response to UV,4/92,91/18986,0.043956044,9.07118968,5.385450775,0.001000273,0.009490951,0.006064087,PIK3R1/PARP1/MMP9/AURKB,4
BP,GO:0098813,nuclear chromosome segregation,7/92,324/18986,0.021604938,4.458601718,4.38158483,0.001001716,0.009490951,0.006064087,PLK1/CDK1/AURKB/NEK2/CCNB1/TOP2A/AURKA,7
BP,GO:0019614,catechol-containing compound catabolic process,2/92,10/18986,0.2,41.27391304,8.889119632,0.001019091,0.009490951,0.006064087,MAOB/MAOA,2
BP,GO:0033148,positive regulation of intracellular estrogen receptor signaling pathway,2/92,10/18986,0.2,41.27391304,8.889119632,0.001019091,0.009490951,0.006064087,PARP1/AR,2
BP,GO:0042420,dopamine catabolic process,2/92,10/18986,0.2,41.27391304,8.889119632,0.001019091,0.009490951,0.006064087,MAOB/MAOA,2
BP,GO:0042424,catecholamine catabolic process,2/92,10/18986,0.2,41.27391304,8.889119632,0.001019091,0.009490951,0.006064087,MAOB/MAOA,2
BP,GO:0072203,cell proliferation involved in metanephros development,2/92,10/18986,0.2,41.27391304,8.889119632,0.001019091,0.009490951,0.006064087,STAT1/PDGFRB,2
BP,GO:1902423,regulation of attachment of mitotic spindle microtubules to kinetochore,2/92,10/18986,0.2,41.27391304,8.889119632,0.001019091,0.009490951,0.006064087,CDK1/AURKB,2
BP,GO:0007143,female meiotic nuclear division,3/92,41/18986,0.073170732,15.10021209,6.306777762,0.001027249,0.009490951,0.006064087,PLK1/TOP2A/AURKA,3
BP,GO:0042307,positive regulation of protein import into nucleus,3/92,41/18986,0.073170732,15.10021209,6.306777762,0.001027249,0.009490951,0.006064087,PTGS2/PIK3R1/CDK1,3
BP,GO:0150077,regulation of neuroinflammatory response,3/92,41/18986,0.073170732,15.10021209,6.306777762,0.001027249,0.009490951,0.006064087,PTGS2/MMP9/IL6,3
BP,GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,3/92,41/18986,0.073170732,15.10021209,6.306777762,0.001027249,0.009490951,0.006064087,CXCL12/ALOX5/IL6,3
BP,GO:0009416,response to light stimulus,7/92,326/18986,0.021472393,4.431248333,4.360561239,0.001038112,0.009543819,0.006097866,PIK3R1/PARP1/MMP9/KIT/FEN1/CDK5/AURKB,7
BP,GO:0030901,midbrain development,4/92,92/18986,0.043478261,8.972589792,5.348951207,0.001041902,0.009543819,0.006097866,NR4A2/MAOB/CALM1/FGF2,4
BP,GO:2000628,regulation of miRNA metabolic process,4/92,92/18986,0.043478261,8.972589792,5.348951207,0.001041902,0.009543819,0.006097866,AR/IL6/FGF2/PPARG,4
BP,GO:0014706,striated muscle tissue development,8/92,424/18986,0.018867925,3.893765381,4.205049571,0.001049736,0.009588186,0.006126214,NOX4/HSD17B1/CDK5/CDK1/TNNC1/FGF2/ALDH1A2/PDGFRB,8
BP,GO:0045824,negative regulation of innate immune response,4/92,93/18986,0.043010753,8.876110332,5.313003013,0.001084733,0.009851709,0.006294587,PARP1/MMP12/AURKB/PPARG,4
BP,GO:2000106,regulation of leukocyte apoptotic process,4/92,93/18986,0.043010753,8.876110332,5.313003013,0.001084733,0.009851709,0.006294587,CXCL12/AURKB/MIF/AXL,4
BP,GO:0010948,negative regulation of cell cycle process,7/92,329/18986,0.021276596,4.390841813,4.329341376,0.001094653,0.009913718,0.006334207,RAD51/PLK1/CDK1/AURKB/NEK2/CCNB1/CHEK1,7
BP,GO:0000266,mitochondrial fission,3/92,42/18986,0.071428571,14.74068323,6.22063027,0.001102407,0.009927859,0.006343242,KDR/PPARG/AURKA,3
BP,GO:0050433,regulation of catecholamine secretion,3/92,42/18986,0.071428571,14.74068323,6.22063027,0.001102407,0.009927859,0.006343242,CXCL12/PRKCB/SNCA,3
BP,GO:0009914,hormone transport,7/92,330/18986,0.021212121,4.377536232,4.31901765,0.001114029,0.010004413,0.006392156,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6/PPARG,7
BP,GO:0007160,cell-matrix adhesion,6/92,241/18986,0.024896266,5.137831499,4.511031494,0.001128521,0.010024615,0.006405063,PIK3R1/MMP12/KDR/CDK5/PRKCZ/PLAU,6
BP,GO:0042445,hormone metabolic process,6/92,241/18986,0.024896266,5.137831499,4.511031494,0.001128521,0.010024615,0.006405063,P4HB/HSD17B1/CYP1B1/AKR1B10/BCHE/ALDH1A2,6
BP,GO:0140115,export across plasma membrane,4/92,94/18986,0.042553191,8.781683626,5.277591691,0.001128785,0.010024615,0.006405063,KCNA5/CALM1/ABCG2/ABCB1,4
BP,GO:1904705,regulation of vascular associated smooth muscle cell proliferation,4/92,94/18986,0.042553191,8.781683626,5.277591691,0.001128785,0.010024615,0.006405063,MMP9/FGF2/PPARG/DNMT1,4
BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,5/92,162/18986,0.030864198,6.369431025,4.789245248,0.001150358,0.010181168,0.00650509,NOX4/KIT/PTPN1/PRKCZ/IL6,5
BP,GO:0071219,cellular response to molecule of bacterial origin,6/92,242/18986,0.024793388,5.116600791,4.497307231,0.001152765,0.010181168,0.00650509,PTGS2/MMP9/MIF/AXL/PRKCE/IL6,6
BP,GO:0009743,response to carbohydrate,6/92,243/18986,0.024691358,5.09554482,4.483658492,0.001177407,0.010370235,0.006625891,PTGS2/NQO1/NOX4/CFTR/PRKCE/PRKCB,6
BP,GO:0043502,regulation of muscle adaptation,4/92,96/18986,0.041666667,8.598731884,5.208324293,0.001220631,0.010672033,0.00681872,PARP1/TNNC1/PDE5A/PPARG,4
BP,GO:1990874,vascular associated smooth muscle cell proliferation,4/92,96/18986,0.041666667,8.598731884,5.208324293,0.001220631,0.010672033,0.00681872,MMP9/FGF2/PPARG/DNMT1,4
BP,GO:0001660,fever generation,2/92,11/18986,0.181818182,37.52173913,8.454621296,0.001241631,0.010672033,0.00681872,PTGS2/PTGES,2
BP,GO:0019372,lipoxygenase pathway,2/92,11/18986,0.181818182,37.52173913,8.454621296,0.001241631,0.010672033,0.00681872,ALOX5/ALOX5AP,2
BP,GO:0033145,positive regulation of intracellular steroid hormone receptor signaling pathway,2/92,11/18986,0.181818182,37.52173913,8.454621296,0.001241631,0.010672033,0.00681872,PARP1/AR,2
BP,GO:0034975,protein folding in endoplasmic reticulum,2/92,11/18986,0.181818182,37.52173913,8.454621296,0.001241631,0.010672033,0.00681872,P4HB/HSP90B1,2
BP,GO:0051593,response to folic acid,2/92,11/18986,0.181818182,37.52173913,8.454621296,0.001241631,0.010672033,0.00681872,BCHE/TYMS,2
BP,GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore,2/92,11/18986,0.181818182,37.52173913,8.454621296,0.001241631,0.010672033,0.00681872,AURKB/CCNB1,2
BP,GO:1904181,positive regulation of membrane depolarization,2/92,11/18986,0.181818182,37.52173913,8.454621296,0.001241631,0.010672033,0.00681872,PARP1/KDR,2
BP,GO:0046627,negative regulation of insulin receptor signaling pathway,3/92,44/18986,0.068181818,14.07065217,6.056865625,0.001262943,0.010826189,0.006917216,PTPN1/PRKCZ/PRKCB,3
BP,GO:0032102,negative regulation of response to external stimulus,8/92,437/18986,0.018306636,3.777932544,4.099580535,0.001272681,0.010880573,0.006951963,PARP1/MMP12/AURKB/ALOX5/MIF/FGF2/PPARG/PLAU,8
BP,GO:0050727,regulation of inflammatory response,8/92,438/18986,0.01826484,3.769307127,4.091635085,0.001291284,0.011010255,0.007034822,PTGS2/MMP9/ALOX5/PTGES/IL6/SNCA/PPARG/ALOX5AP,8
BP,GO:2000116,regulation of cysteine-type endopeptidase activity,5/92,167/18986,0.02994012,6.178729498,4.690514148,0.001316572,0.01117509,0.00714014,XDH/PTGS2/MMP9/DAPK1/SNCA,5
BP,GO:0071346,cellular response to type II interferon,4/92,98/18986,0.040816327,8.42324756,5.141043208,0.001317587,0.01117509,0.00714014,DAPK1/CALM1/STAT1/PPARG,4
BP,GO:0006284,base-excision repair,3/92,45/18986,0.066666667,13.75797101,5.978932837,0.001348433,0.011228773,0.00717444,PARP1/FEN1/APEX1,3
BP,GO:0015872,dopamine transport,3/92,45/18986,0.066666667,13.75797101,5.978932837,0.001348433,0.011228773,0.00717444,CXCL12/PRKCB/SNCA,3
BP,GO:0030574,collagen catabolic process,3/92,45/18986,0.066666667,13.75797101,5.978932837,0.001348433,0.011228773,0.00717444,MMP9/MMP13/MMP12,3
BP,GO:0033574,response to testosterone,3/92,45/18986,0.066666667,13.75797101,5.978932837,0.001348433,0.011228773,0.00717444,NQO1/CA9/AR,3
BP,GO:0048489,synaptic vesicle transport,3/92,45/18986,0.066666667,13.75797101,5.978932837,0.001348433,0.011228773,0.00717444,CDK5/SNCA/DNM1,3
BP,GO:1900077,negative regulation of cellular response to insulin stimulus,3/92,45/18986,0.066666667,13.75797101,5.978932837,0.001348433,0.011228773,0.00717444,PTPN1/PRKCZ/PRKCB,3
BP,GO:1990776,response to angiotensin,3/92,45/18986,0.066666667,13.75797101,5.978932837,0.001348433,0.011228773,0.00717444,PTGS2/CA2/PTPN1,3
BP,GO:0030072,peptide hormone secretion,6/92,250/18986,0.024,4.952869565,4.390169703,0.001361408,0.011274808,0.007203853,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6,6
BP,GO:0009314,response to radiation,8/92,442/18986,0.018099548,3.735195751,4.060084733,0.001367879,0.011274808,0.007203853,RAD51/PIK3R1/PARP1/MMP9/KIT/FEN1/CDK5/AURKB,8
BP,GO:0051781,positive regulation of cell division,4/92,99/18986,0.04040404,8.338164251,5.10811651,0.001368029,0.011274808,0.007203853,PGF/AURKB/PRKCE/FGF2,4
BP,GO:0098869,cellular oxidant detoxification,4/92,99/18986,0.04040404,8.338164251,5.10811651,0.001368029,0.011274808,0.007203853,PTGS2/NQO1/PTGES/ALOX5AP,4
BP,GO:0048738,cardiac muscle tissue development,6/92,252/18986,0.023809524,4.913561077,4.364096923,0.001417811,0.011655137,0.007446858,NOX4/CDK1/TNNC1/FGF2/ALDH1A2/PDGFRB,6
BP,GO:0043524,negative regulation of neuron apoptotic process,5/92,170/18986,0.029411765,6.069693095,4.633186012,0.001424452,0.011679778,0.007462603,NR4A2/KDR/AXL/FGF2/SNCA,5
BP,GO:0021762,substantia nigra development,3/92,46/18986,0.065217391,13.45888469,5.90344272,0.00143748,0.011756534,0.007511644,MAOB/CALM1/FGF2,3
BP,GO:0060047,heart contraction,6/92,253/18986,0.023715415,4.894139887,4.351163485,0.001446674,0.011801623,0.007540453,KCNA5/CALM1/PTPN1/TNNC1/PDE5A/THRB,6
BP,GO:0002551,mast cell chemotaxis,2/92,12/18986,0.166666667,34.39492754,8.074747287,0.001485263,0.011964205,0.007644332,PGF/KIT,2
BP,GO:0019336,phenol-containing compound catabolic process,2/92,12/18986,0.166666667,34.39492754,8.074747287,0.001485263,0.011964205,0.007644332,MAOB/MAOA,2
BP,GO:0070528,protein kinase C signaling,2/92,12/18986,0.166666667,34.39492754,8.074747287,0.001485263,0.011964205,0.007644332,PRKCZ/PRKCH,2
BP,GO:0097048,dendritic cell apoptotic process,2/92,12/18986,0.166666667,34.39492754,8.074747287,0.001485263,0.011964205,0.007644332,CXCL12/AXL,2
BP,GO:2000668,regulation of dendritic cell apoptotic process,2/92,12/18986,0.166666667,34.39492754,8.074747287,0.001485263,0.011964205,0.007644332,CXCL12/AXL,2
BP,GO:0030856,regulation of epithelial cell differentiation,5/92,172/18986,0.029069767,5.999115268,4.595725315,0.001499907,0.012051885,0.007700354,XDH/MMP9/PRKCH/FGF2/STAT1,5
BP,GO:1901617,organic hydroxy compound biosynthetic process,6/92,255/18986,0.023529412,4.855754476,4.325499225,0.001505745,0.012068546,0.007710999,NR4A2/HSD17B1/CFTR/ALDH2/QDPR/SNCA,6
BP,GO:0030261,chromosome condensation,3/92,47/18986,0.063829787,13.17252544,5.830265829,0.001530137,0.012156863,0.007767428,PLK1/CDK1/TOP2A,3
BP,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3/92,47/18986,0.063829787,13.17252544,5.830265829,0.001530137,0.012156863,0.007767428,PTGS2/MMP9/SNCA,3
BP,GO:0071763,nuclear membrane organization,3/92,47/18986,0.063829787,13.17252544,5.830265829,0.001530137,0.012156863,0.007767428,PLK1/CDK1/PRKCB,3
BP,GO:0048732,gland development,8/92,450/18986,0.017777778,3.668792271,3.998068922,0.001531932,0.012156863,0.007767428,XDH/CYP1B1/AR/IL6/FGF2/ALDH1A2/TYMS/AURKA,8
BP,GO:0002790,peptide secretion,6/92,257/18986,0.023346304,4.817966503,4.300100834,0.001566639,0.012401592,0.007923794,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6,6
BP,GO:0006937,regulation of muscle contraction,5/92,174/18986,0.028735632,5.93015992,4.55885107,0.001578268,0.012441492,0.007949287,PTGS2/KIT/CALM1/TNNC1/PDE5A,5
BP,GO:0034308,primary alcohol metabolic process,4/92,103/18986,0.038834951,8.014352047,4.980901275,0.001583321,0.012441492,0.007949287,CYP1B1/ALDH2/AKR1B10/ALDH1A2,4
BP,GO:0051310,metaphase chromosome alignment,4/92,103/18986,0.038834951,8.014352047,4.980901275,0.001583321,0.012441492,0.007949287,CDK1/AURKB/NEK2/CCNB1,4
BP,GO:0099003,vesicle-mediated transport in synapse,6/92,258/18986,0.023255814,4.799292214,4.287499765,0.001597781,0.012524418,0.008002271,CDK5/CALM1/PRKCB/SNCA/DNM1/MYLK,6
BP,GO:0006310,DNA recombination,7/92,352/18986,0.019886364,4.103940217,4.101747227,0.001613065,0.012595219,0.008047508,RAD51/PLK1/PARP1/FEN1/TOP2A/APEX1/CHEK1,7
BP,GO:0050680,negative regulation of epithelial cell proliferation,5/92,175/18986,0.028571429,5.896273292,4.540628723,0.001618559,0.012595219,0.008047508,XDH/AR/ALOX5/STAT1/PPARG,5
BP,GO:0006953,acute-phase response,3/92,48/18986,0.0625,12.89809783,5.75928217,0.001626457,0.012595219,0.008047508,PTGS2/PTGES/IL6,3
BP,GO:0046189,phenol-containing compound biosynthetic process,3/92,48/18986,0.0625,12.89809783,5.75928217,0.001626457,0.012595219,0.008047508,NR4A2/ALDH2/SNCA,3
BP,GO:1901976,regulation of cell cycle checkpoint,3/92,48/18986,0.0625,12.89809783,5.75928217,0.001626457,0.012595219,0.008047508,RAD51/AURKB/CCNB1,3
BP,GO:0050806,positive regulation of synaptic transmission,5/92,176/18986,0.028409091,5.862771739,4.522546898,0.001659603,0.01282093,0.008191723,PTGS2/CA2/PRKCZ/PRKCE/SNCA,5
BP,GO:0001503,ossification,8/92,456/18986,0.01754386,3.620518688,3.952475911,0.001664947,0.012831302,0.008198349,PTGS2/MMP13/ALOX5/IL6/FGF2/PPARG/IGFBP3/IGFBP2,8
BP,GO:1905477,positive regulation of protein localization to membrane,4/92,105/18986,0.038095238,7.861697723,4.919840174,0.001699344,0.013046057,0.008335564,PIK3R1/CDK5/PRKCH/PRKCE,4
BP,GO:0006693,prostaglandin metabolic process,3/92,49/18986,0.06122449,12.63487134,5.69038033,0.001726492,0.013046057,0.008335564,PTGS2/MIF/PTGES,3
BP,GO:0007094,mitotic spindle assembly checkpoint signaling,3/92,49/18986,0.06122449,12.63487134,5.69038033,0.001726492,0.013046057,0.008335564,PLK1/AURKB/CCNB1,3
BP,GO:0050432,catecholamine secretion,3/92,49/18986,0.06122449,12.63487134,5.69038033,0.001726492,0.013046057,0.008335564,CXCL12/PRKCB/SNCA,3
BP,GO:0071173,spindle assembly checkpoint signaling,3/92,49/18986,0.06122449,12.63487134,5.69038033,0.001726492,0.013046057,0.008335564,PLK1/AURKB/CCNB1,3
BP,GO:0071174,mitotic spindle checkpoint signaling,3/92,49/18986,0.06122449,12.63487134,5.69038033,0.001726492,0.013046057,0.008335564,PLK1/AURKB/CCNB1,3
BP,GO:0005996,monosaccharide metabolic process,6/92,262/18986,0.022900763,4.726020577,4.23773541,0.001727093,0.013046057,0.008335564,PFKFB3/PDK4/PDK1/SLC2A1/IGFBP3/PMM2,6
BP,GO:0006086,acetyl-CoA biosynthetic process from pyruvate,2/92,13/18986,0.153846154,31.74916388,7.738811044,0.001749783,0.013046057,0.008335564,PDK4/PDK1,2
BP,GO:0010269,response to selenium ion,2/92,13/18986,0.153846154,31.74916388,7.738811044,0.001749783,0.013046057,0.008335564,PTGS2/MAOB,2
BP,GO:0031650,regulation of heat generation,2/92,13/18986,0.153846154,31.74916388,7.738811044,0.001749783,0.013046057,0.008335564,PTGS2/PTGES,2
BP,GO:0035745,T-helper 2 cell cytokine production,2/92,13/18986,0.153846154,31.74916388,7.738811044,0.001749783,0.013046057,0.008335564,PRKCZ/IL6,2
BP,GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,2/92,13/18986,0.153846154,31.74916388,7.738811044,0.001749783,0.013046057,0.008335564,AR/IGFBP3,2
BP,GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,2/92,13/18986,0.153846154,31.74916388,7.738811044,0.001749783,0.013046057,0.008335564,PIK3R1/PTPN1,2
BP,GO:2000551,regulation of T-helper 2 cell cytokine production,2/92,13/18986,0.153846154,31.74916388,7.738811044,0.001749783,0.013046057,0.008335564,PRKCZ/IL6,2
BP,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,4/92,106/18986,0.037735849,7.787530763,4.889911594,0.001759514,0.013088172,0.008362472,PIK3R1/MCL1/CXCL12/MIF,4
BP,GO:0006936,muscle contraction,7/92,358/18986,0.019553073,4.035159096,4.045545764,0.001775559,0.013176947,0.008419194,PTGS2/KIT/KCNA5/CALM1/TNNC1/PDE5A/MYLK,7
BP,GO:0006692,prostanoid metabolic process,3/92,50/18986,0.06,12.38217391,5.623456703,0.001830295,0.013405635,0.008565311,PTGS2/MIF/PTGES,3
BP,GO:0031577,spindle checkpoint signaling,3/92,50/18986,0.06,12.38217391,5.623456703,0.001830295,0.013405635,0.008565311,PLK1/AURKB/CCNB1,3
BP,GO:0035384,thioester biosynthetic process,3/92,50/18986,0.06,12.38217391,5.623456703,0.001830295,0.013405635,0.008565311,PDK4/SNCA/PDK1,3
BP,GO:0061082,myeloid leukocyte cytokine production,3/92,50/18986,0.06,12.38217391,5.623456703,0.001830295,0.013405635,0.008565311,KIT/MIF/AXL,3
BP,GO:0071616,acyl-CoA biosynthetic process,3/92,50/18986,0.06,12.38217391,5.623456703,0.001830295,0.013405635,0.008565311,PDK4/SNCA/PDK1,3
BP,GO:0141193,nuclear receptor-mediated signaling pathway,5/92,180/18986,0.027777778,5.732487923,4.45158643,0.001831462,0.013405635,0.008565311,PARP1/AR/ALDH1A2/THRB/PPARG,5
BP,GO:1903034,regulation of response to wounding,5/92,181/18986,0.027624309,5.700816719,4.434178748,0.001876392,0.013703215,0.008755445,ALOX5/PRKCE/FGF2/PLAU/MYLK,5
BP,GO:0033045,regulation of sister chromatid segregation,4/92,108/18986,0.037037037,7.64331723,4.831212464,0.001884264,0.013729436,0.008772198,PLK1/CDK1/AURKB/CCNB1,4
BP,GO:1903522,regulation of blood circulation,6/92,267/18986,0.02247191,4.637518319,4.176925764,0.001899753,0.013775945,0.008801914,PTGS2/KCNA5/CALM1/PTPN1/PDE5A/THRB,6
BP,GO:0042391,regulation of membrane potential,8/92,466/18986,0.017167382,3.542825154,3.878164485,0.001906877,0.013775945,0.008801914,PARP1/KDR/KCNA5/CFTR/CDK5/CALM1/PRKCZ/SNCA,8
BP,GO:0006066,alcohol metabolic process,7/92,363/18986,0.019283747,3.979578393,3.999636896,0.001920473,0.013775945,0.008801914,CYP1B1/CFTR/ALDH2/AKR1B10/QDPR/ALDH1A2/SNCA,7
BP,GO:0051090,regulation of DNA-binding transcription factor activity,7/92,363/18986,0.019283747,3.979578393,3.999636896,0.001920473,0.013775945,0.008801914,KIT/CYP1B1/AR/PLA2G1B/PRKCZ/PRKCH/IL6,7
BP,GO:0043534,blood vessel endothelial cell migration,5/92,182/18986,0.027472527,5.66949355,4.416900454,0.001922124,0.013775945,0.008801914,PTGS2/KDR/CYP1B1/FGF2/PPARG,5
BP,GO:0051051,negative regulation of transport,8/92,467/18986,0.017130621,3.535238805,3.870845229,0.001932522,0.013775945,0.008801914,PTGS2/MMP9/MAOB/CDK5/CALM1/PRKCE/PRKCB/SNCA,8
BP,GO:0006636,unsaturated fatty acid biosynthetic process,3/92,51/18986,0.058823529,12.13938619,5.558414797,0.001937914,0.013775945,0.008801914,PTGS2/MIF/PTGES,3
BP,GO:0033046,negative regulation of sister chromatid segregation,3/92,51/18986,0.058823529,12.13938619,5.558414797,0.001937914,0.013775945,0.008801914,PLK1/AURKB/CCNB1,3
BP,GO:0033048,negative regulation of mitotic sister chromatid segregation,3/92,51/18986,0.058823529,12.13938619,5.558414797,0.001937914,0.013775945,0.008801914,PLK1/AURKB/CCNB1,3
BP,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,3/92,51/18986,0.058823529,12.13938619,5.558414797,0.001937914,0.013775945,0.008801914,PLK1/AURKB/CCNB1,3
BP,GO:2000816,negative regulation of mitotic sister chromatid separation,3/92,51/18986,0.058823529,12.13938619,5.558414797,0.001937914,0.013775945,0.008801914,PLK1/AURKB/CCNB1,3
BP,GO:0071216,cellular response to biotic stimulus,6/92,269/18986,0.022304833,4.603038629,4.153021669,0.001972367,0.013989839,0.008938578,PTGS2/MMP9/MIF/AXL/PRKCE/IL6,6
BP,GO:0015833,peptide transport,6/92,270/18986,0.022222222,4.585990338,4.1411574,0.002009453,0.014105123,0.009012237,KCNA5/CFTR/ALOX5/PRKCE/PRKCB/IL6,6
BP,GO:0002526,acute inflammatory response,4/92,110/18986,0.036363636,7.504347826,4.77399956,0.002015018,0.014105123,0.009012237,PTGS2/PTGES/IL6/ALOX5AP,4
BP,GO:0010586,miRNA metabolic process,4/92,110/18986,0.036363636,7.504347826,4.77399956,0.002015018,0.014105123,0.009012237,AR/IL6/FGF2/PPARG,4
BP,GO:0097306,cellular response to alcohol,4/92,110/18986,0.036363636,7.504347826,4.77399956,0.002015018,0.014105123,0.009012237,RAD51/CYP1B1/CFTR/PRKCE,4
BP,GO:1901655,cellular response to ketone,4/92,110/18986,0.036363636,7.504347826,4.77399956,0.002015018,0.014105123,0.009012237,CYP1B1/CFTR/AR/PRKCE,4
BP,GO:1901796,regulation of signal transduction by p53 class mediator,4/92,110/18986,0.036363636,7.504347826,4.77399956,0.002015018,0.014105123,0.009012237,AURKB/MIF/CHEK1/AURKA,4
BP,GO:0006287,"base-excision repair, gap-filling",2/92,14/18986,0.142857143,29.48136646,7.438845529,0.002034987,0.014182974,0.009061979,FEN1/APEX1,2
BP,GO:0032308,positive regulation of prostaglandin secretion,2/92,14/18986,0.142857143,29.48136646,7.438845529,0.002034987,0.014182974,0.009061979,MIF/PTGES,2
BP,GO:0042572,retinol metabolic process,3/92,52/18986,0.057692308,11.90593645,5.49516462,0.002049399,0.01419087,0.009067023,CYP1B1/AKR1B10/ALDH1A2,3
BP,GO:0140353,lipid export from cell,3/92,52/18986,0.057692308,11.90593645,5.49516462,0.002049399,0.01419087,0.009067023,PTGS2/MIF/PTGES,3
BP,GO:1905562,regulation of vascular endothelial cell proliferation,3/92,52/18986,0.057692308,11.90593645,5.49516462,0.002049399,0.01419087,0.009067023,FGF2/ALDH1A2/PPARG,3
BP,GO:0071478,cellular response to radiation,5/92,185/18986,0.027027027,5.577555817,4.365824734,0.002064222,0.014236529,0.009096196,RAD51/PIK3R1/PARP1/MMP9/AURKB,5
BP,GO:0031329,regulation of cellular catabolic process,8/92,472/18986,0.016949153,3.497789241,3.834545709,0.002064874,0.014236529,0.009096196,MCL1/KDR/EEF1A2/EEF1A1/DAPK1/CDK5/PTPN1/SNCA,8
BP,GO:1901990,regulation of mitotic cell cycle phase transition,7/92,368/18986,0.019021739,3.925508034,3.954539796,0.002074418,0.014271642,0.009118631,PLK1/KCNA5/CDK1/AURKB/CCNB1/CHEK1/AURKA,7
BP,GO:0032963,collagen metabolic process,4/92,111/18986,0.036036036,7.436741089,4.745929784,0.002082691,0.014284572,0.009126893,MMP9/MMP13/MMP12/IL6,4
BP,GO:0032386,regulation of intracellular transport,6/92,272/18986,0.022058824,4.552269821,4.117601795,0.002085209,0.014284572,0.009126893,PTGS2/PIK3R1/CDK5/CDK1/PTPN1/TNNC1,6
BP,GO:0042116,macrophage activation,4/92,112/18986,0.035714286,7.370341615,4.71820729,0.00215192,0.014580554,0.009316006,MIF/PRKCE/IL6/SNCA,4
BP,GO:0140888,interferon-mediated signaling pathway,4/92,112/18986,0.035714286,7.370341615,4.71820729,0.00215192,0.014580554,0.009316006,MMP12/PTPN1/STAT1/PPARG,4
BP,GO:0001959,regulation of cytokine-mediated signaling pathway,5/92,187/18986,0.026737968,5.517902813,4.332390278,0.002163126,0.014580554,0.009316006,MMP12/AXL/PTPN1/IL6/PPARG,5
BP,GO:0014075,response to amine,3/92,53/18986,0.056603774,11.68129614,5.433622124,0.002164798,0.014580554,0.009316006,NR4A2/NQO1/CDK1,3
BP,GO:0101023,vascular endothelial cell proliferation,3/92,53/18986,0.056603774,11.68129614,5.433622124,0.002164798,0.014580554,0.009316006,FGF2/ALDH1A2/PPARG,3
BP,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,3/92,53/18986,0.056603774,11.68129614,5.433622124,0.002164798,0.014580554,0.009316006,PLK1/AURKB/CCNB1,3
BP,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,3/92,53/18986,0.056603774,11.68129614,5.433622124,0.002164798,0.014580554,0.009316006,MMP9/FGF2/DNMT1,3
BP,GO:1905819,negative regulation of chromosome separation,3/92,53/18986,0.056603774,11.68129614,5.433622124,0.002164798,0.014580554,0.009316006,PLK1/AURKB/CCNB1,3
BP,GO:0051259,protein complex oligomerization,6/92,275/18986,0.021818182,4.502608696,4.082693036,0.002202873,0.014805892,0.009459981,KCNA5/MIF/ALDH1A2/SNCA/DNM1/ALOX5AP,6
BP,GO:0000724,double-strand break repair via homologous recombination,5/92,188/18986,0.026595745,5.488552266,4.315853035,0.002213855,0.014848573,0.009487252,RAD51/PLK1/PARP1/FEN1/CHEK1,5
BP,GO:0010506,regulation of autophagy,7/92,373/18986,0.018766756,3.872887283,3.910227926,0.002237771,0.014977648,0.009569722,MCL1/KDR/EEF1A2/EEF1A1/DAPK1/CDK5/SNCA,7
BP,GO:0097553,calcium ion transmembrane import into cytosol,5/92,189/18986,0.026455026,5.459512307,4.299433709,0.002265446,0.01503847,0.009608583,CALM1/PLA2G1B/PRKCE/FGF2/SNCA,5
BP,GO:0034976,response to endoplasmic reticulum stress,6/92,277/18986,0.02166065,4.470098886,4.059697804,0.002284059,0.01503847,0.009608583,PIK3R1/P4HB/CFTR/ALOX5/PTPN1/HSP90B1,6
BP,GO:0033138,positive regulation of peptidyl-serine phosphorylation,3/92,54/18986,0.055555556,11.46497585,5.37370871,0.00228416,0.01503847,0.009608583,PTGS2/IL6/SNCA,3
BP,GO:0051985,negative regulation of chromosome segregation,3/92,54/18986,0.055555556,11.46497585,5.37370871,0.00228416,0.01503847,0.009608583,PLK1/AURKB/CCNB1,3
BP,GO:2000117,negative regulation of cysteine-type endopeptidase activity,3/92,54/18986,0.055555556,11.46497585,5.37370871,0.00228416,0.01503847,0.009608583,PTGS2/MMP9/SNCA,3
BP,GO:0010821,regulation of mitochondrion organization,4/92,114/18986,0.035087719,7.241037376,4.663774077,0.002295117,0.01503847,0.009608583,MMP9/KDR/PPARG/AURKA,4
BP,GO:0042752,regulation of circadian rhythm,4/92,114/18986,0.035087719,7.241037376,4.663774077,0.002295117,0.01503847,0.009608583,PARP1/CDK1/TOP2A/PPARG,4
BP,GO:0002903,negative regulation of B cell apoptotic process,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,AURKB/MIF,2
BP,GO:0032306,regulation of prostaglandin secretion,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,MIF/PTGES,2
BP,GO:0033189,response to vitamin A,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,ALDH1A2/TYMS,2
BP,GO:0034501,protein localization to kinetochore,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,CDK1/AURKB,2
BP,GO:0035791,platelet-derived growth factor receptor-beta signaling pathway,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,PTPN1/PDGFRB,2
BP,GO:0050930,induction of positive chemotaxis,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,PGF/CXCL12,2
BP,GO:0070207,protein homotrimerization,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,MIF/ALOX5AP,2
BP,GO:0090235,regulation of metaphase plate congression,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,CDK1/AURKB,2
BP,GO:0097531,mast cell migration,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,PGF/KIT,2
BP,GO:0160049,negative regulation of cGAS/STING signaling pathway,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,PARP1/AURKB,2
BP,GO:1901160,primary amino compound metabolic process,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,MAOB/ALDH2,2
BP,GO:1903083,protein localization to condensed chromosome,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,CDK1/AURKB,2
BP,GO:2001028,positive regulation of endothelial cell chemotaxis,2/92,15/18986,0.133333333,27.51594203,7.168773143,0.002340673,0.01503847,0.009608583,KDR/FGF2,2
BP,GO:0051303,establishment of chromosome localization,4/92,115/18986,0.034782609,7.178071834,4.637048896,0.002369121,0.015174128,0.00969526,CDK1/AURKB/NEK2/CCNB1,4
BP,GO:0048771,tissue remodeling,5/92,191/18986,0.02617801,5.402344639,4.26694275,0.002371253,0.015174128,0.00969526,PDK4/NOX4/AXL/IL6/PPARG,5
BP,GO:0044818,mitotic G2/M transition checkpoint,3/92,55/18986,0.054545455,11.25652174,5.315350783,0.002407529,0.015375576,0.009823971,PLK1/CDK1/CHEK1,3
BP,GO:0000910,cytokinesis,5/92,192/18986,0.026041667,5.374207428,4.250868161,0.002425486,0.015428783,0.009857968,PLK1/CALM1/AURKB/PRKCE/AURKA,5
BP,GO:1904018,positive regulation of vasculature development,5/92,192/18986,0.026041667,5.374207428,4.250868161,0.002425486,0.015428783,0.009857968,KDR/CYP1B1/CXCL12/PRKCB/FGF2,5
BP,GO:2001252,positive regulation of chromosome organization,4/92,116/18986,0.034482759,7.116191904,4.610642052,0.002444754,0.015520556,0.009916604,FEN1/CDK1/AURKB/NEK2,4
BP,GO:0006109,regulation of carbohydrate metabolic process,5/92,193/18986,0.025906736,5.346361793,4.23490557,0.002480615,0.015717101,0.010042184,PDK4/PRKCE/SNCA/PDK1/IGFBP3,5
BP,GO:0007611,learning or memory,6/92,282/18986,0.021276596,4.390841813,4.003152142,0.002496908,0.015789127,0.010088203,PTGS2/KIT/FEN1/CDK5/BCHE/PRKCZ,6
BP,GO:0050878,regulation of body fluid levels,7/92,381/18986,0.018372703,3.791566815,3.840899437,0.002519655,0.015881336,0.010147119,XDH/CFTR/AXL/PRKCE/IL6/F10/PLAU,7
BP,GO:0030857,negative regulation of epithelial cell differentiation,3/92,56/18986,0.053571429,11.05551242,5.258479344,0.002534952,0.015881336,0.010147119,XDH/MMP9/STAT1,3
BP,GO:0000070,mitotic sister chromatid segregation,5/92,194/18986,0.025773196,5.318803227,4.219053565,0.002536651,0.015881336,0.010147119,PLK1/CDK1/AURKB/NEK2/CCNB1,5
BP,GO:0000725,recombinational repair,5/92,194/18986,0.025773196,5.318803227,4.219053565,0.002536651,0.015881336,0.010147119,RAD51/PLK1/PARP1/FEN1/CHEK1,5
BP,GO:0042770,signal transduction in response to DNA damage,5/92,194/18986,0.025773196,5.318803227,4.219053565,0.002536651,0.015881336,0.010147119,RAD51/PLK1/CDK1/MIF/CHEK1,5
BP,GO:0006260,DNA replication,6/92,283/18986,0.021201413,4.375326471,3.99200085,0.002541212,0.015881336,0.010147119,RAD51/PARP1/FEN1/CDK1/CCNA2/CHEK1,6
BP,GO:0030336,negative regulation of cell migration,7/92,383/18986,0.018276762,3.771767511,3.82385973,0.002594228,0.016129057,0.010305396,CYP1B1/CXCL12/MIF/PTPN1/FGF2/PPARG/IGFBP3,7
BP,GO:0046822,regulation of nucleocytoplasmic transport,4/92,118/18986,0.033898305,6.995578482,4.558756767,0.002600974,0.016129057,0.010305396,PTGS2/PIK3R1/CDK5/CDK1,4
BP,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,4/92,118/18986,0.033898305,6.995578482,4.558756767,0.002600974,0.016129057,0.010305396,NOX4/KIT/PTPN1/IL6,4
BP,GO:1904659,D-glucose transmembrane transport,4/92,118/18986,0.033898305,6.995578482,4.558756767,0.002600974,0.016129057,0.010305396,PIK3R1/PLA2G1B/PRKCB/SLC2A1,4
BP,GO:0030522,intracellular receptor signaling pathway,7/92,384/18986,0.018229167,3.761945199,3.81538272,0.002632146,0.016130652,0.010306415,PARP1/NR4A2/AURKB/AR/ALDH1A2/THRB/PPARG,7
BP,GO:0002040,sprouting angiogenesis,5/92,196/18986,0.025510204,5.264529725,4.187675782,0.002651477,0.016130652,0.010306415,PTGS2/PGF/KDR/ALOX5/FGF2,5
BP,GO:0002700,regulation of production of molecular mediator of immune response,5/92,196/18986,0.025510204,5.264529725,4.187675782,0.002651477,0.016130652,0.010306415,KIT/MIF/AXL/PRKCZ/IL6,5
BP,GO:0071470,cellular response to osmotic stress,3/92,57/18986,0.052631579,10.86155606,5.203029631,0.002666473,0.016130652,0.010306415,PTGS2/SLC2A1/MYLK,3
BP,GO:0006266,DNA ligation,2/92,16/18986,0.125,25.79619565,6.923865761,0.002666639,0.016130652,0.010306415,RAD51/TOP2A,2
BP,GO:0032230,"positive regulation of synaptic transmission, GABAergic",2/92,16/18986,0.125,25.79619565,6.923865761,0.002666639,0.016130652,0.010306415,CA2/PRKCE,2
BP,GO:0044849,estrous cycle,2/92,16/18986,0.125,25.79619565,6.923865761,0.002666639,0.016130652,0.010306415,CYP1B1/CA12,2
BP,GO:0048308,organelle inheritance,2/92,16/18986,0.125,25.79619565,6.923865761,0.002666639,0.016130652,0.010306415,PLK1/CDK1,2
BP,GO:0048313,Golgi inheritance,2/92,16/18986,0.125,25.79619565,6.923865761,0.002666639,0.016130652,0.010306415,PLK1/CDK1,2
BP,GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,2/92,16/18986,0.125,25.79619565,6.923865761,0.002666639,0.016130652,0.010306415,KDR/STAT1,2
BP,GO:0071732,cellular response to nitric oxide,2/92,16/18986,0.125,25.79619565,6.923865761,0.002666639,0.016130652,0.010306415,PTPN1/CCNA2,2
BP,GO:1904177,regulation of adipose tissue development,2/92,16/18986,0.125,25.79619565,6.923865761,0.002666639,0.016130652,0.010306415,PARP1/PPARG,2
BP,GO:2000696,regulation of epithelial cell differentiation involved in kidney development,2/92,16/18986,0.125,25.79619565,6.923865761,0.002666639,0.016130652,0.010306415,MMP9/STAT1,2
BP,GO:0022898,regulation of transmembrane transporter activity,5/92,197/18986,0.025380711,5.237806224,4.172147302,0.002710283,0.01636378,0.010455369,MMP9/DAPK1/CFTR/CALM1/SNCA,5
BP,GO:1901988,negative regulation of cell cycle phase transition,6/92,287/18986,0.020905923,4.314346311,3.947906892,0.002724371,0.016417919,0.01048996,RAD51/PLK1/CDK1/AURKB/CCNB1/CHEK1,6
BP,GO:0006998,nuclear envelope organization,3/92,58/18986,0.051724138,10.67428786,5.148940789,0.002802136,0.016791867,0.010728888,PLK1/CDK1/PRKCB,3
BP,GO:0019369,arachidonate metabolic process,3/92,58/18986,0.051724138,10.67428786,5.148940789,0.002802136,0.016791867,0.010728888,PTGS2/CYP1B1/ALOX5,3
BP,GO:0061756,leukocyte adhesion to vascular endothelial cell,3/92,58/18986,0.051724138,10.67428786,5.148940789,0.002802136,0.016791867,0.010728888,CXCL12/ALOX5/IL6,3
BP,GO:0060759,regulation of response to cytokine stimulus,5/92,199/18986,0.025125628,5.185164955,4.14140458,0.002830727,0.016931551,0.010818137,MMP12/AXL/PTPN1/IL6/PPARG,5
BP,GO:0008645,hexose transmembrane transport,4/92,121/18986,0.033057851,6.822134387,4.483155109,0.00284796,0.017002905,0.010863727,PIK3R1/PLA2G1B/PRKCB/SLC2A1,4
BP,GO:0045785,positive regulation of cell adhesion,8/92,499/18986,0.016032064,3.308530104,3.64661449,0.002908247,0.017318184,0.011065169,P4HB/KDR/CXCL12/ALOX5/PRKCZ/PRKCE/IL6/IGFBP2,8
BP,GO:0043500,muscle adaptation,4/92,122/18986,0.032786885,6.766215253,4.458524228,0.002933735,0.017318184,0.011065169,PARP1/TNNC1/PDE5A/PPARG,4
BP,GO:0051092,positive regulation of NF-kappaB transcription factor activity,4/92,122/18986,0.032786885,6.766215253,4.458524228,0.002933735,0.017318184,0.011065169,AR/PLA2G1B/PRKCZ/PRKCH,4
BP,GO:0071482,cellular response to light stimulus,4/92,122/18986,0.032786885,6.766215253,4.458524228,0.002933735,0.017318184,0.011065169,PIK3R1/PARP1/MMP9/AURKB,4
BP,GO:0019748,secondary metabolic process,3/92,59/18986,0.050847458,10.49336772,5.096155569,0.002941984,0.017318184,0.011065169,CYP1B1/AKR1B10/PRKCE,3
BP,GO:0048008,platelet-derived growth factor receptor signaling pathway,3/92,59/18986,0.050847458,10.49336772,5.096155569,0.002941984,0.017318184,0.011065169,PTPN1/SNCA/PDGFRB,3
BP,GO:0060135,maternal process involved in female pregnancy,3/92,59/18986,0.050847458,10.49336772,5.096155569,0.002941984,0.017318184,0.011065169,PTGS2/PARP1/AR,3
BP,GO:0002009,morphogenesis of an epithelium,8/92,500/18986,0.016,3.301913043,3.63990208,0.002943983,0.017318184,0.011065169,MMP12/KDR/CA9/CA2/AR/FGF2/ALDH1A2/STAT1,8
BP,GO:0010042,response to manganese ion,2/92,17/18986,0.117647059,24.27877238,6.700382183,0.003012687,0.017593216,0.011240896,PTGS2/HSP90B1,2
BP,GO:0034310,primary alcohol catabolic process,2/92,17/18986,0.117647059,24.27877238,6.700382183,0.003012687,0.017593216,0.011240896,ALDH2/AKR1B10,2
BP,GO:0090136,epithelial cell-cell adhesion,2/92,17/18986,0.117647059,24.27877238,6.700382183,0.003012687,0.017593216,0.011240896,KIT/CYP1B1,2
BP,GO:2001212,regulation of vasculogenesis,2/92,17/18986,0.117647059,24.27877238,6.700382183,0.003012687,0.017593216,0.011240896,XDH/KDR,2
BP,GO:0050000,chromosome localization,4/92,123/18986,0.032520325,6.711205373,4.434168677,0.003021261,0.017611206,0.011252391,CDK1/AURKB/NEK2/CCNB1,4
BP,GO:0097479,synaptic vesicle localization,3/92,60/18986,0.05,10.31847826,5.044620061,0.003086057,0.01795626,0.011472857,CDK5/SNCA/DNM1,3
BP,GO:0015749,monosaccharide transmembrane transport,4/92,124/18986,0.032258065,6.657082749,4.410082995,0.003110557,0.018066027,0.011542991,PIK3R1/PLA2G1B/PRKCB/SLC2A1,4
BP,GO:0072659,protein localization to plasma membrane,6/92,295/18986,0.020338983,4.197347089,3.862084592,0.003120257,0.018089589,0.011558046,PIK3R1/CDK5/AR/PRKCZ/PRKCH/PRKCE,6
BP,GO:0007051,spindle organization,5/92,204/18986,0.024509804,5.058077579,4.066322034,0.003148759,0.018221877,0.011642569,PLK1/AURKB/NEK2/CCNB1/AURKA,5
BP,GO:2000146,negative regulation of cell motility,7/92,398/18986,0.01758794,3.629615469,3.699599472,0.00320918,0.018538073,0.011844597,CYP1B1/CXCL12/MIF/PTPN1/FGF2/PPARG/IGFBP3,7
BP,GO:1901991,negative regulation of mitotic cell cycle phase transition,5/92,205/18986,0.024390244,5.03340403,4.051599986,0.003215335,0.018540223,0.011845971,PLK1/CDK1/AURKB/CCNB1/CHEK1,5
BP,GO:0042306,regulation of protein import into nucleus,3/92,61/18986,0.049180328,10.14932288,4.994283443,0.003234398,0.018550053,0.011852252,PTGS2/PIK3R1/CDK1,3
BP,GO:0043030,regulation of macrophage activation,3/92,61/18986,0.049180328,10.14932288,4.994283443,0.003234398,0.018550053,0.011852252,MIF/IL6/SNCA,3
BP,GO:0060612,adipose tissue development,3/92,61/18986,0.049180328,10.14932288,4.994283443,0.003234398,0.018550053,0.011852252,PARP1/HSD17B1/PPARG,3
BP,GO:0007623,circadian rhythm,5/92,206/18986,0.024271845,5.00897003,4.036973371,0.003282922,0.018727407,0.011965569,PARP1/CDK1/TOP2A/TYMS/PPARG,5
BP,GO:0002688,regulation of leukocyte chemotaxis,4/92,126/18986,0.031746032,6.551414769,4.362700139,0.003294528,0.018727407,0.011965569,PGF/CXCL12/MIF/IL6,4
BP,GO:0006090,pyruvate metabolic process,4/92,126/18986,0.031746032,6.551414769,4.362700139,0.003294528,0.018727407,0.011965569,SLC16A3/PFKFB3/PDK4/PDK1,4
BP,GO:0010811,positive regulation of cell-substrate adhesion,4/92,126/18986,0.031746032,6.551414769,4.362700139,0.003294528,0.018727407,0.011965569,P4HB/KDR/PRKCZ/PRKCE,4
BP,GO:0034502,protein localization to chromosome,4/92,126/18986,0.031746032,6.551414769,4.362700139,0.003294528,0.018727407,0.011965569,PLK1/PARP1/CDK1/AURKB,4
BP,GO:0002830,positive regulation of type 2 immune response,2/92,18/18986,0.111111111,22.92995169,6.495317965,0.003378619,0.018897209,0.012074061,PRKCZ/IL6,2
BP,GO:0009404,toxin metabolic process,2/92,18/18986,0.111111111,22.92995169,6.495317965,0.003378619,0.018897209,0.012074061,CYP1B1/PRKCE,2
BP,GO:0010517,regulation of phospholipase activity,2/92,18/18986,0.111111111,22.92995169,6.495317965,0.003378619,0.018897209,0.012074061,PLA2G1B/SNCA,2
BP,GO:0031649,heat generation,2/92,18/18986,0.111111111,22.92995169,6.495317965,0.003378619,0.018897209,0.012074061,PTGS2/PTGES,2
BP,GO:0042574,retinal metabolic process,2/92,18/18986,0.111111111,22.92995169,6.495317965,0.003378619,0.018897209,0.012074061,CYP1B1/ALDH1A2,2
BP,GO:0070206,protein trimerization,2/92,18/18986,0.111111111,22.92995169,6.495317965,0.003378619,0.018897209,0.012074061,MIF/ALOX5AP,2
BP,GO:0071371,cellular response to gonadotropin stimulus,2/92,18/18986,0.111111111,22.92995169,6.495317965,0.003378619,0.018897209,0.012074061,CYP1B1/CCNA2,2
BP,GO:1902170,cellular response to reactive nitrogen species,2/92,18/18986,0.111111111,22.92995169,6.495317965,0.003378619,0.018897209,0.012074061,PTPN1/CCNA2,2
BP,GO:0010574,regulation of vascular endothelial growth factor production,3/92,62/18986,0.048387097,9.985624123,4.945097761,0.003387046,0.018897209,0.012074061,PTGS2/CYP1B1/IL6,3
BP,GO:0010965,regulation of mitotic sister chromatid separation,3/92,62/18986,0.048387097,9.985624123,4.945097761,0.003387046,0.018897209,0.012074061,PLK1/AURKB/CCNB1,3
BP,GO:0002832,negative regulation of response to biotic stimulus,4/92,127/18986,0.031496063,6.499828826,4.33939278,0.003389237,0.018897209,0.012074061,PARP1/MMP12/AURKB/PPARG,4
BP,GO:0051260,protein homooligomerization,5/92,208/18986,0.024038462,4.960806856,4.00800195,0.003421162,0.01904209,0.012166631,KCNA5/MIF/ALDH1A2/DNM1/ALOX5AP,5
BP,GO:0007080,mitotic metaphase chromosome alignment,3/92,63/18986,0.047619048,9.827122153,4.89701772,0.00354404,0.019691842,0.012581779,CDK1/AURKB/CCNB1,3
BP,GO:0051209,release of sequestered calcium ion into cytosol,4/92,129/18986,0.031007752,6.399056286,4.293521763,0.003584189,0.019880466,0.012702298,CALM1/PRKCE/FGF2/SNCA,4
BP,GO:0009746,response to hexose,5/92,211/18986,0.023696682,4.890274057,3.96523299,0.003636316,0.020134764,0.012864777,PTGS2/NOX4/CFTR/PRKCE/PRKCB,5
BP,GO:0051283,negative regulation of sequestering of calcium ion,4/92,130/18986,0.030769231,6.349832776,4.270948724,0.003684465,0.0203662,0.013012649,CALM1/PRKCE/FGF2/SNCA,4
BP,GO:0046824,positive regulation of nucleocytoplasmic transport,3/92,64/18986,0.046875,9.67357337,4.8500005,0.003705419,0.020446772,0.013064129,PTGS2/PIK3R1/CDK1,3
BP,GO:0035743,"CD4-positive, alpha-beta T cell cytokine production",2/92,19/18986,0.105263158,21.72311213,6.306228663,0.003764238,0.020454484,0.013069057,PRKCZ/IL6,2
BP,GO:0042402,cellular biogenic amine catabolic process,2/92,19/18986,0.105263158,21.72311213,6.306228663,0.003764238,0.020454484,0.013069057,MAOB/MAOA,2
BP,GO:0060977,coronary vasculature morphogenesis,2/92,19/18986,0.105263158,21.72311213,6.306228663,0.003764238,0.020454484,0.013069057,FGF2/PDGFRB,2
BP,GO:0061098,positive regulation of protein tyrosine kinase activity,2/92,19/18986,0.105263158,21.72311213,6.306228663,0.003764238,0.020454484,0.013069057,NOX4/PTPN1,2
BP,GO:0071318,cellular response to ATP,2/92,19/18986,0.105263158,21.72311213,6.306228663,0.003764238,0.020454484,0.013069057,PTGS2/HSP90B1,2
BP,GO:1904037,positive regulation of epithelial cell apoptotic process,2/92,19/18986,0.105263158,21.72311213,6.306228663,0.003764238,0.020454484,0.013069057,PLA2G1B/IL6,2
BP,GO:1905288,vascular associated smooth muscle cell apoptotic process,2/92,19/18986,0.105263158,21.72311213,6.306228663,0.003764238,0.020454484,0.013069057,PPARG/DNMT1,2
BP,GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,2/92,19/18986,0.105263158,21.72311213,6.306228663,0.003764238,0.020454484,0.013069057,PPARG/DNMT1,2
BP,GO:2000811,negative regulation of anoikis,2/92,19/18986,0.105263158,21.72311213,6.306228663,0.003764238,0.020454484,0.013069057,PDK4/MCL1,2
BP,GO:0008016,regulation of heart contraction,5/92,213/18986,0.023474178,4.844355991,3.937166829,0.00378505,0.020506657,0.013102391,KCNA5/CALM1/PTPN1/PDE5A/THRB,5
BP,GO:0000077,DNA damage checkpoint signaling,4/92,131/18986,0.030534351,6.30136077,4.248611285,0.003786632,0.020506657,0.013102391,RAD51/PLK1/CDK1/CHEK1,4
BP,GO:0010573,vascular endothelial growth factor production,3/92,65/18986,0.046153846,9.524749164,4.804005582,0.003871221,0.020754404,0.013260686,PTGS2/CYP1B1/IL6,3
BP,GO:0021885,forebrain cell migration,3/92,65/18986,0.046153846,9.524749164,4.804005582,0.003871221,0.020754404,0.013260686,CXCL12/CDK5/AXL,3
BP,GO:0048524,positive regulation of viral process,3/92,65/18986,0.046153846,9.524749164,4.804005582,0.003871221,0.020754404,0.013260686,P4HB/AXL/TOP2A,3
BP,GO:0051306,mitotic sister chromatid separation,3/92,65/18986,0.046153846,9.524749164,4.804005582,0.003871221,0.020754404,0.013260686,PLK1/AURKB/CCNB1,3
BP,GO:0051937,catecholamine transport,3/92,65/18986,0.046153846,9.524749164,4.804005582,0.003871221,0.020754404,0.013260686,CXCL12/PRKCB/SNCA,3
BP,GO:1903078,positive regulation of protein localization to plasma membrane,3/92,65/18986,0.046153846,9.524749164,4.804005582,0.003871221,0.020754404,0.013260686,PIK3R1/PRKCH/PRKCE,3
BP,GO:0007127,meiosis I,4/92,132/18986,0.03030303,6.253623188,4.22650506,0.003890704,0.020754738,0.013260899,RAD51/PLK1/TOP2A/AURKA,4
BP,GO:0045834,positive regulation of lipid metabolic process,4/92,132/18986,0.03030303,6.253623188,4.22650506,0.003890704,0.020754738,0.013260899,PTGS2/EEF1A2/PRKCE/PPARG,4
BP,GO:0051282,regulation of sequestering of calcium ion,4/92,132/18986,0.03030303,6.253623188,4.22650506,0.003890704,0.020754738,0.013260899,CALM1/PRKCE/FGF2/SNCA,4
BP,GO:0050679,positive regulation of epithelial cell proliferation,5/92,216/18986,0.023148148,4.777073269,3.895717064,0.004016271,0.021388977,0.013666135,MMP12/KDR/CXCL12/AR/FGF2,5
BP,GO:0010812,negative regulation of cell-substrate adhesion,3/92,66/18986,0.045454545,9.380434783,4.758994593,0.004041481,0.021416509,0.013683727,PIK3R1/MMP12/PTPN1,3
BP,GO:0045453,bone resorption,3/92,66/18986,0.045454545,9.380434783,4.758994593,0.004041481,0.021416509,0.013683727,PDK4/NOX4/IL6,3
BP,GO:0090303,positive regulation of wound healing,3/92,66/18986,0.045454545,9.380434783,4.758994593,0.004041481,0.021416509,0.013683727,PRKCE/PLAU/MYLK,3
BP,GO:0030900,forebrain development,7/92,416/18986,0.016826923,3.472564799,3.558161486,0.004088037,0.021591841,0.013795753,NR4A2/CXCL12/CDK5/AXL/FGF2/ALDH1A2/SLC2A1,7
BP,GO:0040013,negative regulation of locomotion,7/92,416/18986,0.016826923,3.472564799,3.558161486,0.004088037,0.021591841,0.013795753,CYP1B1/CXCL12/MIF/PTPN1/FGF2/PPARG/IGFBP3,7
BP,GO:0051225,spindle assembly,4/92,134/18986,0.029850746,6.160285529,4.182969281,0.004104636,0.021643853,0.013828985,PLK1/AURKB/NEK2/AURKA,4
BP,GO:0002902,regulation of B cell apoptotic process,2/92,20/18986,0.1,20.63695652,6.131102294,0.004169348,0.021698604,0.013863967,AURKB/MIF,2
BP,GO:0006085,acetyl-CoA biosynthetic process,2/92,20/18986,0.1,20.63695652,6.131102294,0.004169348,0.021698604,0.013863967,PDK4/PDK1,2
BP,GO:0032305,positive regulation of icosanoid secretion,2/92,20/18986,0.1,20.63695652,6.131102294,0.004169348,0.021698604,0.013863967,MIF/PTGES,2
BP,GO:0051767,nitric-oxide synthase biosynthetic process,2/92,20/18986,0.1,20.63695652,6.131102294,0.004169348,0.021698604,0.013863967,KDR/STAT1,2
BP,GO:0051769,regulation of nitric-oxide synthase biosynthetic process,2/92,20/18986,0.1,20.63695652,6.131102294,0.004169348,0.021698604,0.013863967,KDR/STAT1,2
BP,GO:0051900,regulation of mitochondrial depolarization,2/92,20/18986,0.1,20.63695652,6.131102294,0.004169348,0.021698604,0.013863967,PARP1/KDR,2
BP,GO:0061298,retina vasculature development in camera-type eye,2/92,20/18986,0.1,20.63695652,6.131102294,0.004169348,0.021698604,0.013863967,CYP1B1/PDGFRB,2
BP,GO:0098761,cellular response to interleukin-7,2/92,20/18986,0.1,20.63695652,6.131102294,0.004169348,0.021698604,0.013863967,P4HB/STAT1,2
BP,GO:0034284,response to monosaccharide,5/92,218/18986,0.02293578,4.733246909,3.868505534,0.004175932,0.021698604,0.013863967,PTGS2/NOX4/CFTR/PRKCE/PRKCB,5
BP,GO:0051983,regulation of chromosome segregation,4/92,135/18986,0.02962963,6.114653784,4.161531513,0.004214528,0.021863717,0.013969463,PLK1/CDK1/AURKB/CCNB1,4
BP,GO:0007162,negative regulation of cell adhesion,6/92,314/18986,0.01910828,3.943367488,3.669873987,0.004231868,0.021918203,0.014004276,PIK3R1/MMP12/CYP1B1/CXCL12/PTPN1/PDE5A,6
BP,GO:0045931,positive regulation of mitotic cell cycle,4/92,136/18986,0.029411765,6.069693095,4.140308526,0.004326393,0.02237164,0.014293992,KCNA5/CDK1/CCNB1/AURKA,4
BP,GO:0048167,regulation of synaptic plasticity,5/92,220/18986,0.022727273,4.690217391,3.841622573,0.004340085,0.022406303,0.014316139,PTGS2/KIT/CDK5/PRKCZ/SNCA,5
BP,GO:0034219,carbohydrate transmembrane transport,4/92,137/18986,0.02919708,6.025388765,4.119296471,0.004440248,0.02288655,0.014622985,PIK3R1/PLA2G1B/PRKCB/SLC2A1,4
BP,GO:0099504,synaptic vesicle cycle,5/92,222/18986,0.022522523,4.647963181,3.815060946,0.0045088,0.023202586,0.014824911,CDK5/PRKCB/SNCA/DNM1/MYLK,5
BP,GO:0035270,endocrine system development,4/92,138/18986,0.028985507,5.981726528,4.098491595,0.004556108,0.023308879,0.014892826,CYP1B1/IL6/FGF2/ALDH1A2,4
BP,GO:0010611,regulation of cardiac muscle hypertrophy,3/92,69/18986,0.043478261,8.972589792,4.629510693,0.004579369,0.023308879,0.014892826,PARP1/PDE5A/PPARG,3
BP,GO:0048857,neural nucleus development,3/92,69/18986,0.043478261,8.972589792,4.629510693,0.004579369,0.023308879,0.014892826,MAOB/CALM1/FGF2,3
BP,GO:0001780,neutrophil homeostasis,2/92,21/18986,0.095238095,19.65424431,5.968265615,0.004593756,0.023308879,0.014892826,AXL/IL6,2
BP,GO:0009310,amine catabolic process,2/92,21/18986,0.095238095,19.65424431,5.968265615,0.004593756,0.023308879,0.014892826,MAOB/MAOA,2
BP,GO:0071731,response to nitric oxide,2/92,21/18986,0.095238095,19.65424431,5.968265615,0.004593756,0.023308879,0.014892826,PTPN1/CCNA2,2
BP,GO:0090141,positive regulation of mitochondrial fission,2/92,21/18986,0.095238095,19.65424431,5.968265615,0.004593756,0.023308879,0.014892826,KDR/AURKA,2
BP,GO:0098760,response to interleukin-7,2/92,21/18986,0.095238095,19.65424431,5.968265615,0.004593756,0.023308879,0.014892826,P4HB/STAT1,2
BP,GO:0009755,hormone-mediated signaling pathway,5/92,223/18986,0.022421525,4.627120296,3.801898434,0.004594888,0.023308879,0.014892826,PARP1/AR/ALDH1A2/THRB/PPARG,5
BP,GO:0090288,negative regulation of cellular response to growth factor stimulus,4/92,139/18986,0.028776978,5.938692524,4.07789024,0.004673989,0.023672685,0.015125273,XDH/PTPN1/FGF2/PPARG,4
BP,GO:1901293,nucleoside phosphate biosynthetic process,6/92,321/18986,0.018691589,3.857375051,3.602823828,0.004707481,0.023804706,0.015209626,PDK4/PARP1/TYMS/SNCA/PDK1/PMM2,6
BP,GO:0043525,positive regulation of neuron apoptotic process,3/92,70/18986,0.042857143,8.844409938,4.588089778,0.004767815,0.024047884,0.015365001,NQO1/MCL1/CDK5,3
BP,GO:0032409,regulation of transporter activity,5/92,225/18986,0.022222222,4.585990338,3.775805731,0.004770572,0.024047884,0.015365001,MMP9/DAPK1/CFTR/CALM1/SNCA,5
BP,GO:0002702,positive regulation of production of molecular mediator of immune response,4/92,140/18986,0.028571429,5.896273292,4.057488839,0.004793909,0.024052068,0.015367674,KIT/MIF/PRKCZ/IL6,4
BP,GO:0031570,DNA integrity checkpoint signaling,4/92,140/18986,0.028571429,5.896273292,4.057488839,0.004793909,0.024052068,0.015367674,RAD51/PLK1/CDK1/CHEK1,4
BP,GO:0061982,meiosis I cell cycle process,4/92,140/18986,0.028571429,5.896273292,4.057488839,0.004793909,0.024052068,0.015367674,RAD51/PLK1/TOP2A/AURKA,4
BP,GO:0007059,chromosome segregation,7/92,429/18986,0.016317016,3.367335563,3.460762876,0.004828659,0.024188566,0.015454887,PLK1/CDK1/AURKB/NEK2/CCNB1/TOP2A/AURKA,7
BP,GO:0006837,serotonin transport,2/92,22/18986,0.090909091,18.76086957,5.816314087,0.005037271,0.025012381,0.01598125,MAOB/SNCA,2
BP,GO:0032303,regulation of icosanoid secretion,2/92,22/18986,0.090909091,18.76086957,5.816314087,0.005037271,0.025012381,0.01598125,MIF/PTGES,2
BP,GO:0034104,negative regulation of tissue remodeling,2/92,22/18986,0.090909091,18.76086957,5.816314087,0.005037271,0.025012381,0.01598125,IL6/PPARG,2
BP,GO:0072111,cell proliferation involved in kidney development,2/92,22/18986,0.090909091,18.76086957,5.816314087,0.005037271,0.025012381,0.01598125,STAT1/PDGFRB,2
BP,GO:0140896,cGAS/STING signaling pathway,2/92,22/18986,0.090909091,18.76086957,5.816314087,0.005037271,0.025012381,0.01598125,PARP1/AURKB,2
BP,GO:0008643,carbohydrate transport,4/92,142/18986,0.028169014,5.813227189,4.017272063,0.005039925,0.025012381,0.01598125,PIK3R1/PLA2G1B/PRKCB/SLC2A1,4
BP,GO:0014743,regulation of muscle hypertrophy,3/92,72/18986,0.041666667,8.598731884,4.507678525,0.005158628,0.025519823,0.016305472,PARP1/PDE5A/PPARG,3
BP,GO:0046626,regulation of insulin receptor signaling pathway,3/92,72/18986,0.041666667,8.598731884,4.507678525,0.005158628,0.025519823,0.016305472,PTPN1/PRKCZ/PRKCB,3
BP,GO:0000018,regulation of DNA recombination,4/92,143/18986,0.027972028,5.772575251,3.997449982,0.005166053,0.025519823,0.016305472,RAD51/PLK1/PARP1/CHEK1,4
BP,GO:0002440,production of molecular mediator of immune response,5/92,230/18986,0.02173913,4.486294896,3.711890746,0.005230634,0.025799097,0.016483909,KIT/MIF/AXL/PRKCZ/IL6,5
BP,GO:0050890,cognition,6/92,329/18986,0.018237082,3.763578697,3.528467636,0.005298109,0.026091761,0.016670903,PTGS2/KIT/FEN1/CDK5/BCHE/PRKCZ,6
BP,GO:0042698,ovulation cycle,3/92,73/18986,0.04109589,8.480941036,4.468633216,0.005361057,0.026361273,0.016843102,CYP1B1/CA12/AXL,3
BP,GO:2000779,regulation of double-strand break repair,4/92,145/18986,0.027586207,5.692953523,3.95836227,0.005424628,0.026633013,0.017016726,RAD51/PLK1/PARP1/CHEK1,4
BP,GO:0010800,positive regulation of peptidyl-threonine phosphorylation,2/92,23/18986,0.086956522,17.94517958,5.674058776,0.005499699,0.026878103,0.017173323,PLK1/CALM1,2
BP,GO:0010888,negative regulation of lipid storage,2/92,23/18986,0.086956522,17.94517958,5.674058776,0.005499699,0.026878103,0.017173323,IL6/PPARG,2
BP,GO:0097164,ammonium ion metabolic process,2/92,23/18986,0.086956522,17.94517958,5.674058776,0.005499699,0.026878103,0.017173323,ALDH2/BCHE,2
BP,GO:0043112,receptor metabolic process,3/92,74/18986,0.040540541,8.366333725,4.430326969,0.00556821,0.027171508,0.017360789,CDK5/PTPN1/SNCA,3
BP,GO:0001889,liver development,4/92,147/18986,0.027210884,5.615498373,3.919995834,0.005691732,0.027564489,0.017611878,IL6/ALDH1A2/TYMS/AURKA,4
BP,GO:0034763,negative regulation of transmembrane transport,4/92,147/18986,0.027210884,5.615498373,3.919995834,0.005691732,0.027564489,0.017611878,MMP9/CALM1/PRKCE/PRKCB,4
BP,GO:0045598,regulation of fat cell differentiation,4/92,147/18986,0.027210884,5.615498373,3.919995834,0.005691732,0.027564489,0.017611878,PTGS2/ALOX5/IL6/PPARG,4
BP,GO:0046887,positive regulation of hormone secretion,4/92,147/18986,0.027210884,5.615498373,3.919995834,0.005691732,0.027564489,0.017611878,CFTR/PRKCE/PRKCB/PPARG,4
BP,GO:0060048,cardiac muscle contraction,4/92,147/18986,0.027210884,5.615498373,3.919995834,0.005691732,0.027564489,0.017611878,KCNA5/CALM1/TNNC1/PDE5A,4
BP,GO:0002685,regulation of leukocyte migration,5/92,236/18986,0.021186441,4.372236551,3.637564105,0.005823244,0.028158852,0.017991636,PIK3R1/PGF/CXCL12/MIF/IL6,5
BP,GO:0009162,deoxyribonucleoside monophosphate metabolic process,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,XDH/TYMS,2
BP,GO:0035162,embryonic hemopoiesis,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,KIT/KDR,2
BP,GO:0045932,negative regulation of muscle contraction,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,PTGS2/PDE5A,2
BP,GO:0046628,positive regulation of insulin receptor signaling pathway,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,PTPN1/PRKCZ,2
BP,GO:0060252,positive regulation of glial cell proliferation,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,PRKCH/IL6,2
BP,GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,AURKB/CCNB1,2
BP,GO:0090280,positive regulation of calcium ion import,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,CXCL12/PDGFRB,2
BP,GO:1903504,regulation of mitotic spindle checkpoint,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,AURKB/CCNB1,2
BP,GO:2000193,positive regulation of fatty acid transport,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,MIF/PTGES,2
BP,GO:2001026,regulation of endothelial cell chemotaxis,2/92,24/18986,0.083333333,17.19746377,5.54048554,0.005980853,0.028482582,0.018198478,KDR/FGF2,2
BP,GO:0006081,cellular aldehyde metabolic process,3/92,76/18986,0.039473684,8.146167048,4.355835345,0.005996801,0.028482582,0.018198478,CYP1B1/ALDH2/ALDH1A2,3
BP,GO:0090307,mitotic spindle assembly,3/92,76/18986,0.039473684,8.146167048,4.355835345,0.005996801,0.028482582,0.018198478,PLK1/AURKB/NEK2,3
BP,GO:0019318,hexose metabolic process,5/92,238/18986,0.021008403,4.335495068,3.613337829,0.006030899,0.028602162,0.018274882,PFKFB3/PDK4/PDK1/IGFBP3/PMM2,5
BP,GO:0061008,hepaticobiliary system development,4/92,150/18986,0.026666667,5.503188406,3.863746859,0.006108645,0.028895997,0.018462623,IL6/ALDH1A2/TYMS/AURKA,4
BP,GO:0030198,extracellular matrix organization,6/92,339/18986,0.017699115,3.652558676,3.438726395,0.006110881,0.028895997,0.018462623,MMP9/MMP13/MMP12/CYP1B1/IL6/PPARG,6
BP,GO:0043062,extracellular structure organization,6/92,340/18986,0.017647059,3.641815857,3.429939187,0.006196891,0.029231459,0.018676961,MMP9/MMP13/MMP12/CYP1B1/IL6/PPARG,6
BP,GO:0006801,superoxide metabolic process,3/92,77/18986,0.038961039,8.040372671,4.31960454,0.006218295,0.029231459,0.018676961,NQO1/NOX4/PRKCE,3
BP,GO:0033135,regulation of peptidyl-serine phosphorylation,3/92,77/18986,0.038961039,8.040372671,4.31960454,0.006218295,0.029231459,0.018676961,PTGS2/IL6/SNCA,3
BP,GO:1905818,regulation of chromosome separation,3/92,77/18986,0.038961039,8.040372671,4.31960454,0.006218295,0.029231459,0.018676961,PLK1/AURKB/CCNB1,3
BP,GO:0045229,external encapsulating structure organization,6/92,341/18986,0.017595308,3.631136045,3.421184996,0.006283782,0.029496053,0.018846019,MMP9/MMP13/MMP12/CYP1B1/IL6/PPARG,6
BP,GO:0007005,mitochondrion organization,7/92,452/18986,0.015486726,3.195988842,3.297251132,0.006382032,0.029723351,0.018991247,PARP1/MMP9/MCL1/KDR/SNCA/PPARG/AURKA,7
BP,GO:0002687,positive regulation of leukocyte migration,4/92,152/18986,0.026315789,5.430778032,3.827081965,0.006397602,0.029723351,0.018991247,PIK3R1/PGF/CXCL12/IL6,4
BP,GO:0010827,regulation of D-glucose transmembrane transport,3/92,78/18986,0.038461538,7.93729097,4.284021817,0.006444626,0.029723351,0.018991247,PIK3R1/PLA2G1B/PRKCB,3
BP,GO:0032890,regulation of organic acid transport,3/92,78/18986,0.038461538,7.93729097,4.284021817,0.006444626,0.029723351,0.018991247,MIF/PTGES/SNCA,3
BP,GO:0043536,positive regulation of blood vessel endothelial cell migration,3/92,78/18986,0.038461538,7.93729097,4.284021817,0.006444626,0.029723351,0.018991247,PTGS2/KDR/FGF2,3
BP,GO:0061045,negative regulation of wound healing,3/92,78/18986,0.038461538,7.93729097,4.284021817,0.006444626,0.029723351,0.018991247,ALOX5/FGF2/PLAU,3
BP,GO:0010623,programmed cell death involved in cell development,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,KIT/FGF2,2
BP,GO:0032727,positive regulation of interferon-alpha production,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,MMP12/STAT1,2
BP,GO:0042953,lipoprotein transport,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,PRKCB/PPARG,2
BP,GO:0046697,decidualization,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,PTGS2/PARP1,2
BP,GO:0048169,regulation of long-term neuronal synaptic plasticity,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,KIT/SNCA,2
BP,GO:0061042,vascular wound healing,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,KDR/ALOX5,2
BP,GO:0090231,regulation of spindle checkpoint,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,AURKB/CCNB1,2
BP,GO:1903902,positive regulation of viral life cycle,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,P4HB/AXL,2
BP,GO:1905063,regulation of vascular associated smooth muscle cell differentiation,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,KIT/DNMT1,2
BP,GO:2000209,regulation of anoikis,2/92,25/18986,0.08,16.50956522,5.414723287,0.006480543,0.029723351,0.018991247,PDK4/MCL1,2
BP,GO:0006997,nucleus organization,4/92,153/18986,0.026143791,5.395282751,3.808991818,0.006545429,0.0299353,0.019126668,PLK1/CDK1/PRKCB/CHEK1,4
BP,GO:0062013,positive regulation of small molecule metabolic process,4/92,153/18986,0.026143791,5.395282751,3.808991818,0.006545429,0.0299353,0.019126668,PTGS2/PRKCE/SNCA/PPARG,4
BP,GO:0046323,D-glucose import,3/92,79/18986,0.037974684,7.836818932,4.249066916,0.00667582,0.030488148,0.019479901,PIK3R1/PLA2G1B/SLC2A1,3
BP,GO:0006469,negative regulation of protein kinase activity,4/92,155/18986,0.025806452,5.325666199,3.77328335,0.006847853,0.031229329,0.019953467,PLK1/PTPN1/PRKCH/SNCA,4
BP,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,3/92,80/18986,0.0375,7.738858696,4.214720461,0.006911903,0.031476647,0.020111487,PTGS2/KDR/FGF2,3
BP,GO:0001783,B cell apoptotic process,2/92,26/18986,0.076923077,15.87458194,5.296019004,0.006998584,0.031479219,0.02011313,AURKB/MIF,2
BP,GO:0002053,positive regulation of mesenchymal cell proliferation,2/92,26/18986,0.076923077,15.87458194,5.296019004,0.006998584,0.031479219,0.02011313,KDR/STAT1,2
BP,GO:0044872,lipoprotein localization,2/92,26/18986,0.076923077,15.87458194,5.296019004,0.006998584,0.031479219,0.02011313,PRKCB/PPARG,2
BP,GO:0051315,attachment of mitotic spindle microtubules to kinetochore,2/92,26/18986,0.076923077,15.87458194,5.296019004,0.006998584,0.031479219,0.02011313,CDK1/AURKB,2
BP,GO:0051882,mitochondrial depolarization,2/92,26/18986,0.076923077,15.87458194,5.296019004,0.006998584,0.031479219,0.02011313,PARP1/KDR,2
BP,GO:0060396,growth hormone receptor signaling pathway,2/92,26/18986,0.076923077,15.87458194,5.296019004,0.006998584,0.031479219,0.02011313,PIK3R1/PTPN1,2
BP,GO:1900078,positive regulation of cellular response to insulin stimulus,2/92,26/18986,0.076923077,15.87458194,5.296019004,0.006998584,0.031479219,0.02011313,PTPN1/PRKCZ,2
BP,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,2/92,26/18986,0.076923077,15.87458194,5.296019004,0.006998584,0.031479219,0.02011313,ALOX5/IL6,2
BP,GO:0043535,regulation of blood vessel endothelial cell migration,4/92,156/18986,0.025641026,5.291527313,3.755660089,0.00700248,0.031479219,0.02011313,PTGS2/KDR/FGF2/PPARG,4
BP,GO:0002274,myeloid leukocyte activation,5/92,247/18986,0.020242915,4.177521563,3.507527109,0.007030294,0.031479219,0.02011313,KIT/MIF/PRKCE/IL6/SNCA,5
BP,GO:0002573,myeloid leukocyte differentiation,5/92,247/18986,0.020242915,4.177521563,3.507527109,0.007030294,0.031479219,0.02011313,PIK3R1/PARP1/MMP9/KIT/PPARG,5
BP,GO:0050769,positive regulation of neurogenesis,5/92,247/18986,0.020242915,4.177521563,3.507527109,0.007030294,0.031479219,0.02011313,KIT/CXCL12/PRKCH/IL6/FGF2,5
BP,GO:0052548,regulation of endopeptidase activity,5/92,248/18986,0.02016129,4.160676718,3.49608159,0.007148062,0.031790914,0.020312283,XDH/PTGS2/MMP9/DAPK1/SNCA,5
BP,GO:0006809,nitric oxide biosynthetic process,3/92,81/18986,0.037037037,7.64331723,4.18096391,0.007152898,0.031790914,0.020312283,PTGS2/NQO1/CYP1B1,3
BP,GO:0021536,diencephalon development,3/92,81/18986,0.037037037,7.64331723,4.18096391,0.007152898,0.031790914,0.020312283,NR4A2/FGF2/ALDH1A2,3
BP,GO:0045921,positive regulation of exocytosis,3/92,81/18986,0.037037037,7.64331723,4.18096391,0.007152898,0.031790914,0.020312283,CFTR/CDK5/SNCA,3
BP,GO:1903036,positive regulation of response to wounding,3/92,81/18986,0.037037037,7.64331723,4.18096391,0.007152898,0.031790914,0.020312283,PRKCE/PLAU/MYLK,3
BP,GO:0034767,positive regulation of monoatomic ion transmembrane transport,4/92,157/18986,0.025477707,5.257823318,3.738187607,0.007159401,0.031790914,0.020312283,CFTR/CALM1/PLA2G1B/SNCA,4
BP,GO:0007612,learning,4/92,159/18986,0.025157233,5.191687175,3.703685691,0.007480186,0.033136531,0.021172042,PTGS2/KIT/CDK5/BCHE,4
BP,GO:0034765,regulation of monoatomic ion transmembrane transport,6/92,354/18986,0.016949153,3.497789241,3.310281621,0.007495886,0.033136531,0.021172042,MMP9/CFTR/CALM1/PLA2G1B/PRKCE/SNCA,6
BP,GO:0045444,fat cell differentiation,5/92,251/18986,0.019920319,4.110947514,3.462102766,0.00750965,0.033136531,0.021172042,PTGS2/NR4A2/ALOX5/IL6/PPARG,5
BP,GO:0002070,epithelial cell maturation,2/92,27/18986,0.074074074,15.28663446,5.183717919,0.007534788,0.033136531,0.021172042,KDR/TYMS,2
BP,GO:0035458,cellular response to interferon-beta,2/92,27/18986,0.074074074,15.28663446,5.183717919,0.007534788,0.033136531,0.021172042,CALM1/STAT1,2
BP,GO:0060333,type II interferon-mediated signaling pathway,2/92,27/18986,0.074074074,15.28663446,5.183717919,0.007534788,0.033136531,0.021172042,STAT1/PPARG,2
BP,GO:0071378,cellular response to growth hormone stimulus,2/92,27/18986,0.074074074,15.28663446,5.183717919,0.007534788,0.033136531,0.021172042,PIK3R1/PTPN1,2
BP,GO:0042063,gliogenesis,6/92,355/18986,0.016901408,3.487936314,3.30196611,0.007595653,0.033358443,0.021313829,PFKFB3/CDK5/CDK1/PRKCH/IL6/FGF2,6
BP,GO:0019233,sensory perception of pain,3/92,83/18986,0.036144578,7.459140911,4.115150255,0.007649727,0.033412841,0.021348586,CXCL12/CDK5/PTGES,3
BP,GO:0051279,regulation of release of sequestered calcium ion into cytosol,3/92,83/18986,0.036144578,7.459140911,4.115150255,0.007649727,0.033412841,0.021348586,CALM1/PRKCE/SNCA,3
BP,GO:0051952,regulation of amine transport,3/92,83/18986,0.036144578,7.459140911,4.115150255,0.007649727,0.033412841,0.021348586,CXCL12/PRKCB/SNCA,3
BP,GO:0071901,negative regulation of protein serine/threonine kinase activity,3/92,83/18986,0.036144578,7.459140911,4.115150255,0.007649727,0.033412841,0.021348586,PLK1/PTPN1/PRKCH,3
BP,GO:0045088,regulation of innate immune response,7/92,470/18986,0.014893617,3.073589269,3.176401106,0.007837443,0.034186178,0.021842697,PIK3R1/PARP1/MMP12/AURKB/PTPN1/PRKCE/PPARG,7
BP,GO:0001523,retinoid metabolic process,3/92,84/18986,0.035714286,7.370341615,4.08305984,0.007905607,0.034250508,0.021883799,CYP1B1/AKR1B10/ALDH1A2,3
BP,GO:0008344,adult locomotory behavior,3/92,84/18986,0.035714286,7.370341615,4.08305984,0.007905607,0.034250508,0.021883799,NR4A2/CXCL12/SNCA,3
BP,GO:0034248,regulation of amide metabolic process,3/92,84/18986,0.035714286,7.370341615,4.08305984,0.007905607,0.034250508,0.021883799,PDK4/SNCA/PDK1,3
BP,GO:0051304,chromosome separation,3/92,84/18986,0.035714286,7.370341615,4.08305984,0.007905607,0.034250508,0.021883799,PLK1/AURKB/CCNB1,3
BP,GO:0070509,calcium ion import,3/92,84/18986,0.035714286,7.370341615,4.08305984,0.007905607,0.034250508,0.021883799,CXCL12/CDK5/PDGFRB,3
BP,GO:0050729,positive regulation of inflammatory response,4/92,162/18986,0.024691358,5.09554482,3.653006897,0.007978925,0.034521504,0.022056948,PTGS2/IL6/SNCA/ALOX5AP,4
BP,GO:0002726,positive regulation of T cell cytokine production,2/92,28/18986,0.071428571,14.74068323,5.077247598,0.008088973,0.034856514,0.022270997,PRKCZ/IL6,2
BP,GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,2/92,28/18986,0.071428571,14.74068323,5.077247598,0.008088973,0.034856514,0.022270997,CDK1/CCNB1,2
BP,GO:0034698,response to gonadotropin,2/92,28/18986,0.071428571,14.74068323,5.077247598,0.008088973,0.034856514,0.022270997,CYP1B1/CCNA2,2
BP,GO:0045930,negative regulation of mitotic cell cycle,5/92,256/18986,0.01953125,4.030655571,3.406629753,0.008140383,0.034955644,0.022334335,PLK1/CDK1/AURKB/CCNB1/CHEK1,5
BP,GO:0071322,cellular response to carbohydrate stimulus,4/92,163/18986,0.024539877,5.064283809,3.636391778,0.00814991,0.034955644,0.022334335,NOX4/CFTR/PRKCE/PRKCB,4
BP,GO:0006970,response to osmotic stress,3/92,85/18986,0.035294118,7.283631714,4.051492634,0.008166493,0.034955644,0.022334335,PTGS2/SLC2A1/MYLK,3
BP,GO:0060337,type I interferon-mediated signaling pathway,3/92,85/18986,0.035294118,7.283631714,4.051492634,0.008166493,0.034955644,0.022334335,MMP12/PTPN1/STAT1,3
BP,GO:1904427,positive regulation of calcium ion transmembrane transport,3/92,85/18986,0.035294118,7.283631714,4.051492634,0.008166493,0.034955644,0.022334335,CALM1/PLA2G1B/SNCA,3
BP,GO:0043010,camera-type eye development,6/92,362/18986,0.016574586,3.420490031,3.24457906,0.008321133,0.035570068,0.022726911,KDR/CYP1B1/FGF2/ALDH1A2/THRB/PDGFRB,6
BP,GO:1901136,carbohydrate derivative catabolic process,5/92,258/18986,0.019379845,3.999410179,3.384833203,0.008402692,0.03585451,0.02290865,XDH/PFKFB3/MMP12/PDE5A/FGF2,5
BP,GO:0001570,vasculogenesis,3/92,86/18986,0.034883721,7.198938322,4.020433635,0.008432408,0.03585451,0.02290865,XDH/KDR/PDGFRB,3
BP,GO:0048678,response to axon injury,3/92,86/18986,0.034883721,7.198938322,4.020433635,0.008432408,0.03585451,0.02290865,CDK1/AXL/FGF2,3
BP,GO:0071357,cellular response to type I interferon,3/92,86/18986,0.034883721,7.198938322,4.020433635,0.008432408,0.03585451,0.02290865,MMP12/PTPN1/STAT1,3
BP,GO:0032801,receptor catabolic process,2/92,29/18986,0.068965517,14.23238381,4.976105072,0.008660954,0.036700948,0.023449468,CDK5/PTPN1,2
BP,GO:0045606,positive regulation of epidermal cell differentiation,2/92,29/18986,0.068965517,14.23238381,4.976105072,0.008660954,0.036700948,0.023449468,PRKCH/FGF2,2
BP,GO:0033673,negative regulation of kinase activity,4/92,166/18986,0.024096386,4.972760608,3.587351145,0.008677267,0.036700948,0.023449468,PLK1/PTPN1/PRKCH/SNCA,4
BP,GO:0070665,positive regulation of leukocyte proliferation,4/92,166/18986,0.024096386,4.972760608,3.587351145,0.008677267,0.036700948,0.023449468,KIT/MIF/IL6/IGFBP2,4
BP,GO:0044773,mitotic DNA damage checkpoint signaling,3/92,87/18986,0.034482759,7.116191904,3.989868445,0.008703372,0.036762861,0.023489027,PLK1/CDK1/CHEK1,3
BP,GO:0006606,protein import into nucleus,4/92,167/18986,0.023952096,4.942983598,3.571265957,0.008857898,0.037366342,0.023874611,PTGS2/PIK3R1/MMP12/CDK1,4
BP,GO:0001649,osteoblast differentiation,5/92,262/18986,0.019083969,3.938350481,3.341890262,0.008944828,0.037533215,0.023981231,IL6/FGF2/PPARG/IGFBP3/IGFBP2,5
BP,GO:0010232,vascular transport,3/92,88/18986,0.034090909,7.035326087,3.959783234,0.008979406,0.037533215,0.023981231,ABCG2/ABCB1/SLC2A1,3
BP,GO:0032024,positive regulation of insulin secretion,3/92,88/18986,0.034090909,7.035326087,3.959783234,0.008979406,0.037533215,0.023981231,CFTR/PRKCE/PRKCB,3
BP,GO:0032370,positive regulation of lipid transport,3/92,88/18986,0.034090909,7.035326087,3.959783234,0.008979406,0.037533215,0.023981231,MIF/PTGES/PPARG,3
BP,GO:0034103,regulation of tissue remodeling,3/92,88/18986,0.034090909,7.035326087,3.959783234,0.008979406,0.037533215,0.023981231,PDK4/IL6/PPARG,3
BP,GO:0150104,transport across blood-brain barrier,3/92,88/18986,0.034090909,7.035326087,3.959783234,0.008979406,0.037533215,0.023981231,ABCG2/ABCB1/SLC2A1,3
BP,GO:1905897,regulation of response to endoplasmic reticulum stress,3/92,88/18986,0.034090909,7.035326087,3.959783234,0.008979406,0.037533215,0.023981231,PIK3R1/ALOX5/PTPN1,3
BP,GO:1990138,neuron projection extension,4/92,169/18986,0.023668639,4.884486751,3.539476745,0.009226504,0.038358212,0.024508349,CXCL12/CDK5/PRKCZ/AURKA,4
BP,GO:0006304,DNA modification,2/92,30/18986,0.066666667,13.75797101,4.879846346,0.009250551,0.038358212,0.024508349,PARP1/CYP1B1,2
BP,GO:0050482,arachidonate secretion,2/92,30/18986,0.066666667,13.75797101,4.879846346,0.009250551,0.038358212,0.024508349,MIF/PLA2G1B,2
BP,GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,2/92,30/18986,0.066666667,13.75797101,4.879846346,0.009250551,0.038358212,0.024508349,CXCL12/MIF,2
BP,GO:1903963,arachidonate transport,2/92,30/18986,0.066666667,13.75797101,4.879846346,0.009250551,0.038358212,0.024508349,MIF/PLA2G1B,2
BP,GO:0016101,diterpenoid metabolic process,3/92,89/18986,0.033707865,6.956277479,3.930164715,0.009260529,0.038358212,0.024508349,CYP1B1/AKR1B10/ALDH1A2,3
BP,GO:0046209,nitric oxide metabolic process,3/92,89/18986,0.033707865,6.956277479,3.930164715,0.009260529,0.038358212,0.024508349,PTGS2/NQO1/CYP1B1,3
BP,GO:0001678,intracellular glucose homeostasis,4/92,170/18986,0.023529412,4.855754476,3.523769066,0.009414505,0.038895494,0.024851637,PIK3R1/NOX4/CFTR/PRKCE,4
BP,GO:0007292,female gamete generation,4/92,170/18986,0.023529412,4.855754476,3.523769066,0.009414505,0.038895494,0.024851637,PLK1/TOP2A/PDE5A/AURKA,4
BP,GO:0046849,bone remodeling,3/92,90/18986,0.033333333,6.878985507,3.901000115,0.00954676,0.039391136,0.025168319,PDK4/NOX4/IL6,3
BP,GO:0010001,glial cell differentiation,5/92,267/18986,0.018726592,3.8645986,3.28938981,0.009655981,0.039790585,0.025423541,PFKFB3/CDK5/CDK1/IL6/FGF2,5
BP,GO:0042176,regulation of protein catabolic process,6/92,374/18986,0.016042781,3.310741688,3.14940083,0.009679042,0.039834416,0.025451546,PLK1/NQO1/EEF1A2/EEF1A1/SNCA/AURKA,6
BP,GO:0051170,import into nucleus,4/92,172/18986,0.023255814,4.799292214,3.492718706,0.009797967,0.039953742,0.025527787,PTGS2/PIK3R1/MMP12/CDK1,4
BP,GO:0044282,small molecule catabolic process,6/92,375/18986,0.016,3.301913043,3.141643864,0.009798932,0.039953742,0.025527787,XDH/SLC16A3/ALDH2/AKR1B10/QDPR/PMM2,6
BP,GO:0010469,regulation of signaling receptor activity,3/92,91/18986,0.032967033,6.80339226,3.872277147,0.009838118,0.039953742,0.025527787,DAPK1/PPARG/PLAU,3
BP,GO:0044774,mitotic DNA integrity checkpoint signaling,3/92,91/18986,0.032967033,6.80339226,3.872277147,0.009838118,0.039953742,0.025527787,PLK1/CDK1/CHEK1,3
BP,GO:0051591,response to cAMP,3/92,91/18986,0.032967033,6.80339226,3.872277147,0.009838118,0.039953742,0.025527787,CYP1B1/CFTR/STAT1,3
BP,GO:2001057,reactive nitrogen species metabolic process,3/92,91/18986,0.032967033,6.80339226,3.872277147,0.009838118,0.039953742,0.025527787,PTGS2/NQO1/CYP1B1,3
BP,GO:0001945,lymph vessel development,2/92,31/18986,0.064516129,13.3141655,4.788077789,0.009857583,0.039953742,0.025527787,KDR/FGF2,2
BP,GO:0030262,apoptotic nuclear changes,2/92,31/18986,0.064516129,13.3141655,4.788077789,0.009857583,0.039953742,0.025527787,TOP2A/IL6,2
BP,GO:0032607,interferon-alpha production,2/92,31/18986,0.064516129,13.3141655,4.788077789,0.009857583,0.039953742,0.025527787,MMP12/STAT1,2
BP,GO:0032647,regulation of interferon-alpha production,2/92,31/18986,0.064516129,13.3141655,4.788077789,0.009857583,0.039953742,0.025527787,MMP12/STAT1,2
BP,GO:0150117,positive regulation of cell-substrate junction organization,2/92,31/18986,0.064516129,13.3141655,4.788077789,0.009857583,0.039953742,0.025527787,PIK3R1/KDR,2
BP,GO:1902751,positive regulation of cell cycle G2/M phase transition,2/92,31/18986,0.064516129,13.3141655,4.788077789,0.009857583,0.039953742,0.025527787,CDK1/CCNB1,2
BP,GO:0050792,regulation of viral process,4/92,173/18986,0.023121387,4.771550641,3.477372587,0.009993452,0.040453291,0.025846966,P4HB/AXL/TOP2A/STAT1,4
BP,GO:0001894,tissue homeostasis,5/92,270/18986,0.018518519,3.821658615,3.258495242,0.010100897,0.040733931,0.026026276,PTGS2/PDK4/NOX4/IL6/SLC2A1,5
BP,GO:0060249,anatomical structure homeostasis,5/92,270/18986,0.018518519,3.821658615,3.258495242,0.010100897,0.040733931,0.026026276,PTGS2/PDK4/NOX4/IL6/SLC2A1,5
BP,GO:0070663,regulation of leukocyte proliferation,5/92,270/18986,0.018518519,3.821658615,3.258495242,0.010100897,0.040733931,0.026026276,KIT/MIF/PDE5A/IL6/IGFBP2,5
BP,GO:0034340,response to type I interferon,3/92,92/18986,0.032608696,6.729442344,3.843983993,0.010134619,0.040767364,0.026047638,MMP12/PTPN1/STAT1,3
BP,GO:2000243,positive regulation of reproductive process,3/92,92/18986,0.032608696,6.729442344,3.843983993,0.010134619,0.040767364,0.026047638,AR/PDE5A/AURKA,3
BP,GO:0030071,regulation of mitotic metaphase/anaphase transition,3/92,93/18986,0.032258065,6.657082749,3.816109275,0.010436282,0.041849162,0.026738835,PLK1/AURKB/CCNB1,3
BP,GO:0032410,negative regulation of transporter activity,3/92,93/18986,0.032258065,6.657082749,3.816109275,0.010436282,0.041849162,0.026738835,MMP9/CALM1/SNCA,3
BP,GO:0035767,endothelial cell chemotaxis,2/92,32/18986,0.0625,12.89809783,4.700449004,0.010481871,0.041849162,0.026738835,KDR/FGF2,2
BP,GO:0045987,positive regulation of smooth muscle contraction,2/92,32/18986,0.0625,12.89809783,4.700449004,0.010481871,0.041849162,0.026738835,PTGS2/KIT,2
BP,GO:0060045,positive regulation of cardiac muscle cell proliferation,2/92,32/18986,0.0625,12.89809783,4.700449004,0.010481871,0.041849162,0.026738835,CDK1/FGF2,2
BP,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,2/92,32/18986,0.0625,12.89809783,4.700449004,0.010481871,0.041849162,0.026738835,PIK3R1/PTPN1,2
BP,GO:0090287,regulation of cellular response to growth factor stimulus,6/92,381/18986,0.015748031,3.249914413,3.095643262,0.010540673,0.042031591,0.026855395,XDH/KDR/PTPN1/PRKCB/FGF2/PPARG,6
BP,GO:0050767,regulation of neurogenesis,6/92,383/18986,0.015665796,3.23294358,3.080511985,0.010796573,0.042998526,0.027473202,KIT/CXCL12/CDK5/PRKCH/IL6/FGF2,6
BP,GO:0003018,vascular process in circulatory system,5/92,276/18986,0.018115942,3.73857908,3.198012762,0.011032676,0.043702326,0.027922883,PTGS2/KCNA5/ABCG2/ABCB1/SLC2A1,5
BP,GO:0002690,positive regulation of leukocyte chemotaxis,3/92,95/18986,0.031578947,6.516933638,3.761571727,0.011055157,0.043702326,0.027922883,PGF/CXCL12/IL6,3
BP,GO:0010660,regulation of muscle cell apoptotic process,3/92,95/18986,0.031578947,6.516933638,3.761571727,0.011055157,0.043702326,0.027922883,PTPN1/PPARG/DNMT1,3
BP,GO:0090316,positive regulation of intracellular protein transport,3/92,95/18986,0.031578947,6.516933638,3.761571727,0.011055157,0.043702326,0.027922883,PTGS2/PIK3R1/CDK1,3
BP,GO:0006308,DNA catabolic process,2/92,33/18986,0.060606061,12.50724638,4.6166469,0.011123237,0.043702326,0.027922883,APEX1/IL6,2
BP,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,2/92,33/18986,0.060606061,12.50724638,4.6166469,0.011123237,0.043702326,0.027922883,TOP2A/IL6,2
BP,GO:0010464,regulation of mesenchymal cell proliferation,2/92,33/18986,0.060606061,12.50724638,4.6166469,0.011123237,0.043702326,0.027922883,KDR/STAT1,2
BP,GO:0010743,regulation of macrophage derived foam cell differentiation,2/92,33/18986,0.060606061,12.50724638,4.6166469,0.011123237,0.043702326,0.027922883,PRKCH/PPARG,2
BP,GO:0033198,response to ATP,2/92,33/18986,0.060606061,12.50724638,4.6166469,0.011123237,0.043702326,0.027922883,PTGS2/HSP90B1,2
BP,GO:0042558,pteridine-containing compound metabolic process,2/92,33/18986,0.060606061,12.50724638,4.6166469,0.011123237,0.043702326,0.027922883,QDPR/TYMS,2
BP,GO:0045684,positive regulation of epidermis development,2/92,33/18986,0.060606061,12.50724638,4.6166469,0.011123237,0.043702326,0.027922883,PRKCH/FGF2,2
BP,GO:1903169,regulation of calcium ion transmembrane transport,4/92,179/18986,0.022346369,4.611610396,3.387699707,0.011219684,0.044027304,0.028130523,CALM1/PLA2G1B/PRKCE/SNCA,4
BP,GO:0002042,cell migration involved in sprouting angiogenesis,3/92,96/18986,0.03125,6.449048913,3.734888171,0.011372399,0.044463308,0.0284091,PTGS2/KDR/FGF2,3
BP,GO:0015837,amine transport,3/92,96/18986,0.03125,6.449048913,3.734888171,0.011372399,0.044463308,0.0284091,CXCL12/PRKCB/SNCA,3
BP,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,3/92,96/18986,0.03125,6.449048913,3.734888171,0.011372399,0.044463308,0.0284091,PLK1/AURKB/CCNB1,3
BP,GO:0035265,organ growth,4/92,181/18986,0.022099448,4.560653375,3.358687324,0.011649022,0.045446956,0.029037586,MMP13/CDK1/AR/FGF2,4
BP,GO:0007091,metaphase/anaphase transition of mitotic cell cycle,3/92,97/18986,0.030927835,6.382563873,3.708581563,0.011694866,0.045446956,0.029037586,PLK1/AURKB/CCNB1,3
BP,GO:0010631,epithelial cell migration,3/92,97/18986,0.030927835,6.382563873,3.708581563,0.011694866,0.045446956,0.029037586,MMP9/KIT/PRKCE,3
BP,GO:0051899,membrane depolarization,3/92,97/18986,0.030927835,6.382563873,3.708581563,0.011694866,0.045446956,0.029037586,PARP1/KDR/PRKCZ,3
BP,GO:1904063,negative regulation of cation transmembrane transport,3/92,97/18986,0.030927835,6.382563873,3.708581563,0.011694866,0.045446956,0.029037586,MMP9/CALM1/PRKCE,3
BP,GO:0002828,regulation of type 2 immune response,2/92,34/18986,0.058823529,12.13938619,4.536390729,0.011781505,0.045453075,0.029041496,PRKCZ/IL6,2
BP,GO:0009112,nucleobase metabolic process,2/92,34/18986,0.058823529,12.13938619,4.536390729,0.011781505,0.045453075,0.029041496,XDH/TYMS,2
BP,GO:0033146,regulation of intracellular estrogen receptor signaling pathway,2/92,34/18986,0.058823529,12.13938619,4.536390729,0.011781505,0.045453075,0.029041496,PARP1/AR,2
BP,GO:0035456,response to interferon-beta,2/92,34/18986,0.058823529,12.13938619,4.536390729,0.011781505,0.045453075,0.029041496,CALM1/STAT1,2
BP,GO:0060055,angiogenesis involved in wound healing,2/92,34/18986,0.058823529,12.13938619,4.536390729,0.011781505,0.045453075,0.029041496,KDR/ALOX5,2
BP,GO:2000191,regulation of fatty acid transport,2/92,34/18986,0.058823529,12.13938619,4.536390729,0.011781505,0.045453075,0.029041496,MIF/PTGES,2
BP,GO:0031214,biomineral tissue development,4/92,182/18986,0.021978022,4.53559484,3.344339228,0.011867604,0.045730216,0.029218571,PTGS2/MMP13/CFTR/ALOX5,4
BP,GO:1903037,regulation of leukocyte cell-cell adhesion,6/92,392/18986,0.015306122,3.158717835,3.013628808,0.012003019,0.046196495,0.029516492,CXCL12/ALOX5/PRKCZ/PDE5A/IL6/IGFBP2,6
BP,GO:0002262,myeloid cell homeostasis,4/92,183/18986,0.021857923,4.510810169,3.330094657,0.01208881,0.046359718,0.02962078,KIT/AXL/IL6/STAT1,4
BP,GO:0017157,regulation of exocytosis,4/92,183/18986,0.021857923,4.510810169,3.330094657,0.01208881,0.046359718,0.02962078,CFTR/CDK5/PRKCB/SNCA,4
BP,GO:0072331,signal transduction by p53 class mediator,4/92,183/18986,0.021857923,4.510810169,3.330094657,0.01208881,0.046359718,0.02962078,AURKB/MIF/CHEK1/AURKA,4
BP,GO:0006637,acyl-CoA metabolic process,3/92,99/18986,0.03030303,6.253623188,3.657061688,0.012355523,0.047093797,0.030089808,PDK4/SNCA/PDK1,3
BP,GO:0035383,thioester metabolic process,3/92,99/18986,0.03030303,6.253623188,3.657061688,0.012355523,0.047093797,0.030089808,PDK4/SNCA/PDK1,3
BP,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,3/92,99/18986,0.03030303,6.253623188,3.657061688,0.012355523,0.047093797,0.030089808,XDH/DAPK1/SNCA,3
BP,GO:0051262,protein tetramerization,3/92,99/18986,0.03030303,6.253623188,3.657061688,0.012355523,0.047093797,0.030089808,ALDH1A2/SNCA/DNM1,3
BP,GO:0042113,B cell activation,5/92,284/18986,0.017605634,3.633266993,3.119947586,0.012364369,0.047093797,0.030089808,PIK3R1/KIT/MIF/PRKCB/IL6,5
BP,GO:0001893,maternal placenta development,2/92,35/18986,0.057142857,11.79254658,4.459427905,0.0124565,0.047093797,0.030089808,PTGS2/PARP1,2
BP,GO:0006084,acetyl-CoA metabolic process,2/92,35/18986,0.057142857,11.79254658,4.459427905,0.0124565,0.047093797,0.030089808,PDK4/PDK1,2
BP,GO:0016486,peptide hormone processing,2/92,35/18986,0.057142857,11.79254658,4.459427905,0.0124565,0.047093797,0.030089808,P4HB/BCHE,2
BP,GO:0043276,anoikis,2/92,35/18986,0.057142857,11.79254658,4.459427905,0.0124565,0.047093797,0.030089808,PDK4/MCL1,2
BP,GO:0060191,regulation of lipase activity,2/92,35/18986,0.057142857,11.79254658,4.459427905,0.0124565,0.047093797,0.030089808,PLA2G1B/SNCA,2
BP,GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,2/92,35/18986,0.057142857,11.79254658,4.459427905,0.0124565,0.047093797,0.030089808,KIT/MIF,2
BP,GO:0110110,positive regulation of animal organ morphogenesis,2/92,35/18986,0.057142857,11.79254658,4.459427905,0.0124565,0.047093797,0.030089808,PRKCB/FGF2,2
BP,GO:0006721,terpenoid metabolic process,3/92,100/18986,0.03,6.191086957,3.631830488,0.012693742,0.047821546,0.030554791,CYP1B1/AKR1B10/ALDH1A2,3
BP,GO:0044784,metaphase/anaphase transition of cell cycle,3/92,100/18986,0.03,6.191086957,3.631830488,0.012693742,0.047821546,0.030554791,PLK1/AURKB/CCNB1,3
BP,GO:0090132,epithelium migration,3/92,100/18986,0.03,6.191086957,3.631830488,0.012693742,0.047821546,0.030554791,MMP9/KIT/PRKCE,3
BP,GO:0043542,endothelial cell migration,5/92,287/18986,0.017421603,3.595288593,3.09139624,0.012890736,0.04850669,0.030992553,PTGS2/KDR/CYP1B1/FGF2/PPARG,5
BP,GO:0010657,muscle cell apoptotic process,3/92,101/18986,0.02970297,6.129789066,3.606940338,0.013037236,0.048771736,0.0311619,PTPN1/PPARG/DNMT1,3
BP,GO:0034446,substrate adhesion-dependent cell spreading,3/92,101/18986,0.02970297,6.129789066,3.606940338,0.013037236,0.048771736,0.0311619,PIK3R1/P4HB/AXL,3
BP,GO:0042773,ATP synthesis coupled electron transport,3/92,101/18986,0.02970297,6.129789066,3.606940338,0.013037236,0.048771736,0.0311619,CDK1/CCNB1/SNCA,3
BP,GO:0042775,mitochondrial ATP synthesis coupled electron transport,3/92,101/18986,0.02970297,6.129789066,3.606940338,0.013037236,0.048771736,0.0311619,CDK1/CCNB1/SNCA,3
BP,GO:1903035,negative regulation of response to wounding,3/92,101/18986,0.02970297,6.129789066,3.606940338,0.013037236,0.048771736,0.0311619,ALOX5/FGF2/PLAU,3
BP,GO:0010613,positive regulation of cardiac muscle hypertrophy,2/92,36/18986,0.055555556,11.46497585,4.385530466,0.013148048,0.049071761,0.031353596,PARP1/PDE5A,2
BP,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,2/92,36/18986,0.055555556,11.46497585,4.385530466,0.013148048,0.049071761,0.031353596,PTPN1/PRKCB,2
BP,GO:0032412,regulation of monoatomic ion transmembrane transporter activity,4/92,188/18986,0.021276596,4.390841813,3.260377526,0.013234564,0.049165715,0.031413626,MMP9/DAPK1/CFTR/CALM1,4
BP,GO:0032640,tumor necrosis factor production,4/92,188/18986,0.021276596,4.390841813,3.260377526,0.013234564,0.049165715,0.031413626,PIK3R1/MIF/AXL/IL6,4
BP,GO:0032680,regulation of tumor necrosis factor production,4/92,188/18986,0.021276596,4.390841813,3.260377526,0.013234564,0.049165715,0.031413626,PIK3R1/MIF/AXL/IL6,4
BP,GO:1905952,regulation of lipid localization,4/92,188/18986,0.021276596,4.390841813,3.260377526,0.013234564,0.049165715,0.031413626,MIF/PTGES/IL6/PPARG,4
BP,GO:0003300,cardiac muscle hypertrophy,3/92,102/18986,0.029411765,6.069693095,3.582383022,0.013386018,0.049613379,0.031699654,PARP1/PDE5A/PPARG,3
BP,GO:0016079,synaptic vesicle exocytosis,3/92,102/18986,0.029411765,6.069693095,3.582383022,0.013386018,0.049613379,0.031699654,CDK5/PRKCB/SNCA,3
BP,GO:0001764,neuron migration,4/92,189/18986,0.021164021,4.367609846,3.246726164,0.013471734,0.049815893,0.031829047,NR4A2/CXCL12/CDK5/AXL,4
BP,GO:0045766,positive regulation of angiogenesis,4/92,189/18986,0.021164021,4.367609846,3.246726164,0.013471734,0.049815893,0.031829047,KDR/CYP1B1/PRKCB/FGF2,4
CC,GO:0098687,chromosomal region,13/92,404/19960,0.032178218,6.981274214,8.26476689,4.15E-08,9.58E-06,6.46E-06,RAD51/PLK1/PARP1/FEN1/CDK1/AURKB/NEK2/CCNB1/TOP2A/APEX1/DNMT1/CHEK1/AURKA,13
CC,GO:0045177,apical part of cell,13/92,474/19960,0.02742616,5.950284351,7.422397262,2.63E-07,2.90E-05,1.95E-05,SLC16A3/KCNA5/CFTR/CA4/CA2/CA12/ABCG2/ABCB1/PRKCZ/PDGFRB/SLC2A1/MGAM/IGFBP2,13
CC,GO:0016324,apical plasma membrane,12/92,408/19960,0.029411765,6.381074169,7.472908978,3.76E-07,2.90E-05,1.95E-05,SLC16A3/KCNA5/CFTR/CA4/CA12/ABCG2/ABCB1/PRKCZ/PDGFRB/SLC2A1/MGAM/IGFBP2,12
CC,GO:0005641,nuclear envelope lumen,3/92,11/19960,0.272727273,59.16996047,13.13169458,1.52E-05,0.000713921,0.000481478,ALOX5/BCHE/PTGES,3
CC,GO:0043073,germ cell nucleus,5/92,68/19960,0.073529412,15.95268542,8.404669783,1.55E-05,0.000713921,0.000481478,RAD51/TOP2A/DNMT1/AURKA/SLC2A1,5
CC,GO:0045120,pronucleus,3/92,14/19960,0.214285714,46.49068323,11.58630074,3.32E-05,0.001164285,0.000785209,CCNA2/AURKA/SLC2A1,3
CC,GO:0005876,spindle microtubule,5/92,83/19960,0.060240964,13.06966998,7.497996787,4.08E-05,0.001164285,0.000785209,PLK1/CDK1/CALM1/AURKB/AURKA,5
CC,GO:1902554,serine/threonine protein kinase complex,6/92,139/19960,0.043165468,9.365029715,6.734391101,4.47E-05,0.001164285,0.000785209,DAPK1/CDK5/CDK1/CCNB1/PRKCZ/CCNA2,6
CC,GO:0030496,midbody,7/92,207/19960,0.033816425,7.336693972,6.236165058,4.85E-05,0.001164285,0.000785209,PLK1/CDK1/AURKB/NEK2/AURKA/SLC2A1/HSP90B1,7
CC,GO:0000793,condensed chromosome,8/92,284/19960,0.028169014,6.111451317,5.903658383,5.04E-05,0.001164285,0.000785209,RAD51/PLK1/AURKB/NEK2/CCNB1/TOP2A/CHEK1/AURKA,8
CC,GO:0001674,female germ cell nucleus,3/92,17/19960,0.176470588,38.28644501,10.46565518,6.15E-05,0.001291332,0.000870891,DNMT1/AURKA/SLC2A1,3
CC,GO:1902911,protein kinase complex,6/92,153/19960,0.039215686,8.508098892,6.343845185,7.62E-05,0.001466668,0.000989141,DAPK1/CDK5/CDK1/CCNB1/PRKCZ/CCNA2,6
CC,GO:0009897,external side of plasma membrane,9/92,407/19960,0.022113022,4.797564363,5.267225052,0.0001089,0.001935065,0.001305034,P4HB/KIT/KDR/CXCL12/CA4/ABCG2/ABCB1/F10/PLAU,9
CC,GO:0000781,"chromosome, telomeric region",6/92,173/19960,0.034682081,7.524503644,5.8649833,0.000149663,0.002440259,0.001645743,RAD51/PARP1/FEN1/CDK1/APEX1/CHEK1,6
CC,GO:0000307,cyclin-dependent protein kinase holoenzyme complex,4/92,59/19960,0.06779661,14.70891673,7.175925504,0.000158458,0.002440259,0.001645743,CDK5/CDK1/CCNB1/CCNA2,4
CC,GO:0031526,brush border membrane,4/92,60/19960,0.066666667,14.46376812,7.107255649,0.000169182,0.002442558,0.001647294,CA4/ABCG2/SLC28A3/PRKCB,4
CC,GO:0000922,spindle pole,6/92,180/19960,0.033333333,7.231884058,5.715164048,0.000185692,0.002523224,0.001701696,PLK1/CALM1/AURKB/NEK2/CCNB1/AURKA,6
CC,GO:0000775,"chromosome, centromeric region",7/92,262/19960,0.026717557,5.796548291,5.318077077,0.000210043,0.002695548,0.001817914,PLK1/AURKB/NEK2/CCNB1/TOP2A/DNMT1/AURKA,7
CC,GO:0061695,"transferase complex, transferring phosphorus-containing groups",7/92,302/19960,0.023178808,5.02879355,4.800594756,0.000494823,0.006016004,0.004057273,PIK3R1/DAPK1/CDK5/CDK1/CCNB1/PRKCZ/CCNA2,7
CC,GO:0000794,condensed nuclear chromosome,4/92,81/19960,0.049382716,10.71390231,5.961083444,0.000536226,0.006193414,0.004176921,RAD51/PLK1/NEK2/CHEK1,4
CC,GO:0005788,endoplasmic reticulum lumen,7/92,314/19960,0.022292994,4.836610357,4.662959851,0.000623377,0.006857145,0.00462455,PTGS2/P4HB/BCHE/IL6/F10/IGFBP3/HSP90B1,7
CC,GO:0051233,spindle midzone,3/92,38/19960,0.078947368,17.12814645,6.77167359,0.000711259,0.007468218,0.005036666,PLK1/AURKB/AURKA,3
CC,GO:0097431,mitotic spindle pole,3/92,39/19960,0.076923077,16.68896321,6.673554438,0.00076797,0.007542277,0.005086612,PLK1/AURKB/AURKA,3
CC,GO:0000228,nuclear chromosome,6/92,236/19960,0.025423729,5.515843773,4.74879739,0.000783613,0.007542277,0.005086612,RAD51/PLK1/PARP1/NEK2/TOP2A/CHEK1,6
CC,GO:0001939,female pronucleus,2/92,10/19960,0.2,43.39130435,9.124131939,0.000923197,0.008530336,0.005752972,CCNA2/SLC2A1,2
CC,GO:0034663,endoplasmic reticulum chaperone complex,2/92,11/19960,0.181818182,39.44664032,8.67921405,0.001124968,0.009994911,0.006740701,P4HB/HSP90B1,2
CC,GO:0000776,kinetochore,5/92,173/19960,0.028901734,6.270419703,4.737666684,0.001235955,0.010574278,0.007131434,PLK1/AURKB/NEK2/CCNB1/AURKA,5
CC,GO:0043209,myelin sheath,3/92,48/19960,0.0625,13.55978261,5.928318477,0.00141057,0.011637205,0.007848286,CALM1/CA2/PRKCZ,3
CC,GO:0005903,brush border,4/92,109/19960,0.036697248,7.96170722,4.959341743,0.001625752,0.012382226,0.008350738,CA4/ABCG2/SLC28A3/PRKCB,4
CC,GO:0000779,"condensed chromosome, centromeric region",5/92,185/19960,0.027027027,5.863689777,4.52251183,0.001661684,0.012382226,0.008350738,PLK1/AURKB/NEK2/CCNB1/AURKA,5
CC,GO:0101002,ficolin-1-rich granule,5/92,185/19960,0.027027027,5.863689777,4.52251183,0.001661684,0.012382226,0.008350738,MMP9/EEF1A1/ALOX5/MIF/MGAM,5
CC,GO:0098574,cytoplasmic side of lysosomal membrane,2/92,14/19960,0.142857143,30.99378882,7.639301787,0.001844631,0.013215664,0.00891282,EEF1A2/EEF1A1,2
CC,GO:0005874,microtubule,8/92,489/19960,0.016359918,3.549390949,3.884033507,0.001887952,0.013215664,0.00891282,PLK1/CDK5/CDK1/CALM1/AURKB/NEK2/DNM1/AURKA,8
CC,GO:0005635,nuclear envelope,8/92,498/19960,0.016064257,3.485245329,3.821874577,0.002114651,0.01436719,0.009689424,SLC16A3/PTGS2/PARP1/ALOX5/BCHE/PTGES/PRKCZ/ALOX5AP,8
CC,GO:1904813,ficolin-1-rich granule lumen,4/92,124/19960,0.032258065,6.998597475,4.559526459,0.002601707,0.017171264,0.011580529,MMP9/EEF1A1/ALOX5/MIF,4
CC,GO:0000940,outer kinetochore,2/92,20/19960,0.1,21.69565217,6.301120205,0.003782816,0.024273067,0.016370079,PLK1/CCNB1,2
CC,GO:0005819,spindle,7/92,434/19960,0.016129032,3.499298738,3.582140527,0.003926031,0.024511169,0.016530658,PLK1/CDK1/CALM1/AURKB/NEK2/CCNB1/AURKA,7
CC,GO:0044305,calyx of Held,2/92,21/19960,0.095238095,20.66252588,6.134561081,0.004168515,0.025340181,0.017089755,CALM1/PRKCB,2
CC,GO:0097038,perinuclear endoplasmic reticulum,2/92,22/19960,0.090909091,19.72332016,5.979152567,0.004571671,0.027078357,0.018262004,PIK3R1/NOX4,2
CC,GO:0005657,replication fork,3/92,75/19960,0.04,8.67826087,4.533325721,0.005035717,0.029081266,0.019612793,PARP1/DNMT1/CHEK1,3
CC,GO:0099523,presynaptic cytosol,2/92,24/19960,0.083333333,18.07971014,5.697093296,0.005429692,0.030591681,0.020631437,CALM1/PRKCB,2
CC,GO:0030864,cortical actin cytoskeleton,3/92,80/19960,0.0375,8.135869565,4.351810078,0.006026779,0.033147284,0.02235497,EEF1A1/PRKCB/SLC2A1,3
CC,GO:0031253,cell projection membrane,6/92,358/19960,0.016759777,3.636142822,3.424888869,0.006250073,0.033575973,0.022644083,EEF1A1/CA9/CA4/ABCG2/SLC28A3/PRKCB,6
CC,GO:0005901,caveola,3/92,82/19960,0.036585366,7.937433722,4.283567918,0.006453506,0.033880906,0.022849734,PTGS2/KCNA5/SLC2A1,3
CC,GO:0016323,basolateral plasma membrane,5/92,264/19960,0.018939394,4.109025033,3.4603768,0.007532509,0.038666878,0.026077457,SLC16A3/CA9/CA12/AURKA/SLC2A1,5
CC,GO:0098862,cluster of actin-based cell projections,4/92,173/19960,0.023121387,5.016335763,3.610350068,0.008430663,0.042336591,0.028552361,CA4/ABCG2/SLC28A3/PRKCB,4
MF,GO:0004674,protein serine/threonine kinase activity,13/92,429/18737,0.03030303,6.171607378,7.611756719,1.72E-07,5.03E-05,3.52E-05,PLK1/DAPK1/CDK5/CDK1/AURKB/NEK2/PRKCZ/PRKCH/PRKCE/PRKCB/CHEK1/AURKA/MYLK,13
MF,GO:0106310,protein serine kinase activity,12/92,363/18737,0.033057851,6.732662594,7.747453826,2.10E-07,5.03E-05,3.52E-05,PLK1/DAPK1/CDK5/CDK1/AURKB/NEK2/PRKCZ/PRKCH/PRKCE/PRKCB/CHEK1/AURKA,12
MF,GO:0004089,carbonate dehydratase activity,4/92,15/18737,0.266666667,54.31014493,14.50876782,7.13E-07,0.000113144,7.92E-05,CA9/CA4/CA2/CA12,4
MF,GO:0004697,diacylglycerol-dependent serine/threonine kinase activity,4/92,16/18737,0.25,50.91576087,14.03086105,9.47E-07,0.000113144,7.92E-05,PRKCZ/PRKCH/PRKCE/PRKCB,4
MF,GO:0016836,hydro-lyase activity,5/92,61/18737,0.081967213,16.69369209,8.623811816,1.22E-05,0.001170715,0.000819835,CYP1B1/CA9/CA4/CA2/CA12,5
MF,GO:0140996,histone H3 kinase activity,3/92,12/18737,0.25,50.91576087,12.14978419,2.44E-05,0.001944464,0.001361681,PRKCB/CHEK1/AURKA,3
MF,GO:0031994,insulin-like growth factor I binding,3/92,13/18737,0.230769231,46.99916388,11.65395821,3.16E-05,0.002158982,0.001511905,IGFBP6/IGFBP3/IGFBP2,3
MF,GO:0016835,carbon-oxygen lyase activity,5/92,79/18737,0.063291139,12.89006604,7.439032,4.33E-05,0.002515394,0.001761496,CYP1B1/CA9/CA4/CA2/CA12,5
MF,GO:0019838,growth factor binding,6/92,132/18737,0.045454545,9.257411067,6.68755231,4.74E-05,0.002515394,0.001761496,KIT/KDR/PDGFRB/IGFBP6/IGFBP3/IGFBP2,6
MF,GO:0005520,insulin-like growth factor binding,3/92,19/18737,0.157894737,32.15732265,9.544613998,0.000104857,0.00501218,0.003509961,IGFBP6/IGFBP3/IGFBP2,3
MF,GO:0004879,nuclear receptor activity,4/92,59/18737,0.06779661,13.80766396,6.921208037,0.000201501,0.00734619,0.005144436,NR4A2/AR/THRB/PPARG,4
MF,GO:0004714,transmembrane receptor protein tyrosine kinase activity,4/92,60/18737,0.066666667,13.57753623,6.854389847,0.000215088,0.00734619,0.005144436,KIT/KDR/AXL/PDGFRB,4
MF,GO:0098531,ligand-activated transcription factor activity,4/92,60/18737,0.066666667,13.57753623,6.854389847,0.000215088,0.00734619,0.005144436,NR4A2/AR/THRB/PPARG,4
MF,GO:0016702,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",3/92,24/18737,0.125,25.45788043,8.421779923,0.00021516,0.00734619,0.005144436,PTGS2/ALOX5/ALOX5AP,3
MF,GO:0016701,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",3/92,25/18737,0.12,24.43956522,8.237787983,0.000243633,0.00751077,0.005259689,PTGS2/ALOX5/ALOX5AP,3
MF,GO:0016853,isomerase activity,6/92,180/18737,0.033333333,6.788768116,5.481755746,0.000260262,0.00751077,0.005259689,P4HB/CFTR/MIF/TOP2A/PTGES/PMM2,6
MF,GO:0035173,histone kinase activity,7/92,256/18737,0.02734375,5.568911345,5.170364237,0.000267119,0.00751077,0.005259689,DAPK1/CDK5/CDK1/NEK2/PRKCB/CHEK1/AURKA,7
MF,GO:0016829,lyase activity,6/92,201/18737,0.029850746,6.079493835,5.085827369,0.000468954,0.012453342,0.008720905,CYP1B1/CA9/CA4/CA2/CA12/ALOX5AP,6
MF,GO:0042910,xenobiotic transmembrane transporter activity,3/92,32/18737,0.09375,19.09341033,7.195611777,0.000512498,0.012893381,0.009029058,ABCG2/ABCB1/SLC2A1,3
MF,GO:0071889,14-3-3 protein binding,3/92,33/18737,0.090909091,18.51482213,7.073699607,0.000561751,0.013425854,0.009401941,CFTR/PRKCZ/PRKCE,3
MF,GO:0019199,transmembrane receptor protein kinase activity,4/92,79/18737,0.050632911,10.31205283,5.826095395,0.000617315,0.014051263,0.009839907,KIT/KDR/AXL/PDGFRB,4
MF,GO:0019903,protein phosphatase binding,5/92,144/18737,0.034722222,7.071633454,5.137634627,0.000719236,0.015627045,0.010943405,PIK3R1/NEK2/PTPN1/STAT1/HSP90B1,5
MF,GO:0016209,antioxidant activity,4/92,86/18737,0.046511628,9.472699697,5.531859446,0.000849994,0.016929038,0.011855173,PTGS2/NQO1/PTGES/ALOX5AP,4
MF,GO:0050660,flavin adenine dinucleotide binding,4/92,86/18737,0.046511628,9.472699697,5.531859446,0.000849994,0.016929038,0.011855173,XDH/NOX4/MAOB/MAOA,4
MF,GO:0072341,modified amino acid binding,4/92,88/18737,0.045454545,9.257411067,5.453918267,0.00092645,0.017713727,0.01240468,NOX4/AXL/PTGES/TYMS,4
MF,GO:0016620,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",3/92,41/18737,0.073170732,14.90217391,6.259670231,0.001066863,0.019544508,0.013686751,ALDH2/AKR1B10/ALDH1A2,3
MF,GO:0051213,dioxygenase activity,4/92,93/18737,0.043010753,8.759700795,5.269483652,0.001138586,0.019544508,0.013686751,PTGS2/P4HB/ALOX5/ALOX5AP,4
MF,GO:0042056,chemoattractant activity,3/92,42/18737,0.071428571,14.54736025,6.174015974,0.001144867,0.019544508,0.013686751,PGF/MIF/FGF2,3
MF,GO:0004523,RNA-DNA hybrid ribonuclease activity,2/92,11/18737,0.181818182,37.02964427,8.396242357,0.00127437,0.021005126,0.014709602,FEN1/APEX1,2
MF,GO:0001223,transcription coactivator binding,3/92,45/18737,0.066666667,13.57753623,5.933693459,0.001400175,0.022309449,0.015623001,AR/THRB/STAT1,3
MF,GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",3/92,47/18737,0.063829787,12.99976873,5.785865226,0.001588704,0.024496785,0.017154763,ALDH2/AKR1B10/ALDH1A2,3
MF,GO:0140359,ABC-type transporter activity,3/92,48/18737,0.0625,12.72894022,5.71528008,0.001688633,0.02522395,0.017663986,CFTR/ABCG2/ABCB1,3
MF,GO:0043560,insulin receptor substrate binding,2/92,13/18737,0.153846154,31.33277592,7.684854963,0.00179577,0.025964502,0.018182584,PIK3R1/PRKCZ,2
MF,GO:0004252,serine-type endopeptidase activity,5/92,178/18737,0.028089888,5.720872008,4.445351429,0.001846847,0.025964502,0.018182584,MMP9/MMP13/MMP12/F10/PLAU,5
MF,GO:0008559,ABC-type xenobiotic transporter activity,2/92,14/18737,0.142857143,29.0947205,7.386729128,0.002088382,0.02699492,0.018904172,ABCG2/ABCB1,2
MF,GO:0016888,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters",2/92,14/18737,0.142857143,29.0947205,7.386729128,0.002088382,0.02699492,0.018904172,FEN1/APEX1,2
MF,GO:0016860,intramolecular oxidoreductase activity,3/92,53/18737,0.056603774,11.5280968,5.391430778,0.002247037,0.02699492,0.018904172,P4HB/MIF/PTGES,3
MF,GO:0019207,kinase regulator activity,6/92,273/18737,0.021978022,4.476110846,4.064088936,0.00226778,0.02699492,0.018904172,PIK3R1/CALM1/CCNB1/PRKCH/CCNA2/SNCA,6
MF,GO:0050661,NADP binding,3/92,54/18737,0.055555556,11.31461353,5.331847163,0.002370824,0.02699492,0.018904172,HSD17B1/QDPR/HSD11B1,3
MF,GO:0051287,NAD binding,3/92,54/18737,0.055555556,11.31461353,5.331847163,0.002370824,0.02699492,0.018904172,PARP1/ALDH2/QDPR,3
MF,GO:0005126,cytokine receptor binding,6/92,277/18737,0.02166065,4.411473866,4.018067642,0.00243831,0.02699492,0.018904172,PIK3R1/PGF/CXCL12/MIF/IL6/STAT1,6
MF,GO:0019902,phosphatase binding,5/92,191/18737,0.02617801,5.331493285,4.226495005,0.002509507,0.02699492,0.018904172,PIK3R1/NEK2/PTPN1/STAT1/HSP90B1,5
MF,GO:0009055,electron transfer activity,4/92,116/18737,0.034482759,7.022863568,4.570689072,0.002563281,0.02699492,0.018904172,NOX4/MAOB/ALDH2/QDPR,4
MF,GO:0001221,transcription coregulator binding,4/92,117/18737,0.034188034,6.962839093,4.544722196,0.002644179,0.02699492,0.018904172,AR/THRB/STAT1/PPARG,4
MF,GO:0004029,aldehyde dehydrogenase (NAD+) activity,2/92,16/18737,0.125,25.45788043,6.874885128,0.00273638,0.02699492,0.018904172,ALDH2/ALDH1A2,2
MF,GO:0015562,efflux transmembrane transporter activity,2/92,16/18737,0.125,25.45788043,6.874885128,0.00273638,0.02699492,0.018904172,ABCG2/ABCB1,2
MF,GO:0016641,"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor",2/92,16/18737,0.125,25.45788043,6.874885128,0.00273638,0.02699492,0.018904172,MAOB/MAOA,2
MF,GO:0008236,serine-type peptidase activity,5/92,195/18737,0.025641026,5.22212932,4.163146628,0.002744278,0.02699492,0.018904172,MMP9/MMP13/MMP12/F10/PLAU,5
MF,GO:0004601,peroxidase activity,3/92,57/18737,0.052631579,10.71910755,5.162101488,0.002767262,0.02699492,0.018904172,PTGS2/PTGES/ALOX5AP,3
MF,GO:0017171,serine hydrolase activity,5/92,199/18737,0.025125628,5.117161896,4.101514042,0.002994587,0.027364166,0.01916275,MMP9/MMP13/MMP12/F10/PLAU,5
MF,GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",3/92,59/18737,0.050847458,10.35574797,5.055807074,0.003052906,0.027364166,0.01916275,PTGS2/PTGES/ALOX5AP,3
MF,GO:0004030,aldehyde dehydrogenase [NAD(P)+] activity,2/92,17/18737,0.117647059,23.96035806,6.652752297,0.003091349,0.027364166,0.01916275,ALDH2/ALDH1A2,2
MF,GO:0036041,long-chain fatty acid binding,2/92,17/18737,0.117647059,23.96035806,6.652752297,0.003091349,0.027364166,0.01916275,PPARG/ALOX5AP,2
MF,GO:0046965,nuclear retinoid X receptor binding,2/92,17/18737,0.117647059,23.96035806,6.652752297,0.003091349,0.027364166,0.01916275,NR4A2/PPARG,2
MF,GO:0003746,translation elongation factor activity,2/92,18/18737,0.111111111,22.62922705,6.448921474,0.003466691,0.029590684,0.02072195,EEF1A2/EEF1A1,2
MF,GO:0072542,protein phosphatase activator activity,2/92,18/18737,0.111111111,22.62922705,6.448921474,0.003466691,0.029590684,0.02072195,CALM1/IGFBP3,2
MF,GO:0046624,sphingolipid transporter activity,2/92,19/18737,0.105263158,21.4382151,6.260963952,0.003862201,0.032388281,0.022681069,ABCG2/ABCB1,2
MF,GO:0031072,heat shock protein binding,4/92,131/18737,0.030534351,6.218718885,4.210408189,0.003967359,0.032696512,0.022896919,KDR/CDK5/CDK1/SNCA,4
MF,GO:0016638,"oxidoreductase activity, acting on the CH-NH2 group of donors",2/92,20/18737,0.1,20.36630435,6.086880688,0.004277676,0.034656427,0.02426942,MAOB/MAOA,2
MF,GO:0016922,nuclear receptor binding,4/92,137/18737,0.02919708,5.946366233,4.08170148,0.004650836,0.035640597,0.024958621,PARP1/NR4A2/PRKCB/PPARG,4
MF,GO:0019211,phosphatase activator activity,2/92,21/18737,0.095238095,19.39648033,5.925009189,0.004712916,0.035640597,0.024958621,CALM1/IGFBP3,2
MF,GO:0005518,collagen binding,3/92,69/18737,0.043478261,8.854914934,4.5916449,0.004749853,0.035640597,0.024958621,MMP9/MMP13/MMP12,3
MF,GO:0004713,protein tyrosine kinase activity,4/92,138/18737,0.028985507,5.903276623,4.06099355,0.004771963,0.035640597,0.024958621,KIT/KDR/AXL/PDGFRB,4
MF,GO:0070851,growth factor receptor binding,4/92,138/18737,0.028985507,5.903276623,4.06099355,0.004771963,0.035640597,0.024958621,PGF/IL6/FGF2/PDGFRB,4
MF,GO:0008028,monocarboxylic acid transmembrane transporter activity,3/92,73/18737,0.04109589,8.369714116,4.431603197,0.005559628,0.040112415,0.028090174,SLC16A3/ABCG2/SLC2A1,3
MF,GO:0004602,glutathione peroxidase activity,2/92,23/18737,0.086956522,17.70982987,5.632533615,0.005641889,0.040112415,0.028090174,PTGES/ALOX5AP,2
MF,GO:0005158,insulin receptor binding,2/92,23/18737,0.086956522,17.70982987,5.632533615,0.005641889,0.040112415,0.028090174,PIK3R1/PTPN1,2
MF,GO:0003684,damaged DNA binding,3/92,74/18737,0.040540541,8.256609871,4.393494284,0.005774191,0.040112415,0.028090174,PARP1/FEN1/APEX1,3
MF,GO:0140993,histone modifying activity,7/92,438/18737,0.015981735,3.254888823,3.354282754,0.005790286,0.040112415,0.028090174,DAPK1/CDK5/CDK1/NEK2/PRKCB/CHEK1/AURKA,7
MF,GO:0016895,"DNA exonuclease activity, producing 5'-phosphomonoesters",2/92,25/18737,0.08,16.29304348,5.374709327,0.006647541,0.044152974,0.030919722,FEN1/APEX1,2
MF,GO:0042974,nuclear retinoic acid receptor binding,2/92,25/18737,0.08,16.29304348,5.374709327,0.006647541,0.044152974,0.030919722,NR4A2/PPARG,2
MF,GO:0005506,iron ion binding,4/92,153/18737,0.026143791,5.324524013,3.772815682,0.006850632,0.044152974,0.030919722,XDH/CYP1B1/ALOX5/SNCA,4
MF,GO:0033293,monocarboxylic acid binding,3/92,79/18737,0.037974684,7.734039626,4.21315879,0.0069212,0.044152974,0.030919722,PLA2G1B/PPARG/ALOX5AP,3
MF,GO:0019887,protein kinase regulator activity,5/92,243/18737,0.020576132,4.190597602,3.51650228,0.006938267,0.044152974,0.030919722,CALM1/CCNB1/PRKCH/CCNA2/SNCA,5
MF,GO:0004529,DNA exonuclease activity,2/92,26/18737,0.076923077,15.66638796,5.256691644,0.007178633,0.044152974,0.030919722,FEN1/APEX1,2
MF,GO:0043548,phosphatidylinositol 3-kinase binding,2/92,26/18737,0.076923077,15.66638796,5.256691644,0.007178633,0.044152974,0.030919722,PIK3R1/AXL,2
MF,GO:0070412,R-SMAD binding,2/92,26/18737,0.076923077,15.66638796,5.256691644,0.007178633,0.044152974,0.030919722,PARP1/PPARG,2
MF,GO:0044024,histone H2AS1 kinase activity,5/92,246/18737,0.020325203,4.139492754,3.481753316,0.007297249,0.044152974,0.030919722,DAPK1/CDK5/NEK2/CHEK1/AURKA,5
MF,GO:0140995,histone H2A kinase activity,5/92,246/18737,0.020325203,4.139492754,3.481753316,0.007297249,0.044152974,0.030919722,DAPK1/CDK5/NEK2/CHEK1/AURKA,5
MF,GO:0140097,"catalytic activity, acting on DNA",5/92,249/18737,0.020080321,4.089619347,3.447552131,0.00766903,0.045606584,0.031937665,RAD51/FEN1/TOP2A/APEX1/DNMT1,5
MF,GO:0004364,glutathione transferase activity,2/92,27/18737,0.074074074,15.08615137,5.145036949,0.007728312,0.045606584,0.031937665,PTGES/ALOX5AP,2
MF,GO:0099106,ion channel regulator activity,4/92,159/18737,0.025157233,5.123598578,3.667977161,0.007826743,0.045624185,0.031949991,CFTR/CALM1/PRKCZ/PRKCB,4
MF,GO:0005178,integrin binding,4/92,161/18737,0.02484472,5.059951391,3.634200045,0.008171396,0.046941855,0.032872737,P4HB/KDR/CXCL12/FGF2,4
MF,GO:0051393,alpha-actinin binding,2/92,28/18737,0.071428571,14.54736025,5.039176459,0.008296387,0.046941855,0.032872737,KCNA5/PPARG,2
MF,GO:0008083,growth factor activity,4/92,162/18737,0.024691358,5.028717123,3.617520735,0.008347401,0.046941855,0.032872737,PGF/CXCL12/IL6/FGF2,4
MF,GO:0004693,cyclin-dependent protein serine/threonine kinase activity,2/92,29/18737,0.068965517,14.04572714,4.938610411,0.008882668,0.048665366,0.034079688,CDK5/CDK1,2
MF,GO:0097472,cyclin-dependent protein kinase activity,2/92,29/18737,0.068965517,14.04572714,4.938610411,0.008882668,0.048665366,0.034079688,CDK5/CDK1,2
MF,GO:0046982,protein heterodimerization activity,6/92,363/18737,0.016528926,3.366331297,3.197997817,0.008959314,0.048665366,0.034079688,PIK3R1/P4HB/NR4A2/MCL1/TOP2A/AURKA,6
MF,GO:0016247,channel regulator activity,4/92,167/18737,0.023952096,4.87815673,3.536134691,0.00926477,0.049290976,0.034517794,CFTR/CALM1/PRKCZ/PRKCB,4
MF,GO:0001968,fibronectin binding,2/92,30/18737,0.066666667,13.57753623,4.842897642,0.009486966,0.049290976,0.034517794,IGFBP6/IGFBP3,2
MF,GO:0033764,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",2/92,30/18737,0.066666667,13.57753623,4.842897642,0.009486966,0.049290976,0.034517794,HSD17B1/HSD11B1,2
MF,GO:0051721,protein phosphatase 2A binding,2/92,30/18737,0.066666667,13.57753623,4.842897642,0.009486966,0.049290976,0.034517794,PTPN1/STAT1,2
MF,GO:0141108,transporter regulator activity,4/92,169/18737,0.023668639,4.820427065,3.504482215,0.009649394,0.049595809,0.034731265,CFTR/CALM1/PRKCZ/PRKCB,4
